|
Delaware
(State or other jurisdiction of incorporation or organization) |
| |
6770
(Primary Standard Industrial Classification Code Number) |
| |
85-1972187
(I.R.S. Employer Identification No.) |
|
|
Matthew R. Pacey, P.C.
Bryan D. Flannery Kirkland & Ellis LLP 609 Main Street Houston, TX 77002 Tel: (713) 836-3600 |
| |
John T. Gaffney
Evan M. D’Amico Gibson, Dunn & Crutcher LLP 200 Park Avenue New York, NY 10166 Tel: (212) 351-4000 |
|
| Large accelerated filer ☐ | | | Accelerated filer ☐ | |
| Non-accelerated filer ☒ | | | Smaller reporting company ☒ | |
| | | | Emerging growth company ☒ | |
| Sincerely, | | | | |
|
/s/ Eric Scheyer
Eric Scheyer
Chief Executive Officer |
| | | |
| | | | | iii | | | |
| | | | | v | | | |
| | | | | 1 | | | |
| | | | | 14 | | | |
| | | | | 15 | | | |
| | | | | 17 | | | |
| | | | | 19 | | | |
| | | | | 21 | | | |
| | | | | 22 | | | |
| | | | | 25 | | | |
| | | | | 64 | | | |
| | | | | 74 | | | |
| | | | | 75 | | | |
| | | | | 81 | | | |
| | | | | 81 | | | |
| | | | | 81 | | | |
| | | | | 81 | | | |
| | | | | 81 | | | |
| | | | | 82 | | | |
| | | | | 82 | | | |
| | | | | 84 | | | |
| | | | | 85 | | | |
| | | | | 85 | | | |
| | | | | 85 | | | |
| | | | | 86 | | | |
| | | | | 86 | | | |
| | | | | 87 | | | |
| | | | | 89 | | | |
| | | | | 91 | | | |
| | | | | 96 | | | |
| | | | | 111 | | | |
| | | | | 123 | | | |
| | | | | 124 | | | |
| | | | | 144 | | | |
| | | | | 147 | | | |
| | | | | 154 | | | |
| | | | | 154 | | |
| | | | | 154 | | | |
| | | | | 155 | | | |
| | | | | 159 | | | |
| | | | | 163 | | | |
| | | | | 166 | | | |
| | | | | 168 | | | |
| | | | | 171 | | | |
| | | | | 172 | | | |
| | | | | 173 | | | |
| | | | | 174 | | | |
| | | | | 175 | | | |
| | | | | 176 | | | |
| | | | | 192 | | | |
| | | | | 192 | | | |
| | | | | 192 | | | |
| | | | | 192 | | | |
| | | | | 193 | | | |
| | | | | 193 | | | |
| | | | | 193 | | | |
| | | | | 194 | | | |
| | | | | 194 | | | |
| | | | | 199 | | | |
| | | | | 200 | | | |
| | | | | 207 | | | |
| | | | | 208 | | | |
| | | | | 213 | | | |
| | | | | 213 | | | |
| | | | | 213 | | | |
| | | | | 227 | | | |
| | | | | 234 | | | |
| | | | | 234 | | | |
| | | | | 237 | | | |
| | | | | 238 | | | |
| | | | | 239 | | | |
| | | | | 239 | | | |
| | | | | 240 | | |
| | |
Share Ownership in
New Stem(1) |
| | | | | | | | | | | | | |||||||||
| | |
No
Redemptions(2) |
| |
Maximum Possible
Redemption(3) |
| ||||||||||||||||||
| | |
Number of
Shares |
| |
Percentage of
Outstanding Shares |
| |
Number of
Shares |
| |
Percentage of
Outstanding Shares |
| ||||||||||||
| | |
(in millions)
|
| | | | | | | |
(in millions)
|
| | | | | | | ||||||
Former equityholders of Stem
|
| | | | 65.0(4) | | | | | | 48.0% | | | | | | 65.0(4) | | | | | | 66.9% | | |
STPK’s public stockholders
|
| | | | 38.4 | | | | | | 28.3% | | | | | | — | | | | | | — | | |
STPK Founder Shares
|
| | | | 9.6 | | | | | | 7.1% | | | | | | 9.6 | | | | | | 9.9% | | |
PIPE Investors
|
| | | | 22.5 | | | | | | 16.6% | | | | | | 22.5 | | | | | | 23.2% | | |
| | |
For the
period from October 29, 2018 (inception) through December 31, 2018 |
| |
For the
Year Ended December 31, 2019 |
| |
For the Nine
Months Ended September 30, 2019 |
| |
For the Nine
Months Ended September 30, 2020 |
| ||||||||||||
Statements of Operations Data: | | | | | | | | | | | | | | | | | | | | | | | | | |
Net loss
|
| | | $ | (8,144) | | | | | $ | (10,406) | | | | | $ | (9,956) | | | | | $ | (376,602) | | |
Weighted average shares outstanding of Class A Common Stock
|
| | | | — | | | | | | — | | | | | | — | | | | | | 37,878,718 | | |
Weighted average shares outstanding of Class B Common Stock(1)
|
| | | | 9,589,626 | | | | | | 9,589,626 | | | | | | 9,589,626 | | | | | | 9,589,626 | | |
Basic and diluted net loss per share, Class A
|
| | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 0.00 | | |
Basic and diluted net loss per share, Class B
|
| | | $ | (0.04) | | | | | $ | (0.00) | | | | | $ | (0.00) | | | | | $ | (0.04) | | |
Cash Flow Data: | | | | | | | | | | | | | | | | | | | | | | | | | |
Net cash used in operating activities
|
| | | | (2,578) | | | | | | (10,344) | | | | | | (10,344) | | | | | | (934,736) | | |
Net cash provided by (used in) investing activities
|
| | | | — | | | | | | — | | | | | | — | | | | | | (383,585,040) | | |
Net cash provided by (used by) financing activities
|
| | | | 162,250 | | | | | | (149,328) | | | | | | (149,328) | | | | | | 386,360,290 | | |
| | |
December 31,
2018 |
| |
December 31,
2019 |
| |
September 30,
2019 |
| |
September 30,
2020 |
| ||||||||||||
Balance Sheets Data (end of period): | | | | | | | | | | | | | | | | | | | | | | | | | |
Total current assets
|
| | | $ | 159,672 | | | | | $ | 1,594 | | | | | $ | — | | | | | $ | 2,575,989 | | |
Investments held in Trust Account
|
| | | | — | | | | | | — | | | | | | — | | | | | | 383,603,554 | | |
Deferred Offering Costs
|
| | | | 322,078 | | | | | | 251,424 | | | | | | — | | | | | | — | | |
Total assets
|
| | | | 481,750 | | | | | | 253,018 | | | | | | 251,424 | | | | | | 386,179,543 | | |
Total liabilities
|
| | | | 464,894 | | | | | | 246,568 | | | | | | 244,524 | | | | | | 14,345,414 | | |
Temporary Equity: | | | | | | ||||||||||||||||||||
Class A Common Stock, subject to possible redemption
|
| | | | — | | | | | | — | | | | | | — | | | | | | 366,834,120 | | |
Stockholders’ Equity: | | | | | | | | | | | | | | | | | | | | | | | | | |
Class A Common Stock
|
| | | | — | | | | | | — | | | | | | — | | | | | | 168 | | |
Class B Common Stock
|
| | | | 1,006 | | | | | | 1,006 | | | | | | 1,006 | | | | | | 959 | | |
Total stockholders’ equity
|
| | | | 16,856 | | | | | | 6,450 | | | | | | 6,900 | | | | | | 5,000,009 | | |
| | |
Years Ended
December 31, |
| |
Nine Months Ended
September 30, |
| ||||||||||||||||||
| | |
2019
|
| |
2018
|
| |
2020
|
| |
2019
|
| ||||||||||||
| | |
(in thousands, except share and per share data)
|
| |||||||||||||||||||||
Consolidated Statement of Operations Data: | | | | | | | | | | | | | | | | | | | | | | | | | |
Total revenue
|
| | | $ | 17,552 | | | | | $ | 7,032 | | | | | $ | 17,661 | | | | | $ | 10,429 | | |
Total costs and expenses
|
| | | | (65,402) | | | | | | (49,448) | | | | | | (54,323) | | | | | | (47,465) | | |
Loss from operations
|
| | | | (47,850) | | | | | | (42,416) | | | | | | (36,662) | | | | | | (37,036) | | |
Other (income) expense, net:
|
| | | | | | | | | | | | | | | | | | | | | | | | |
Interest expense
|
| | | | (12,548) | | | | | | (5,533) | | | | | | (13,826) | | | | | | (8,658) | | |
Change in fair value of warrants and embedded derivative
|
| | | | 1,493 | | | | | | (253) | | | | | | (3,005) | | | | | | 852 | | |
Other expenses, net
|
| | | | (503) | | | | | | (832) | | | | | | (1,602) | | | | | | (204) | | |
Loss before income taxes
|
| | | | (59,408) | | | | | | (49,034) | | | | | | (55,095) | | | | | | (45,046) | | |
Income tax expense
|
| | | | (6) | | | | | | (13) | | | | | | (142) | | | | | | (2) | | |
Net loss
|
| | | $ | (59,414) | | | | | $ | (49,047) | | | | | $ | (55,237) | | | | | $ | (45,048) | | |
Less: Deemed dividend to preferred stockholders
|
| | | | (5,353) | | | | | | — | | | | | | (9,484) | | | | | | (5,353) | | |
Net loss attributable to common stockholders
|
| | | $ | (64,767) | | | | | $ | (49,047) | | | | | $ | (64,721) | | | | | $ | (50,401) | | |
Net loss per share
|
| | | $ | (6.05) | | | | | $ | (5.74) | | | | | $ | (7.07) | | | | | $ | (4.65) | | |
|
| | |
December 31,
|
| |
September 30,
2020 |
| ||||||||||||
| | |
2019
|
| |
2018
|
| ||||||||||||
| | |
(in thousands)
|
| |||||||||||||||
Consolidated Balance Sheet Data: | | | | | |||||||||||||||
Cash and cash equivalents
|
| | | $ | 12,889 | | | | | $ | 21,894 | | | | | $ | 7,943 | | |
Working capital (deficit)(1)
|
| | | | (80,550) | | | | | | (43,452) | | | | | | (125,066) | | |
Total assets
|
| | | | 188,047 | | | | | | 155,594 | | | | | | 200,189 | | |
Notes payable, current portion
|
| | | | 28,895 | | | | | | 48,502 | | | | | | 33,849 | | |
Financing obligation, current portion
|
| | | | 6,373 | | | | | | 7,763 | | | | | | 13,471 | | |
Convertible promissory notes
|
| | | | 34,925 | | | | | | — | | | | | | 49,895 | | |
Deferred revenue, current
|
| | | | 10,948 | | | | | | 2,919 | | | | | | 38,878 | | |
Deferred revenue, noncurrent
|
| | | | 9,780 | | | | | | 8,940 | | | | | | 14,100 | | |
Financing obligation
|
| | | | 74,640 | | | | | | 46,772 | | | | | | 75,268 | | |
Convertible preferred stock
|
| | | | 231,129 | | | | | | 218,931 | | | | | | 220,524 | | |
Accumulated deficit
|
| | | | (259,054) | | | | | | (210,596) | | | | | | (306,954) | | |
| | |
Stem
|
| |
STPK
|
| |
Pro Forma
Combined (Assuming No Redemption) |
| |
Pro Forma
Combined (Assuming Maximum Redemption) |
| ||||||||||||
| | |
(in thousands, except share and per share data)
|
| |||||||||||||||||||||
Statement of Operations Data – Nine Months Ended September 30, 2020:
|
| | | | | | | | | | | | | | | | | | | | | | | | |
Revenue
|
| | | $ | 17,661 | | | | | $ | — | | | | | $ | 17,661 | | | | | $ | 17,661 | | |
Cost of revenue
|
| | | | 22,522 | | | | | | — | | | | | | 22,522 | | | | | | 22,522 | | |
Operating expenses
|
| | | | 31,801 | | | | | | 395 | | | | | | 32,196 | | | | | | 32,196 | | |
Operating loss
|
| | | | (36,662) | | | | | | (395) | | | | | | (37,057) | | | | | | (37,057) | | |
Net loss
|
| | | | (55,237) | | | | | | (376) | | | | | | (40,606) | | | | | | (40,606) | | |
Balance Sheet Data – As of September 30, 2020: | | | | | | | | | | | | | | | | | | | | | | | | | |
Total current assets
|
| | | $ | 44,189 | | | | | $ | 2,576 | | | | | $ | 601,615 | | | | | $ | 218,030 | | |
Total assets
|
| | | | 200,189 | | | | | | 386,180 | | | | | | 757,819 | | | | | | 374,030 | | |
Total current liabilities
|
| | | | 169,255 | | | | | | 716 | | | | | | 120,076 | | | | | | 120,076 | | |
Total liabilities
|
| | | | 281,642 | | | | | | 14,346 | | | | | | 220,281 | | | | | | 220,281 | | |
Convertible preferred stock
|
| | | | 220,524 | | | | | | — | | | | | | — | | | | | | — | | |
Common stock subject to redemption
|
| | | | — | | | | | | 366,834 | | | | | | — | | | | | | — | | |
Total stockholders’ (deficit) equity
|
| | | | (301,977) | | | | | | 5,000 | | | | | | 537,334 | | | | | | 153,749 | | |
Statement of Operations Data – Year Ended December 31, 2019:
|
| | | | | | | | | | | | | | | | | | | | | | | | |
Revenue
|
| | | $ | 17,552 | | | | | $ | — | | | | | $ | 17,552 | | | | | $ | 17,552 | | |
Cost of revenue
|
| | | | 20,812 | | | | | | — | | | | | | 20,812 | | | | | | 20,812 | | |
Operating expenses
|
| | | | 44,590 | | | | | | 11 | | | | | | 44,601 | | | | | | 44,601 | | |
Operating loss
|
| | | | (47,850) | | | | | | (11) | | | | | | (47,861) | | | | | | (47,861) | | |
Net loss
|
| | | | (59,414) | | | | | | (11) | | | | | | (53,228) | | | | | | (53,228) | | |
| | |
Stem
(Historical) |
| |
STPK
(Historical) |
| |
Pro Forma
Combined (Assuming No Redemption) |
| |
Pro Forma
Combined (Assuming Maximum Redemption) |
| |
Stem
Equivalent Pro Forma Combined (Assuming No Redemption) |
| |
Stem
Equivalent Pro Forma Combined (Assuming Maximum Redemption)(2) |
| ||||||||||||||||||
| | |
(in thousands, except share and per share amounts)
|
| |||||||||||||||||||||||||||||||||
Nine Months Ended September 30, 2020
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net loss
|
| | | $ | (55,237) | | | | | $ | (376) | | | | | $ | (40,606) | | | | | $ | (40,606) | | | | | | | | | | | | | | |
Less: Deemed dividend to preferred stockholders
|
| | | | (9,484) | | | | | | — | | | | | | (9,484) | | | | | | (9,484) | | | | | | | | | | | | | | |
Net loss attributable to common stockholders
|
| | | $ | (64,721) | | | | | $ | (376) | | | | | $ | (50,090) | | | | | $ | (50,090) | | | | | | | | | | | | | | |
Total stockholder’s (deficit) equity
|
| | | $ | (301,977) | | | | | $ | 5,000 | | | | | $ | 537,334 | | | | | $ | 128,730 | | | | | | | | | | | | | | |
Weighted-average shares outstanding
used in computing net loss per share, basic and diluted, Class A |
| | | | — | | | | | | 37,878,718 | | | | | | 135,448,130 | | | | | | 97,089,626 | | | | | | 65,000,000 | | | | | | 65,000,000 | | |
Weighted-average shares outstanding
used in computing net loss per share, basic and diluted, Class B(1) |
| | | | — | | | | | | 9,589,626 | | | | | | | | | | | | | | | | | | | | | | | | | | |
Weighted-average shares outstanding
of Stem common stock per share, basic and diluted |
| | | | 9,155,906 | | | | | | — | | | | | | | | | | | | | | | | | | | | | |
| | |
Stem
(Historical) |
| |
STPK
(Historical) |
| |
Pro Forma
Combined (Assuming No Redemption) |
| |
Pro Forma
Combined (Assuming Maximum Redemption) |
| |
Stem
Equivalent Pro Forma Combined (Assuming No Redemption) |
| |
Stem
Equivalent Pro Forma Combined (Assuming Maximum Redemption)(2) |
| ||||||||||||||||||
| | |
(in thousands, except share and per share amounts)
|
| |||||||||||||||||||||||||||||||||
Basic and diluted net loss per share, Class A
|
| | | | — | | | | | $ | — | | | | | $ | (0.37) | | | | | $ | (0.52) | | | | | $ | (1.70) | | | | | $ | (2.39) | | |
Basic and diluted net loss per share, Class B
|
| | | | — | | | | | $ | (0.04) | | | | | | | | | | | | | | | | | | | | | | | | | | |
Basic and diluted net loss per share of Stem common stock
|
| | | $ | (7.07) | | | | | | — | | | | | | | | | | | | | | | | | | | | | | | | | | |
Book Value per share – basic and
diluted(3) |
| | | $ | (32.98) | | | | | $ | 0.13 | | | | | $ | 3.97 | | | | | $ | 1.58 | | | | | $ | 18.27 | | | | | $ | 7.27 | | |
Year Ended December 31, 2019: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net loss
|
| | | $ | (59,414) | | | | | $ | (11) | | | | | $ | (53,228) | | | | | $ | (53,228) | | | | | | | | | | | | | | |
Less: Deemed dividend to preferred stockholders
|
| | | | (5,353) | | | | | | — | | | | | | (5,353) | | | | | | (5,353) | | | | | | | | | | | | | | |
Net loss attributable to common stockholders
|
| | | $ | (64,767) | | | | | $ | (11) | | | | | $ | (58,581) | | | | | $ | (58,581) | | | | | | | | | | | | | | |
Weighted-average shares used in
computing net loss per share, basic and diluted, Class A |
| | | | — | | | | | | 8,750,000 | | | | | | 135,448,130 | | | | | | 97,089,626 | | | | | | 65,000,000 | | | | | | 65,000,000 | | |
Weighted-average shares used in
computing net loss per share, basic and diluted, Class B(1) |
| | | | — | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Weighted-average shares outstanding
of Stem common stock per share, basic and diluted |
| | | | 10,703,380 | | | | | | — | | | | | | | | | | | | | | | | | | | | | | | | | | |
Basic and diluted net loss per share, Class A
|
| | | | — | | | | | $ | (0.00) | | | | | $ | (0.43) | | | | | $ | (0.60) | | | | | $ | (1.98) | | | | | $ | (2.76) | | |
Basic and diluted net loss per share, Class B
|
| | | | — | | | | | $ | (0.00) | | | | | | | | | | | | | | | | | | | | | | | | | | |
Basic and diluted net loss per share of Stem common stock
|
| | | $ | (6.05) | | | | | | — | | | | | | | | | | | | | | | | | | | | | | | | | | |
Book Value per share – basic and diluted(3)
|
| | | $ | (23.89) | | | | | $ | 0.00 | | | | | | |
| | | | | | | | | | | | | | |
Scenario 1
Assuming No Redemptions into Cash |
| |
Scenario 2
Assuming Maximum Redemptions into Cash |
| ||||||||||||||||||||||||||||||
| | |
(A)
Stem (Historical) |
| |
(B)
STPK (Historical) |
| |
Pro Forma
Adjustments |
| | | | | | | |
Pro Forma
Balance Sheet |
| |
Pro Forma
Adjustments |
| | | | | | | |
Pro Forma
Balance Sheet |
| ||||||||||||||||||
ASSETS | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Current assets: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Cash and cash equivalents
|
| | | $ | 7,943 | | | | | $ | 1,841 | | | | | $ | 383,604 | | | | |
|
(1)
|
| | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | 225,000 | | | | |
|
(2)
|
| | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | (53,754) | | | | |
|
(3)
|
| | | | $ | 564,634 | | | | | $ | (383,585) | | | | |
|
(4)
|
| | | | $ | 181,049 | | |
Accounts receivable, net
|
| | | | 12,645 | | | | | | — | | | | | | — | | | | | | | | | | | | 12,645 | | | | | | — | | | | | | | | | | | | 12,645 | | |
Prepaid expenses
|
| | | | — | | | | | | 735 | | | | | | — | | | | | | | | | | | | 735 | | | | | | — | | | | | | | | | | | | 735 | | |
Inventory, net
|
| | | | 21,174 | | | | | | — | | | | | | — | | | | | | | | | | | | 21,174 | | | | | | — | | | | | | | | | | | | 21,174 | | |
Other current assets
|
| | | | 1,589 | | | | | | — | | | | | | — | | | | | | | | | | | | 1,589 | | | | | | — | | | | | | | | | | | | 1,589 | | |
Deferred costs with suppliers
|
| | | | 838 | | | | | | — | | | | | | — | | | | | | | | | | | | 838 | | | | | | — | | | | | | | | | | | | 838 | | |
Total current assets
|
| | | | 44,189 | | | | | | 2,576 | | | | | | 554,850 | | | | | | | | | | | | 601,615 | | | | | | (383,585) | | | | | | | | | | | | 218,030 | | |
Cash and marketable securities – held in
trust |
| | | | — | | | | | | 383,604 | | | | | | (383,604) | | | | |
|
(1)
|
| | | | | — | | | | | | — | | | | | | | | | | | | — | | |
Energy storage systems, net
|
| | | | 126,114 | | | | | | — | | | | | | — | | | | | | | | | | | | 126,114 | | | | | | — | | | | | | | | | | | | 126,114 | | |
Contract origination costs, net
|
| | | | 10,241 | | | | | | — | | | | | | — | | | | | | | | | | | | 10,241 | | | | | | — | | | | | | | | | | | | 10,241 | | |
Goodwill
|
| | | | 1,673 | | | | | | — | | | | | | — | | | | | | | | | | | | 1,673 | | | | | | — | | | | | | | | | | | | 1,673 | | |
Intangible assets, net
|
| | | | 11,583 | | | | | | — | | | | | | — | | | | | | | | | | | | 11,583 | | | | | | — | | | | | | | | | | | | 11,583 | | |
Other noncurrent assets
|
| | | | 6,389 | | | | | | — | | | | | | — | | | | | | | | | | | | 6,389 | | | | | | — | | | | | | | | | | | | 6,389 | | |
Total assets
|
| | | $ | 200,189 | | | | | $ | 386,180 | | | | | $ | 171,246 | | | | | | | | | | | $ | 757,615 | | | | | $ | (383,585) | | | | | | | | | | | $ | 374,030 | | |
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Current liabilities: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Accounts payable
|
| | | $ | 18,738 | | | | | $ | 445 | | | | | $ | — | | | | | | | | | | | $ | 19,183 | | | | | $ | — | | | | | | | | | | | $ | 19,183 | | |
Accrued liabilities
|
| | | | 6,290 | | | | | | 121 | | | | | | — | | | | | | | | | | | | 6,411 | | | | | | — | | | | | | | | | | | | 6,411 | | |
Franchise tax payable
|
| | | | — | | | | | | 150 | | | | | | — | | | | | | | | | | | | 150 | | | | | | — | | | | | | | | | | | | 150 | | |
Accrued payroll
|
| | | | 5,844 | | | | | | — | | | | | | — | | | | | | | | | | | | 5,844 | | | | | | — | | | | | | | | | | | | 5,844 | | |
Notes payable, current portion
|
| | | | 33,849 | | | | | | — | | | | | | — | | | | | | | | | | | | 33,849 | | | | | | — | | | | | | | | | | | | 33,849 | | |
Convertible promissory notes
|
| | | | 49,895 | | | | | | — | | | | | | (49,895) | | | | |
|
(7)
|
| | | | | — | | | | | | — | | | | | | | | | | | | — | | |
Deferred revenue, current financing obligation, current portion
|
| | | | 13,471 | | | | | | — | | | | | | — | | | | | | | | | | | | 13,471 | | | | | | — | | | | | | | | | | | | 13,471 | | |
Deferred revenue
|
| | | | 38,878 | | | | | | — | | | | | | — | | | | | | | | | | | | 38,878 | | | | | | — | | | | | | | | | | | | 38,878 | | |
Other current liabilities
|
| | | | 2,290 | | | | | | — | | | | | | — | | | | | | | | | | | | 2,290 | | | | | | — | | | | | | | | | | | | 2,290 | | |
Total current liabilities
|
| | | | 169,255 | | | | | | 716 | | | | | | (49,895) | | | | | | | | | | | | 120,076 | | | | | | — | | | | | | | | | | | | 120,076 | | |
Deferred revenue, noncurrent
|
| | | | 14,100 | | | | | | — | | | | | | — | | | | | | | | | | | | 14,100 | | | | | | — | | | | | | | | | | | | 14,100 | | |
Asset retirement obligation
|
| | | | 6,474 | | | | | | — | | | | | | — | | | | | | | | | | | | 6,474 | | | | | | — | | | | | | | | | | | | 6,474 | | |
Notes payable, noncurrent
|
| | | | 4,290 | | | | | | — | | | | | | — | | | | | | | | | | | | 4,290 | | | | | | — | | | | | | | | | | | | 4,290 | | |
Financing obligation, noncurrent
|
| | | | 75,268 | | | | | | — | | | | | | — | | | | | | | | | | | | 75,268 | | | | | | — | | | | | | | | | | | | 75,268 | | |
Warrant liabilities
|
| | | | 12,182 | | | | | | — | | | | | | (12,182) | | | | |
|
(8)
|
| | | | | — | | | | | | — | | | | | | | | | | | | — | | |
Lease liability, noncurrent
|
| | | | 73 | | | | | | — | | | | | | — | | | | | | | | | | | | 73 | | | | | | — | | | | | | | | | | | | 73 | | |
Deferred legal fees
|
| | | | — | | | | | | 204 | | | | | | (204) | | | | |
|
(3)
|
| | | | | — | | | | | | — | | | | | | | | | | | | — | | |
Deferred underwriting commissions in connection with the initial public offering
|
| | | | — | | | | | | 13,426 | | | | | | (13,426) | | | | |
|
(3)
|
| | | | | — | | | | | | — | | | | | | | | | | | | — | | |
Total liabilities
|
| | | | 281,642 | | | | | | 14,346 | | | | | | (75,707) | | | | | | | | | | | | 220,281 | | | | | | — | | | | | | | | | | | | 220,281 | | |
Commitments and contingencies | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Convertible preferred stock(10)
|
| | | | 220,524 | | | | | | — | | | | | | (220,524) | | | | |
|
(9)
|
| | | | | — | | | | | | — | | | | | | | | | | | | — | | |
Common stock subject to redemption(10)
|
| | | | — | | | | | | 366,834 | | | | | | (366,834) | | | | |
|
(4)
|
| | | | | — | | | | | | — | | | | | | | | | | | | — | | |
| | | | | 220,524 | | | | | | 366,834 | | | | | | (587,358) | | | | | | | | | | | | — | | | | | | — | | | | | | | | | | | | — | | |
| | | | | | | | | | | | | | |
Scenario 1
Assuming No Redemptions into Cash |
| |
Scenario 2
Assuming Maximum Redemptions into Cash |
| ||||||||||||||||||||||||||||||
| | |
(A)
Stem (Historical) |
| |
(B)
STPK (Historical) |
| |
Pro Forma
Adjustments |
| | | | | | | |
Pro Forma
Balance Sheet |
| |
Pro Forma
Adjustments |
| | | | | | | |
Pro Forma
Balance Sheet |
| ||||||||||||||||||
Stockholders’ equity (deficit): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Common stock(10)
|
| | | | — | | | | | | — | | | | | | — | | | | |
|
(5)
|
| | | | | | | | | | | | | | | | | | | | | | | | | |
Class A common stock(10)
|
| | | | — | | | | | | — | | | | | | 2 | | | | |
|
(2)
|
| | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | 4 | | | | |
|
(4)
|
| | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | 6 | | | | |
|
(5)
|
| | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | 13 | | | | | | (4) | | | | |
|
(4)
|
| | | | | 9 | | |
Class B common stock(10)
|
| | | | — | | | | | | 1 | | | | | | — | | | | | | | | | | | | — | | | | | | — | | | | | | | | | | | | — | | |
Additional paid-in capital
|
| | | | 4,964 | | | | | | 5,394 | | | | | | 224,998 | | | | |
|
(2)
|
| | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | (40,124) | | | | |
|
(3)
|
| | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | 366,830 | | | | |
|
(4)
|
| | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | (6) | | | | |
|
(5)
|
| | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | (395) | | | | |
|
(6)
|
| | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | 49,895 | | | | |
|
(7)
|
| | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | 12,182 | | | | |
|
(8)
|
| | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | 220,524 | | | | |
|
(9)
|
| | | | | 844,262 | | | | | | (383,581) | | | | |
|
(4)
|
| | | | | 460,681 | | |
Accumulated other comprehensive income
|
| | | | 13 | | | | | | — | | | | | | | | | | | | | | | | | | 13 | | | | | | — | | | | | | | | | | | | 13 | | |
Accumulated deficit
|
| | | | (306,954) | | | | | | (395) | | | | | | 395 | | | | |
|
(6)
|
| | | | | (306,954) | | | | | | — | | | | | | | | | | | | (306,954) | | |
Total stockholders’ equity (deficit)
|
| | | | (301,977) | | | | | | 5,000 | | | | | | 834,311 | | | | | | | | | | | | 537,334 | | | | | | (383,585) | | | | | | | | | | | | 153,749 | | |
Total liabilities, convertible preferred stock and stockholders' equity (deficit)
|
| | | $ | 200,189 | | | | | $ | 386,180 | | | | | $ | 171,246 | | | | | | | | | | | $ | 757,615 | | | | | $ | (383,585) | | | | | | | | | | | $ | 374,030 | | |
|
| | |
September 30, 2020
|
| |
Pro Forma Combined Company
Assuming No Redemptions |
| |
Pro Forma Combined Company
Assuming Maximum Redemptions |
| |||||||||||||||||||||||||||||||||||||||||||||
| | |
Authorized
|
| |
Issued
|
| |
Outstanding
|
| |
Authorized
|
| |
Issued
|
| |
Outstanding
|
| |
Authorized
|
| |
Issued
|
| |
Outstanding
|
| |||||||||||||||||||||||||||
Stem convertible preferred stock
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Series D’
|
| | | | 190,000,000 | | | | | | 105,560,563 | | | | | | 105,560,563 | | | | | | N/A | | | | | | N/A | | | | | | N/A | | | | | | N/A | | | | | | N/A | | | | | | N/A | | |
Series D
|
| | | | 87,235,535 | | | | | | 33,371,462 | | | | | | 33,371,462 | | | | | | N/A | | | | | | N/A | | | | | | N/A | | | | | | N/A | | | | | | N/A | | | | | | N/A | | |
Series C
|
| | | | 64,129,209 | | | | | | 23,298,388 | | | | | | 23,298,388 | | | | | | N/A | | | | | | N/A | | | | | | N/A | | | | | | N/A | | | | | | N/A | | | | | | N/A | | |
Series B
|
| | | | 36,969,407 | | | | | | 9,185,302 | | | | | | 9,185,302 | | | | | | N/A | | | | | | N/A | | | | | | N/A | | | | | | N/A | | | | | | N/A | | | | | | N/A | | |
Series A’
|
| | | | 30,991,277 | | | | | | 4,158,503 | | | | | | 4,158,503 | | | | | | N/A | | | | | | N/A | | | | | | N/A | | | | | | N/A | | | | | | N/A | | | | | | N/A | | |
Series A
|
| | | | 21,288 | | | | | | 16,740 | | | | | | 16,740 | | | | | | N/A | | | | | | N/A | | | | | | N/A | | | | | | N/A | | | | | | N/A | | | | | | N/A | | |
Stem Series 1 convertible preferred stock
|
| | | | 4,305 | | | | | | 2,961 | | | | | | 2,961 | | | | | | N/A | | | | | | N/A | | | | | | N/A | | | | | | N/A | | | | | | N/A | | | | | | N/A | | |
Stem common stock
|
| | | | 474,728,323 | | | | | | 9,427,528 | | | | | | 9,427,528 | | | | | | N/A | | | | | | N/A | | | | | | N/A | | | | | | N/A | | | | | | N/A | | | | | | N/A | | |
STPK preferred stock
|
| | | | 1,000,000 | | | | | | — | | | | | | — | | | | | | 1,000,000 | | | | | | — | | | | | | — | | | | | | 1,000,000 | | | | | | — | | | | | | — | | |
STPK class A common stock subject to possible redemption
|
| | | | 38,358,504 | | | | | | 38,358,504 | | | | | | 38,358,504 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
STPK class A common stock
|
| | | | 400,000,000 | | | | | | 1,675,092 | | | | | | 1,675,092 | | | | | | 500,000,000 | | | | | | 135,448,130 | | | | | | 135,448,130 | | | | | | 500,000,000 | | | | | | 97,089,626 | | | | | | 97,089,626 | | |
STPK class B common stock
|
| | | | 40,000,000 | | | | | | 9,589,626 | | | | | | 9,589,626 | | | | | | N/A | | | | | | N/A | | | | | | N/A | | | | | | N/A | | | | | | N/A | | | | | | N/A | | |
| | | | | | | | | | | | | | |
Scenario 1
Assuming No Redemptions into Cash |
| |
Scenario 2
Assuming Maximum Redemptions into Cash |
| ||||||||||||||||||||||||||||||
| | |
(A)
Stem (Historical) |
| |
(B)
STPK (Historical) |
| |
Pro Forma
Adjustments |
| | | | | | | |
Pro Forma
Income Statement |
| |
Pro Forma
Adjustments |
| | | | | | | |
Pro Forma
Income Statement |
| ||||||||||||||||||
Service revenue
|
| | | $ | 10,711 | | | | | $ | — | | | | | $ | — | | | | | | | | | | | $ | 10,711 | | | | | $ | — | | | | | | | | | | | $ | 10,711 | | |
Hardware revenue
|
| | | | 6,950 | | | | | | — | | | | | | — | | | | | | | | | | | | 6,950 | | | | | | — | | | | | | | | | | | | 6,950 | | |
Total revenue
|
| | | | 17,661 | | | | | | — | | | | | | — | | | | | | | | | | | | 17,661 | | | | | | — | | | | | | | | | | | | 17,661 | | |
Cost of service revenue
|
| | | $ | 16,083 | | | | | $ | — | | | | | $ | — | | | | | | | | | | | $ | 16,083 | | | | | $ | — | | | | | | | | | | | $ | 16,083 | | |
Cost of hardware revenue
|
| | | | 6,439 | | | | | | — | | | | | | — | | | | | | | | | | | | 6,439 | | | | | | — | | | | | | | | | | | | 6,439 | | |
Total cost of revenue
|
| | | | 22,522 | | | | | | — | | | | | | — | | | | | | | | | | | | 22,522 | | | | | | — | | | | | | | | | | | | 22,522 | | |
Gross Margin
|
| | | | (4,861) | | | | | | — | | | | | | — | | | | | | | | | | | | (4,861) | | | | | | — | | | | | | | | | | | | (4,861) | | |
Operating expenses: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Sales and marketing
|
| | | | 11,699 | | | | | | — | | | | | | — | | | | | | | | | | | | 11,699 | | | | | | — | | | | | | | | | | | | 11,699 | | |
Research and development
|
| | | | 12,084 | | | | | | — | | | | | | — | | | | | | | | | | | | 12,084 | | | | | | — | | | | | | | | | | | | 12,084 | | |
General and administrative
|
| | | | 8,018 | | | | | | 111 | | | | | | 151 | | | | |
|
(4)
|
| | | | | 8,280 | | | | | | — | | | | | | | | | | | | 8,129 | | |
General and administration – Related party
|
| | | | — | | | | | | 133 | | | | | | — | | | | | | | | | | | | 133 | | | | | | — | | | | | | | | | | | | 133 | | |
Franchise tax expense
|
| | | | — | | | | | | 151 | | | | | | (151) | | | | |
|
(4)
|
| | | | | — | | | | | | — | | | | | | | | | | | | — | | |
Total operating expenses
|
| | | | 31,801 | | | | | | 395 | | | | | | — | | | | | | | | | | | | 32,196 | | | | | | — | | | | | | | | | | | | 32,196 | | |
Loss from operations
|
| | | | (36,662) | | | | | | (395) | | | | | | — | | | | | | | | | | | | (37,057) | | | | | | — | | | | | | | | | | | | (37,057) | | |
Other income (expense), net: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Interest expense
|
| | | | (13,826) | | | | | | — | | | | | | 11,737 | | | | |
|
(3)
|
| | | | | (2,089) | | | | | | — | | | | | | | | | | | | (2,089) | | |
Change in fair value of warrants and
embedded derivative |
| | | | (3,005) | | | | | | — | | | | | | 3,005 | | | | |
|
(5)
|
| | | | | — | | | | | | — | | | | | | | | | | | | — | | |
Other income
|
| | | | — | | | | | | 19 | | | | | | (19) | | | | |
|
(1)
|
| | | | | — | | | | | | — | | | | | | | | | | | | — | | |
Other expenses, net
|
| | | | (1,602) | | | | | | — | | | | | | — | | | | | | | | | | | | (1,602) | | | | | | — | | | | | | | | | | | | (1,602) | | |
Total other income (expense)
|
| | | | (18,433) | | | | | | 19 | | | | | | 14,723 | | | | | | | | | | | | (3,691) | | | | | | — | | | | | | | | | | | | (3,691) | | |
Loss before income taxes
|
| | | | (55,095) | | | | | | (376) | | | | | | 14,723 | | | | | | | | | | | | (40,748) | | | | | | — | | | | | | | | | | | | (40,748) | | |
Income tax expense
|
| | | | (142) | | | | | | — | | | | | | — | | | | | | | | | | | | (142) | | | | | | — | | | | | | | | | | | | (142) | | |
Net loss
|
| | | $ | (55,237) | | | | | $ | (376) | | | | | $ | 14,723 | | | | | | | | | | | $ | (40,606) | | | | | $ | — | | | | | | | | | | | $ | (40,606) | | |
Less: Deemed dividend to preferred stockholders
|
| | | $ | (9,484) | | | | | | | | | | | | | | | | | | | | | | | $ | (9,484) | | | | | | | | | | | | | | | | | $ | (9,484) | | |
Net loss attributable to common stockholders
|
| | | $ | (64,721) | | | | | | | | | | | | | | | | | | | | | | | $ | (50,090) | | | | | | | | | | | | | | | | | $ | (50,090) | | |
Net loss per share attributable to Stem common stockholders, basic and
diluted |
| | | $ | (7.07) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Weighted-average shares of Stem common stock used in computing net loss per share, basic and diluted
|
| | | | 9,155,906 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Weighted average Class A ordinary shares outstanding, basic and diluted
|
| | | | | | | | | | 37,878,718 | | | | | | 97,569,412 | | | | |
|
(2)
|
| | | | | 135,448,130 | | | | | | (38,358,504) | | | | |
|
(2)
|
| | | | | 97,089,626 | | |
Basic and diluted net loss per ordinary share, Class A
|
| | | | | | | | | $ | (0.00) | | | | | | | | | | | | | | | | | $ | (0.37) | | | | | | | | | | | | | | | | | $ | (0.52) | | |
Weighted average Class B ordinary shares
outstanding, basic and diluted(1) |
| | | | | | | | | | 9,589,626 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Basic and diluted net loss per ordinary share, Class B
|
| | | | | | | | | $ | (0.04) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
| | | | | | | | | | | | | | |
Scenario 1
Assuming No Redemptions into Cash |
| |
Scenario 2
Assuming Maximum Redemptions into Cash |
| ||||||||||||||||||||||||
| | |
(C)
Stem (Historical) |
| |
(D)
STPK (Historical) |
| |
Pro Forma
Adjustments |
| | | | | | | |
Pro Forma
Income Statement |
| |
Pro Forma
Adjustments |
| |
Pro Forma
Income Statement |
| ||||||||||||||||||
Service revenue
|
| | | $ | 13,482 | | | | | $ | — | | | | | $ | — | | | | | | | | | | | $ | 13,482 | | | | | $ | — | | | | | $ | 13,482 | | |
Hardware revenue
|
| | | | 4,070 | | | | | | — | | | | | | — | | | | | | | | | | | | 4,070 | | | | | | — | | | | | | 4,070 | | |
Total revenue
|
| | | | 17,552 | | | | | | — | | | | | | — | | | | | | | | | | | | 17,552 | | | | | | — | | | | | | 17,552 | | |
Cost of service revenue
|
| | | $ | 16,958 | | | | | $ | — | | | | | $ | — | | | | | | | | | | | $ | 16,958 | | | | | $ | — | | | | | $ | 16,958 | | |
Cost of hardware revenue
|
| | | | 3,854 | | | | | | — | | | | | | — | | | | | | | | | | | | 3,854 | | | | | | — | | | | | | 3,854 | | |
Total cost of revenue
|
| | | | 20,812 | | | | | | — | | | | | | — | | | | | | | | | | | | 20,812 | | | | | | — | | | | | | 20,812 | | |
Gross Margin
|
| | | | (3,260) | | | | | | — | | | | | | — | | | | | | | | | | | | (3,260) | | | | | | — | | | | | | (3,260) | | |
Operating expenses: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Sales and marketing
|
| | | | 17,462 | | | | | | — | | | | | | — | | | | | | | | | | | | 17,462 | | | | | | — | | | | | | 17,462 | | |
Research and development
|
| | | | 14,703 | | | | | | — | | | | | | — | | | | | | | | | | | | 14,703 | | | | | | — | | | | | | 14,703 | | |
General and administrative
|
| | | | 12,425 | | | | | | 10 | | | | | | 1 | | | | |
|
(4)
|
| | | | | 12,436 | | | | | | — | | | | | | 12,436 | | |
Franchise tax expense
|
| | | | — | | | | | | 1 | | | | | | (1) | | | | |
|
(4)
|
| | | | | — | | | | | | — | | | | | | — | | |
Total operating expenses
|
| | | | 44,590 | | | | | | 11 | | | | | | — | | | | | | | | | | | | 44,601 | | | | | | — | | | | | | 44,601 | | |
Loss from operations
|
| | | | (47,850) | | | | | | (11) | | | | | | — | | | | | | | | | | | | (47,861) | | | | | | — | | | | | | (47,861) | | |
Other income (expense), net: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Interest expense
|
| | | | (12,548) | | | | | | — | | | | | | 7,690 | | | | |
|
(3)
|
| | | | | (4,858) | | | | | | — | | | | | | (4,858) | | |
Change in fair value of warrants and embedded derivative
|
| | | | 1,493 | | | | | | — | | | | | | (1,493) | | | | |
|
(5)
|
| | | | | — | | | | | | — | | | | | | — | | |
Other expenses, net
|
| | | | (503) | | | | | | — | | | | | | — | | | | | | | | | | | | (503) | | | | | | — | | | | | | (503) | | |
Total other income (expense)
|
| | | | (11,558) | | | | | | — | | | | | | 6,197 | | | | | | | | | | | | (5,361) | | | | | | — | | | | | | (5,361) | | |
Loss before income taxes
|
| | | | (59,408) | | | | | | (11) | | | | | | 6,197 | | | | | | | | | | | | (53,222) | | | | | | — | | | | | | (53,222) | | |
Income tax expense
|
| | | | (6) | | | | | | — | | | | | | — | | | | | | | | | | | | (6) | | | | | | — | | | | | | (6) | | |
Net loss
|
| | | $ | (59,414) | | | | | $ | (11) | | | | | $ | 6,197 | | | | | | | | | | | $ | (53,228) | | | | | $ | — | | | | | $ | (53,228) | | |
Less: Deemed dividend to preferred stockholders
|
| | | $ | (5,353) | | | | | | | | | | | | | | | | | | | | | | | $ | (5,353) | | | | | | | | | | | $ | (5,353) | | |
Net loss attributable to common stockholders
|
| | | $ | (64,767) | | | | | | | | | | | | | | | | | | | | | | | $ | (58,581) | | | | | | | | | | | $ | (58,581) | | |
Net loss per share attributable to Stem common shareholders, basic and diluted
|
| | | $ | (6.05) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Weighted-average shares of Stem common stock used in computing net loss per share, basic and diluted
|
| | | | 10,703,380 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net loss per share attributable to common
shareholders, basic and diluted |
| | | | | | | | | $ | — | | | | | $ | — | | | | | | | | | | | $ | (0.43) | | | | | $ | — | | | | | $ | (0.60) | | |
Weighted-average shares used in
computing net loss per share, basic and diluted |
| | | | | | | | | | 8,750,000 | | | | | | 126,698,130 | | | | |
|
(2)
|
| | | | | 135,448,130 | | | | | | (38,358,504) | | | | | | 97,089,626 | | |
|
| | |
Scenario 1
Combined (Assuming No Redemption into Cash) |
| |
%
|
| |
Scenario 2
Combined (Assuming Maximum Redemptions into Cash) |
| |
%
|
| ||||||||||||
STPK public shares
|
| | | | 38,358,504 | | | | | | 28.3% | | | | | | — | | | | | | — | | |
STPK Founder Shares
|
| | | | 9,589,626 | | | | | | 7.1% | | | | | | 9,589,626 | | | | | | 9.9% | | |
STPK shares issued in the merger
|
| | | | 65,000,000(1) | | | | | | 48.0% | | | | | | 65,000,000(1) | | | | | | 66.9% | | |
STPK shares issued to PIPE Investors
|
| | | | 22,500,000 | | | | | | 16.6% | | | | | | 22,500,000 | | | | | | 23.2% | | |
Pro Forma Common Stock at September 30, 2020
|
| | | | 135,448,130 | | | | | | | | | | | | 97,089,626 | | | | | | | | |
Name
|
| |
Age
|
| |
Title
|
|
Michael C. Morgan | | |
52
|
| | Chairman of the Board | |
Eric Scheyer | | |
55
|
| | Chief Executive Officer and Director | |
Michael D. Wilds | | |
63
|
| | Chief Financial Officer and Chief Accounting Officer | |
Adam E. Daley | | |
44
|
| | Director | |
Alec Litowitz | | |
53
|
| | Director | |
C. Park Shaper | | |
51
|
| | Director | |
Desirée Rogers | | |
61
|
| | Director | |
| | |
For the period
from October 29, 2018 (inception) through December 31, 2018 |
| |
For the
Year Ended December 31, 2019 |
| |
For the
Nine Months Ended September 30, 2019 |
| |
For the
Nine Months Ended September 30, 2020 |
| ||||||||||||
Statements of Operations Data: | | | | | | | | | | | | | | | | | | | | | | | | | |
Net loss
|
| | | $ | (8,144) | | | | | $ | (10,406) | | | | | $ | (9,956) | | | | | $ | (376,602) | | |
Weighted average shares outstanding of Class A Common Stock
|
| | | | — | | | | | | — | | | | | | — | | | | | | 37,878,718 | | |
Weighted average shares outstanding of Class B Common Stock(1)
|
| | | | 9,589,626 | | | | | | 9,589,626 | | | | | | 9,589,626 | | | | | | 9,589,626 | | |
Basic and diluted net loss per share, Class A
|
| | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 0.00 | | |
Basic and diluted net loss per share, Class B
|
| | | $ | (0.04) | | | | | $ | (0.00) | | | | | $ | (0.00) | | | | | $ | (0.04) | | |
Cash Flow Data: | | | | | | | | | | | | | | | | | | | | | | | | | |
Net cash used in operating activities
|
| | | | (2,578) | | | | | | (10,344) | | | | | | (10,344) | | | | | | (934,736) | | |
Net cash provided by (used in) investing activities
|
| | | | — | | | | | | — | | | | | | — | | | | | | (383,585,040) | | |
Net cash provided by (used by) financing activities
|
| | | | 162,250 | | | | | | (149,328) | | | | | | (149,328) | | | | | | 386,360,290 | | |
| | |
December 31,
2018 |
| |
December 31,
2019 |
| |
September 30,
2019 |
| |
September 30,
2020 |
| ||||||||||||
Balance Sheets Data (end of period): | | | | | | | | | | | | | | | | | | | | | | | | | |
Total current assets
|
| | | $ | 159,672 | | | | | $ | 1,594 | | | | | $ | — | | | | | $ | 2,575,989 | | |
Investments held in Trust Account
|
| | | | — | | | | | | — | | | | | | — | | | | | | 383,603,554 | | |
Deferred Offering Costs
|
| | | | 322,078 | | | | | | 251,424 | | | | | | — | | | | | | — | | |
Total assets
|
| | | | 481,750 | | | | | | 253,018 | | | | | | 251,424 | | | | | | 386,179,543 | | |
Total liabilities
|
| | | | 464,894 | | | | | | 246,568 | | | | | | 244,524 | | | | | | 14,345,414 | | |
Temporary Equity: | | | | | | ||||||||||||||||||||
Class A Common Stock, subject to possible redemption
|
| | | | — | | | | | | — | | | | | | — | | | | | | 366,834,120 | | |
Stockholders’ Equity: | | | | | | ||||||||||||||||||||
Class A Common Stock
|
| | | | — | | | | | | — | | | | | | — | | | | | | 168 | | |
Class B Common Stock
|
| | | | 1,006 | | | | | | 1,006 | | | | | | 1,006 | | | | | | 959 | | |
Total stockholders’ equity
|
| | | | 16,856 | | | | | | 6,450 | | | | | | 6,900 | | | | | | 5,000,009 | | |
Name and principal position
|
| |
Year
|
| |
Salary
($)(1) |
| |
Option
Awards ($)(2) |
| |
Non-Equity
Incentive Plan Compensation ($)(3) |
| |
All Other
Compensation ($)(4) |
| |
Total
($) |
| ||||||||||||||||||
John Carrington
|
| | | | 2019 | | | | | $ | 375,000.00 | | | | | $ | 2,813,943.60 | | | | | $ | 350,625.00 | | | | | $ | — | | | | | $ | 3,539,568.60 | | |
Chief Executive Officer | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Mark Triplett
|
| | | | 2019 | | | | | $ | 328,750.00 | | | | | $ | 1,556,864.26 | | | | | $ | 150,000.00 | | | | | $ | — | | | | | $ | 2,035,614.26 | | |
Chief Operating Officer | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Alan Russo
|
| | | | 2019 | | | | | $ | 275,000.00 | | | | | $ | 623,051.66 | | | | | $ | 286,875.00 | | | | | $ | 77,170.32 | | | | | $ | 1,262,096.98 | | |
Chief Revenue Officer | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
Metrics
|
| |
Weight
|
| |
Measurement
|
| |
Target
|
| |
Actual
|
| |
Performance vs.
Target |
|
|
Bookings
|
| |
35%
|
| |
Total Bookings ($)
|
| |
$95.5M
|
| |
$87.6M
|
| |
92%
|
|
| | | | | | |
Total Bookings (MWh)
|
| |
188.2 MWh
|
| |
197.2 MWh
|
| |
105%
|
|
|
Operations
|
| |
20%
|
| |
Installations (MWh)
|
| |
122.3 MWh
|
| |
91.5 MWh
|
| |
75%
|
|
|
Cash EBITDA
|
| |
20%
|
| |
Net System Cash Flows
(includes Drop Down, Pre-Drop Down funding, HW and Install Costs) + Customer Collections (SPV Distributions, Balance Sheet Asset Collections, SGIP, etc.) - OpEx - Revolver Repayments /Draws One-off unusual items removed from the calculation of EBITDA at year end |
| |
$(35.1M)
|
| |
$(51.0M)
|
| |
(146)%
|
|
|
Cash
|
| |
25%
|
| |
Year End Cash
(not inclusive of any capital raises) |
| |
$6.1M
|
| |
$13.1M
|
| |
215%
|
|
| | |
Option Awards(1)
|
| |||||||||||||||||||||
Name
|
| |
Grant Date
|
| |
Number of
securities underlying unexercised options exercisable (#) |
| |
Number of
securities underlying unexercised options unexercisable (#) |
| |
Option
exercise price ($) |
| |
Option
expiration date |
| |||||||||
John Carrington
|
| |
2/8/2015(2)
|
| | | | 4,900,993 | | | | | | — | | | | | $ | 0.21 | | | |
2/8/2025
|
|
| | |
10/28/2015(3)
|
| | | | 4,669,262 | | | | | | — | | | | | $ | 0.27 | | | |
10/28/2025
|
|
| | |
10/22/2019(4)
|
| | | | 2,631,586 | | | | | | 2,779,844 | | | | | $ | 0.52 | | | |
10/22/2029
|
|
Mark Triplett
|
| |
1/30/2019(5)
|
| | | | 1,418,892 | | | | | | 1,758,382 | | | | | $ | 0.49 | | | |
1/30/2029
|
|
Alan Russo
|
| |
1/30/2019(6)
|
| | | | 555,643 | | | | | | 715,891 | | | | | $ | 0.49 | | | |
1/30/2029
|
|
| | |
Years Ended
December 31, |
| |
Nine Months Ended
September 30, |
| ||||||||||||||||||
| | |
2019
|
| |
2018
|
| |
2020
|
| |
2019
|
| ||||||||||||
| | |
(in thousands, except share and per share data)
|
| |||||||||||||||||||||
Consolidated Statement of Operations Data: | | | | | | | | | | | | | | | | | | | | | | | | | |
Total revenue
|
| | | $ | 17,552 | | | | | $ | 7,032 | | | | | $ | 17,661 | | | | | $ | 10,429 | | |
Total costs and expenses
|
| | | | (65,402) | | | | | | (49,448) | | | | | | (54,323) | | | | | | (47,465) | | |
Loss from operations
|
| | | | (47,850) | | | | | | (42,416) | | | | | | (36,662) | | | | | | (37,036) | | |
Other income (expense), net: | | | | | | | | | | | | | | | | | | | | | | | | | |
Interest expense
|
| | | | (12,548) | | | | | | (5,533) | | | | | | (13,826) | | | | | | (8,658) | | |
Change in fair value of warrants and embedded
derivative |
| | | | 1,493 | | | | | | (253) | | | | | | (3,005) | | | | | | 852 | | |
Other expenses, net
|
| | | | (503) | | | | | | (832) | | | | | | (1,602) | | | | | | (204) | | |
Loss before income taxes
|
| | | | (59,408) | | | | | | (49,034) | | | | | | (55,095) | | | | | | (45,046) | | |
Income tax expense
|
| | | | (6) | | | | | | (13) | | | | | | (142) | | | | | | (2) | | |
Net loss
|
| | | $ | (59,414) | | | | | $ | (49,047) | | | | | $ | (55,237) | | | | | $ | (45,048) | | |
Less: Deemed dividend to preferred stockholders
|
| | | | (5,353) | | | | | | — | | | | | | (9,484) | | | | | | (5,353) | | |
Net loss attributable to common stockholders
|
| | | $ | (64,767) | | | | | $ | (49,047) | | | | | $ | (64,721) | | | | | $ | (50,401) | | |
Net loss per share
|
| | | $ | (6.05) | | | | | $ | (5.74) | | | | | $ | (7.07) | | | | | $ | (4.65) | | |
|
| | |
December 31,
|
| |
September 30,
2020 |
| ||||||||||||
| | |
2019
|
| |
2018
|
| ||||||||||||
| | |
(in thousands)
|
| |||||||||||||||
Balance Sheets Data (end of period): | | | | | | | | | | | | | | | |||||
Total assets
|
| | | $ | 188,047 | | | | | $ | 155,594 | | | | | $ | 200,189 | | |
Total long-term debt and financing obligations
|
| | | | 151,401 | | | | | | 110,103 | | | | | | 176,773 | | |
| | |
Year Ended
December 31, |
| |
Nine Months Ended
September 30, |
| ||||||||||||||||||
| | |
2019
|
| |
2018
|
| |
2020
|
| |
2019
|
| ||||||||||||
| | |
(in thousands)
|
| |||||||||||||||||||||
Net loss
|
| | | $ | (59,414) | | | | | $ | (49,047) | | | | | $ | (55,237) | | | | | $ | (45,048) | | |
Adjusted to exclude the following: | | | | | | | | | | | | | | | | | | | | | | | | | |
Depreciation and amortization
|
| | | | 13,889 | | | | | | 6,994 | | | | | | 13,769 | | | | | | 9,941 | | |
Interest expense
|
| | | | 12,548 | | | | | | 5,533 | | | | | | 13,826 | | | | | | 8,658 | | |
Stock-based compensation
|
| | | | 1,531 | | | | | | 1,257 | | | | | | 1,427 | | | | | | 1,237 | | |
Change in fair value of warrants and embedded
derivative |
| | | | (1,493) | | | | | | 253 | | | | | | 3,005 | | | | | | (852) | | |
Provision for income taxes
|
| | | | 6 | | | | | | 13 | | | | | | 142 | | | | | | 2 | | |
Adjusted EBITDA
|
| | | $ | (32,933) | | | | | $ | (34,997) | | | | | $ | (23,068) | | | | | $ | (26,062) | | |
| | |
Year Ended
December 31, |
| |
Nine Months Ended
September 30, |
| ||||||||||||||||||
| | |
2019
|
| |
2018
|
| |
2020
|
| |
2019
|
| ||||||||||||
| | |
(in thousands)
|
| |||||||||||||||||||||
Bookings
|
| | | $ | 87,634 | | | | | $ | 76,067 | | | | | $ | 94,311 | | | | | $ | 67,752 | | |
Revenue
|
| | | $ | 17,552 | | | | | $ | 7,032 | | | | | $ | 17,661 | | | | | $ | 10,429 | | |
Net loss
|
| | | $ | (59,414) | | | | | $ | (49,047) | | | | | $ | (55,237) | | | | | $ | (45,048) | | |
Adjusted EBITDA
|
| | | $ | (32,933) | | | | | $ | (34,997) | | | | | $ | (23,068) | | | | | $ | (26,062) | | |
| | |
Nine Months Ended
September 30, |
| | | | | | | | | | | | | |||||||||
| | |
2020
|
| |
2019
|
| |
$ Change
|
| |
% Change
|
| ||||||||||||
| | |
(In thousands, except percentage)
|
| |||||||||||||||||||||
Service revenue
|
| | | $ | 10,711 | | | | | $ | 9,235 | | | | | $ | 1,476 | | | | | | 16% | | |
Hardware revenue
|
| | | | 6,950 | | | | | | 1,194 | | | | | | 5,756 | | | | | | 482% | | |
Total revenue
|
| | | | 17,661 | | | | | | 10,429 | | | | | | 7,232 | | | | | | 69% | | |
Cost of service revenue
|
| | | | 16,083 | | | | | | 10,932 | | | | | | 5,151 | | | | | | 47% | | |
Cost of hardware revenue
|
| | | | 6,439 | | | | | | 1,053 | | | | | | 5,386 | | | | | | 511% | | |
Total cost of revenue
|
| | | | 22,522 | | | | | | 11,985 | | | | | | 10,537 | | | | | | 88% | | |
Gross margin
|
| | | | (4,861) | | | | | | (1,556) | | | | | | (3,305) | | | | | | 212% | | |
Operating expenses:(1) | | | | | | | | | | | | | | | | | | | | | | | | | |
Sales and marketing
|
| | | | 11,699 | | | | | | 12,684 | | | | | | (985) | | | | | | (8)% | | |
Research and development
|
| | | | 12,084 | | | | | | 11,576 | | | | | | 508 | | | | | | 4% | | |
General and administrative
|
| | | | 8,018 | | | | | | 11,220 | | | | | | (3,202) | | | | | | (29)% | | |
Total operating expenses
|
| | | | 31,801 | | | | | | 35,480 | | | | | | (3,679) | | | | | | (10)% | | |
Loss from operations
|
| | | | (36,662) | | | | | | (37,036) | | | | | | (374) | | | | | | (1)% | | |
Other income/(expense), net: | | | | | | | | | | | | | | | | | | | | | | | | | |
Interest expense
|
| | | | (13,826) | | | | | | (8,658) | | | | | | (5,168) | | | | | | 60% | | |
Change in fair value of warrants and embedded derivative
|
| | | | (3,005) | | | | | | 852 | | | | | | (3,857) | | | | | | (453)% | | |
Other expenses, net
|
| | | | (1,602) | | | | | | (204) | | | | | | (1,398) | | | | | | 685% | | |
Total other income (expense)
|
| | | | (18,433) | | | | | | (8,010) | | | | | | (10,423) | | | | | | 130% | | |
Loss before income taxes
|
| | | | (55,095) | | | | | | (45,046) | | | | | | (10,049) | | | | | | 22% | | |
Income tax expense
|
| | | | (142) | | | | | | (2) | | | | | | (140) | | | | | | 7,000% | | |
Net loss
|
| | | $ | (55,237) | | | | | $ | (45,048) | | | | | $ | (10,189) | | | | | | 23% | | |
| | |
Nine Months Ended
September 30, |
| |||||||||
| | |
2020
|
| |
2019
|
| ||||||
| | |
(in thousands)
|
| |||||||||
Sales and marketing
|
| | | $ | 196 | | | | | $ | 361 | | |
Research and development
|
| | | | 519 | | | | | | 652 | | |
General and administrative
|
| | | | 712 | | | | | | 224 | | |
Total stock-based compensation expense
|
| | | $ | 1,427 | | | | | $ | 1,237 | | |
| | |
Twelve Months Ended
December 31, |
| | | | | | | | | | | | | |||||||||
| | |
2019
|
| |
2018
|
| |
$ Change
|
| |
% Change
|
| ||||||||||||
| | |
(In thousands, except percentage)
|
| |||||||||||||||||||||
Service revenue
|
| | | $ | 13,482 | | | | | $ | 6,526 | | | | | $ | 6,956 | | | | | | 107% | | |
Hardware revenue
|
| | | | 4,070 | | | | | | 506 | | | | | | 3,564 | | | | | | 704% | | |
Total revenue
|
| | | | 17,552 | | | | | | 7,032 | | | | | | 10,520 | | | | | | 150% | | |
Cost of service revenue
|
| | | | 16,958 | | | | | | 9,234 | | | | | | 7,724 | | | | | | 84% | | |
Cost of hardware revenue
|
| | | | 3,854 | | | | | | 456 | | | | | | 3,398 | | | | | | 745% | | |
Total cost of revenue
|
| | | | 20,812 | | | | | | 9,690 | | | | | | 11,122 | | | | | | 115% | | |
Gross margin
|
| | | | (3,260) | | | | | | (2,658) | | | | | | (602) | | | | | | 23% | | |
Operating expenses:(1) | | | | | | | | | | | | | | | | | | | | | | | | | |
Sales and marketing
|
| | | | 17,462 | | | | | | 16,226 | | | | | | 1,236 | | | | | | 8% | | |
Research and development
|
| | | | 14,703 | | | | | | 12,677 | | | | | | 2,026 | | | | | | 16% | | |
General and administrative
|
| | | | 12,425 | | | | | | 10,855 | | | | | | 1,570 | | | | | | 14% | | |
Total operating expenses
|
| | | | 44,590 | | | | | | 39,758 | | | | | | 4,832 | | | | | | 12% | | |
Loss from operations
|
| | | | (47,850) | | | | | | (42,416) | | | | | | (5,434) | | | | | | 13% | | |
Other income/(expense), net: | | | | | | | | | | | | | | | | | | | | | | | | | |
Interest expense
|
| | | | (12,548) | | | | | | (5,533) | | | | | | (7,015) | | | | | | 127% | | |
Change in fair value of warrants and embedded derivative
|
| | | | 1,493 | | | | | | (253) | | | | | | 1,746 | | | | | | 690% | | |
Other expenses, net
|
| | | | (503) | | | | | | (832) | | | | | | 329 | | | | | | (40)% | | |
Total other income (expense)
|
| | | | (11,558) | | | | | | (6,618) | | | | | | (4,940) | | | | | | 75% | | |
Loss before income taxes
|
| | | | (59,408) | | | | | | (49,034) | | | | | | (10,374) | | | | | | 21% | | |
Income tax expense
|
| | | | (6) | | | | | | (13) | | | | | | 7 | | | | | | (54)% | | |
Net loss
|
| | | $ | (59,414) | | | | | $ | (49,047) | | | | | $ | (10,367) | | | | | | 21% | | |
| | |
Year Ended
December 31, |
| |||||||||
| | |
2019
|
| |
2018
|
| ||||||
| | |
(in thousands)
|
| |||||||||
Sales and marketing
|
| | | $ | 364 | | | | | $ | 284 | | |
Research and development
|
| | | | 901 | | | | | | 422 | | |
General and administrative
|
| | | | 266 | | | | | | 551 | | |
Total stock-based compensation expense
|
| | | $ | 1,531 | | | | | $ | 1,257 | | |
| | |
Nine Months Ended
September 30, |
| |||||||||
| | |
2020
|
| |
2019
|
| ||||||
Cash Flow Data: | | | | | | | | | | | | | |
Net cash used in operating activities
|
| | | $ | (17,921) | | | | | $ | (18,004) | | |
Net cash used in investing activities
|
| | | | (7,719) | | | | | | (38,194) | | |
Net cash provided by financing activities
|
| | | | 21,043 | | | | | | 56,471 | | |
Effect of exchange rate changed on cash
|
| | | | (349) | | | | | | (158) | | |
Net increase (decrease) in cash and cash equivalents
|
| | | $ | (4,946) | | | | | $ | 115 | | |
| | |
Years Ended
December 31, |
| |||||||||
| | |
2019
|
| |
2018
|
| ||||||
Cash Flow Data: | | | | | | | | | | | | | |
Net cash used in operating activities
|
| | | $ | (29,678) | | | | | $ | (44,845) | | |
Net cash used in investing activities
|
| | | | (46,358) | | | | | | (64,375) | | |
Net cash provided by financing activities
|
| | | | 67,201 | | | | | | 126,355 | | |
Effect of exchange rate changed on cash
|
| | | | (170) | | | | | | — | | |
Net increase (decrease) in cash, cash equivalents
|
| | | $ | (9,005) | | | | | $ | 17,135 | | |
| | |
Payments Due by Period
|
| |||||||||||||||||||||||||||
| | |
Total
|
| |
Less than
1 Year |
| |
1 – 3 Years
|
| |
3 – 5 Years
|
| |
More than
5 years |
| |||||||||||||||
| | |
(in thousands)
|
| |||||||||||||||||||||||||||
Notes payable
|
| | | $ | 35,463 | | | | | $ | 28,894 | | | | | $ | 1,697 | | | | | $ | 2,414 | | | | | $ | 2,458 | | |
Interest on notes payable
|
| | | | 6,253 | | | | | | 2,634 | | | | | | 2,038 | | | | | | 1,290 | | | | | | 291 | | |
Convertible promissory notes
|
| | | | 35,596 | | | | | | 35,596 | | | | | | — | | | | | | — | | | | | | — | | |
Interest on convertible notes
|
| | | | 2,732 | | | | | | 2,732 | | | | | | — | | | | | | — | | | | | | — | | |
Operating lease obligations
|
| | | | 1,035 | | | | | | 645 | | | | | | 390 | | | | | | — | | | | | | — | | |
Total
|
| | | $ | 81,079 | | | | | $ | 70,501 | | | | | $ | 4,125 | | | | | $ | 3,704 | | | | | $ | 2,749 | | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | |
After the Business Combination
|
| |||||||||||||||||||||
| | |
Before the Business Combination
|
| |
No Redemption
|
| |
Maximum Possible
Redemption |
| |||||||||||||||||||||||||||||||||||||||
Name and Address of Beneficial Owner(1)
|
| |
Number of
shares of STPK Class A Common Stock |
| |
%
|
| |
Number of
shares of STPK Class B Common Stock |
| |
%
|
| |
Number of
shares of New Stem Common Stock |
| |
%
|
| |
Number of
shares of New Stem Common Stock |
| |
%
|
| ||||||||||||||||||||||||
Directors and Executive Officers of
STPK: |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Michael C. Morgan(2)
|
| | | | — | | | | | | — | | | | | | 9,509,626 | | | | | | 99.2% | | | | | | 9,559,626 | | | | | | 7.2% | | | | | | 9,559,626 | | | | | | 10.2% | | |
Eric Scheyer(2)
|
| | | | — | | | | | | — | | | | | | 9,509,626 | | | | | | 99.2% | | | | | | 9,519,626 | | | | | | 7.2% | | | | | | 9,519,626 | | | | | | 10.1% | | |
Michael D. Wilds
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Alec Litowitz(2)
|
| | | | — | | | | | | — | | | | | | 9,509,626 | | | | | | 99.2% | | | | | | 9,530,626 | | | | | | 7.2% | | | | | | 9,530,626 | | | | | | 10.2% | | |
Adam E. Daley
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 10,000 | | | | | | — | | | | | | 10,000 | | | | | | — | | |
C. Park Shaper(3)
|
| | | | — | | | | | | — | | | | | | 40,000 | | | | | | * | | | | | | 40,000 | | | | | | * | | | | | | 40,000 | | | | | | * | | |
Desirée Rogers(3)
|
| | | | — | | | | | | — | | | | | | 40,000 | | | | | | * | | | | | | 40,000 | | | | | | * | | | | | | 40,000 | | | | | | * | | |
All Directors and Executive
Officers of STPK as a Group (7 Individuals) |
| | | | — | | | | | | — | | | | | | 9,589,626 | | | | | | 100.0% | | | | | | 9,680,626 | | | | | | 7.3% | | | | | | 9,680,626 | | | | | | 10.3% | | |
Five Percent Holders of STPK: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Star Peak Sponsor LLC
|
| | | | — | | | | | | — | | | | | | 9,509,626 | | | | | | 99.2% | | | | | | 9,509,626 | | | | | | 7.2% | | | | | | 9,509,626 | | | | | | 10.1% | | |
Michael C. Morgan(2)
|
| | | | — | | | | | | — | | | | | | 9,509,626 | | | | | | 99.2% | | | | | | 9,559,626 | | | | | | 7.2% | | | | | | 9,559,626 | | | | | | 10.2% | | |
Eric Scheyer(2)
|
| | | | — | | | | | | — | | | | | | 9,509,626 | | | | | | 99.2% | | | | | | 9,519,626 | | | | | | 7.2% | | | | | | 9,519,626 | | | | | | 10.1% | | |
Alec Litowitz(2)
|
| | | | — | | | | | | — | | | | | | 9,509,626 | | | | | | 99.2% | | | | | | 9,530,626 | | | | | | 7.2% | | | | | | 9,530,626 | | | | | | 10.2% | | |
Directors and Executive Officers of
New Stem After Consummation of the Business Combination: |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
John Carrington(4)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 3,115,811 | | | | | | 2.4% | | | | | | 3,115,811 | | | | | | 3.3% | | |
Bill Bush(5)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 804,140 | | | | | | * | | | | | | 804,140 | | | | | | * | | |
Mark Triplett(6)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 499,972 | | | | | | * | | | | | | 499,972 | | | | | | * | | |
Alan Russo(7)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 216,035 | | | | | | * | | | | | | 216,035 | | | | | | * | | |
Larsh Johnson(8)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 798,310 | | | | | | * | | | | | | 798,310 | | | | | | * | | |
Prakesh Patel(9)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 827,988 | | | | | | * | | | | | | 827,988 | | | | | | * | | |
David Buzby(10)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 630,938 | | | | | | * | | | | | | 630,938 | | | | | | * | | |
Michael C. Morgan(2)
|
| | | | — | | | | | | — | | | | | | 9,509,626 | | | | | | 99.2% | | | | | | 9,559,626 | | | | | | 7.2% | | | | | | 9,559,626 | | | | | | 10.2% | | |
Anil Tammineedi(11)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 4,892,797 | | | | | | 3.7% | | | | | | 4,892,797 | | | | | | 5.2% | | |
Adam E. Daley
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 10,000 | | | | | | — | | | | | | 10,000 | | | | | | — | | |
All Directors and Executive Officers of New Stem as a Group (10 Individuals)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 21,355,581 | | | | | | 16.1% | | | | | | 21,355,581 | | | | | | 22.7% | | |
Five Percent Holders of New
Stem After Consummation of the Business Combination: |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Star Peak Sponsor LLC
|
| | | | — | | | | | | — | | | | | | 9,509,626 | | | | | | 99.2% | | | | | | 9,509,626 | | | | | | 7.2% | | | | | | 9,509,626 | | | | | | 10.1% | | |
Michael C. Morgan(2)
|
| | | | — | | | | | | — | | | | | | 9,509,626 | | | | | | 99.2% | | | | | | 9,559,626 | | | | | | 7.2% | | | | | | 9,559,626 | | | | | | 10.2% | | |
Eric Scheyer(2)
|
| | | | — | | | | | | — | | | | | | 9,509,626 | | | | | | 99.2% | | | | | | 9,519,626 | | | | | | 7.2% | | | | | | 9,519,626 | | | | | | 10.1% | | |
Alec Litowitz(2)
|
| | | | — | | | | | | — | | | | | | 9,509,626 | | | | | | 99.2% | | | | | | 9,530,626 | | | | | | 7.2% | | | | | | 9,530,626 | | | | | | 10.2% | | |
2561549 Ontario Limited(12)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 7,399,293 | | | | | | 5.6% | | | | | | 7,399,293 | | | | | | 7.9% | | |
RWE Supply & Trading GMBH(13)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 5,616,224 | | | | | | 4.2% | | | | | | 5,616,224 | | | | | | 6.0% | | |
Angeleno Investors III, L.P.(14)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 4,892,797 | | | | | | 3.7% | | | | | | 4,892,797 | | | | | | 5.2% | | |
Copec Overseas S.P.A.(15)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 4,814,081 | | | | | | 3.6% | | | | | | 4,814,081 | | | | | | 5.1% | | |
Name
|
| |
Age
|
| |
Position
|
|
John Carrington | | |
54
|
| | Chief Executive Officer and Director | |
Bill Bush | | |
55
|
| | Chief Financial Officer | |
Mark Triplett | | |
59
|
| | Chief Operating Officer | |
Alan Russo | | |
51
|
| | Chief Revenue Officer | |
Larsh Johnson | | |
63
|
| | Chief Technical Officer | |
Prakesh Patel | | |
45
|
| | Chief Strategy Officer | |
Michael C. Morgan | | |
52
|
| | Director | |
Anil Tammineedi | | |
44
|
| | Director | |
David Buzby | | |
61
|
| | Director | |
Adam E. Daley | | |
44
|
| | Director | |
| | |
Revenue Growth
|
| |
Gross Margin
|
| |
EBITDA Margin
|
| |||||||||
| | |
2021E
|
| |
2021E
|
| |
2021E
|
| |||||||||
Solar Technology Solutions | | | | | | | | | | | | | | | | | | | |
Array
|
| | | | 14% | | | | | | 22% | | | | | | 17% | | |
Enphase
|
| | | | 63% | | | | | | 38% | | | | | | 26% | | |
SolarEdge
|
| | | | 22% | | | | | | 33% | | | | | | 19% | | |
Distributed Solar | | | | | | | | | | | | | | | | | | | |
Sunnova(3)
|
| | | | 31% | | | | | | 60% | | | | | | 80% | | |
Sunpower
|
| | | | 26% | | | | | | 18% | | | | | | 9% | | |
Sunrun
|
| | | | 53% | | | | | | 27% | | | | | | NM | | |
| | |
Revenue Growth
|
| |
Gross Margin
|
| |
EBITDA Margin
|
| |||||||||
| | |
2021E
|
| |
2021E
|
| |
2021E
|
| |||||||||
Sustainable Infrastructure | | | | | | | | | | | | | | | | | | | |
Bloom Energy
|
| | | | 29% | | | | | | 27% | | | | | | 12% | | |
Chargepoint(4)
|
| | | | 47% | | | | | | 31% | | | | | | NM | | |
Diversified Energy | | | | | | | | | | | | | | | | | | | |
Tesla
|
| | | | 46% | | | | | | 22% | | | | | | 19% | | |
Median (across peers)
|
| | | | 31% | | | | | | 27% | | | | | | 18% | | |
| | |
Enterprise Value / Revenue
|
| |
Enterprise Value / EBITDA
|
| ||||||||||||||||||
| | |
2021E
|
| |
2022E
|
| |
2021E
|
| |
2022E
|
| ||||||||||||
Solar Technology Solutions | | | | | | | | | | | | | | | | | | | | | | | | | |
Array(5)
|
| | | | 5.7x | | | | | | 4.9x | | | | | | 33.1x | | | | | | 29.0x | | |
Enphase
|
| | | | 13.5x | | | | | | 10.7x | | | | | | 52.1x | | | | | | 40.0x | | |
SolarEdge
|
| | | | 8.1x | | | | | | 6.7x | | | | | | 42.9x | | | | | | 33.9x | | |
Distributed Solar | | | | | | | | | | | | | | | | | | | | | | | | | |
Sunnova
|
| | | | 27.7x | | | | | | 20.4x | | | | | | 34.7x | | | | | | 23.9x | | |
Sunpower
|
| | | | 3.0x | | | | | | 2.6x | | | | | | 33.6x | | | | | | 22.6x | | |
Sunrun
|
| | | | 11.8x | | | | | | 10.7x | | | | | | NM | | | | | | NM | | |
Sustainable Infrastructure | | | | | | | | | | | | | | | | | | | | | | | | | |
Bloomenergy
|
| | | | 5.2x | | | | | | 4.2x | | | | | | 43.9x | | | | | | 27.4x | | |
Chargepoint(6)
|
| | | | 41.9x | | | | | | 24.0x | | | | | | NM | | | | | | NM | | |
Diversified Energy | | | | | | | | | | | | | | | | | | | | | | | | | |
Tesla
|
| | | | 14.3x | | | | | | 11.7x | | | | | | 75.1x | | | | | | 60.3x | | |
Median (across peers)
|
| | | | 11.8x | | | | | | 10.7x | | | | | | 42.9x | | | | | | 29.0x | | |
Name
|
| |
Office
|
|
John Carrington | | |
Chief Executive Officer
|
|
Bill Bush | | |
Chief Financial Officer
|
|
Mark Triplett | | |
Chief Operating Officer
|
|
Alan Russo | | |
Chief Revenue Officer
|
|
Larsh Johnson | | |
Chief Technical Officer
|
|
Prakesh Patel | | |
Chief Strategy Officer
|
|
| | |
Existing Charter
|
| |
Proposed Charter
|
|
Authorized Shares (Proposal No. 2)
|
| | STPK’s existing charter authorizes (a) 440,000,000 shares of common stock, consisting of 400,000,000 shares of Class A Common Stock and 40,000,000 shares of Class B Common Stock and (b) 1,000,000 shares of preferred stock. | | | New Stem’s charter will authorize 500,000,000 shares of common stock and 1,000,000 shares of preferred stock. | |
| | |
Existing Charter
|
| |
Proposed Charter
|
|
Elimination of Class B Common Stock (Proposal No. 3)
|
| | STPK’s existing charter contains provisions regarding the conversion of Class B Common Stock and anti-dilution protections in respect of Class B Common Stock. STPK’s existing charter also requires the affirmative vote of the holders of a majority of the shares of Class B Common Stock in order to make any amendment that would alter or change the powers, preferences or other rights of the holders of Class B Common Stock. | | | New Stem’s charter will eliminate Class B Common Stock and any rights of holders thereof. | |
No Class Vote on Changes in Authorized Number of Shares of Stock (Proposal No. 4)
|
| | STPK’s existing charter contains no specific provision regarding the required vote to change the authorized shares of any class of stock. | | | New Stem’s charter will provide that, subject to the rights of the holders of any outstanding series of Preferred Stock, the number of authorized shares of Common Stock or Preferred Stock may be increased or decreased (but not below the number of shares thereof then outstanding) by the affirmative vote of at least a majority of the voting power of the stock outstanding and entitled to vote thereon irrespective of the provisions of Section 242(b)(2) of the DGCL. | |
Removal of Directors (Proposal No. 5)
|
| | STPK’s existing charter provides that any director, or the entire board, may be removed from office at any time, but only for cause and only by the affirmative vote of at least a majority of the voting power of the stock outstanding and entitled to vote thereon voting together as a single class. | | | New Stem’s charter will provide that any director, or the entire board, may be removed from office at any time, but only for cause and only by the affirmative vote of at least 662∕3% of the voting power of the stock outstanding and entitled to vote thereon. | |
Amendments to Waiver of Corporate Opportunities Provision (Proposal No. 6)
|
| | STPK’s existing charter has no specific provision regarding when an amendment to the waiver of corporate opportunities is effective. | | | New Stem’s charter will provide that any alteration, amendment, addition to or repeal of the provisions of the New Stem Certificate of Incorporation that relate to the waiver of corporate opportunities will eliminate or reduce such provisions in respect of any business opportunity first identified or any other matter occurring, or any cause of action, suit or claim that, but for such | |
| | |
Existing Charter
|
| |
Proposed Charter
|
|
| | | | | | provisions, would accrue or arise, prior to such alteration, amendment, addition repeal or adoption. In addition, the Proposed Charter includes several clarificatory amendments to the Corporate Opportunity provision, including that the waiver of corporate opportunity applies to the affiliates of officers and directors and that limitations on the waiver of corporate opportunity do not apply to circumstances where a director or officer cannot refer an opportunity to New Stem without violating a separate legal obligation. | |
Supermajority Provisions of the Charter and Bylaws (Proposal No. 7)
|
| | Under STPK’s existing charter, the affirmative vote of the holders of at least a majority of the voting power of all then outstanding capital stock entitled to vote generally in the election of directors, voting together as a single class, is required to amend the bylaws or charter provisions (other than the requirement that any amendment to Article IX of the existing charter (Business Combination Requirements; Existence)) prior to the consummation of the initial “business combination” be approved by the affirmative vote of the holders of at 65% of all then outstanding shares of the Common Stock. | | | New Stem’s charter will provide that the affirmative vote of 66 2∕3% of the voting power of the stock outstanding and entitled to vote thereon, voting together as a single class, shall be required to adopt, amend or repeal the bylaws or any provision of the Proposed Charter inconsistent with Section 5.2 of Article V (Classification of the Board of Directors), Article VI (Stockholder Action), Article VIII (Amendment), Article IX (Liability of Directors), Article X (Corporate Opportunity) or Article XI (Forum for Adjudication of Disputes). | |
|
Total shares remaining available for new grants under the 2009 Plan as of , 2021
|
| | | | | | |
|
Total shares underlying outstanding stock options (excluding contingent options)
|
| | | | | | |
|
Weighted average exercise price of outstanding stock options
|
| | | $ | | | |
|
Weighted average remaining contractual life of outstanding stock options (in years)
|
| | | | | | |
|
Number of new shares being authorized under the Incentive Plan
|
| | | | | | |
|
Number of shares underlying options that are contingent upon approval of the Incentive Plan
|
| | | | | | |
|
Total number of shares available for future awards if this proposal is approved (excluding contingent option awards)
|
| | | | | | |
|
Total shares of common stock outstanding as of the record date
|
| | | | | | |
STPK
|
| |
New Stem
|
| |
Stem
|
|
| | | | | | be designated Series D Preferred Stock, and 50,000,000 of which shall be designated Series D’ Preferred Stock. As of , 2021, there were shares of Series 1 Preferred Stock, shares of Series A Preferred Stock, shares of Series B Preferred Stock, shares of Series C Preferred Stock and shares of Series D Preferred Stock outstanding. | |
Rights of Preferred Stock
|
| ||||||
STPK’s board of directors may fix for any series of preferred stock such voting powers, full or limited, or no voting powers, and such preferences, designations and relative, participating, optional or other special rights and such qualifications, limitations or restrictions thereof, as may be stated in the resolutions of the STPK board of directors providing for the issuance of such series. | | | Same as STPK. | | | The rights of the Stem preferred stock are established under the Stem certificate. | |
Number and Qualification of Directors
|
| ||||||
The STPK board of directors shall consist of one or more members, the number thereof to be fixed solely by resolution adopted from time to time by the board of directors by a majority of the directors then in office.
STPK’s board of directors consists of three classes of directors, with staggered three-year terms. Only one class of directors will be elected at each annual meeting of stockholders, with the other classes continuing for the remainder of their respective three-year terms.
|
| |
The New Stem board of directors shall consist of one or more members, the number thereof to be fixed solely by resolution adopted from time to time by the board of directors by a majority of the directors then in office.
New Stem’s board of directors consists of three classes of directors, with staggered three-year terms. Only one class of directors will be elected at each annual meeting of stockholders, with the other classes continuing for the remainder of their respective three-year terms.
|
| | The Stem board of directors shall consist of nine members. | |
Election of Directors
|
| ||||||
Holders of the Class A Common Stock and holders of the Class B Common Stock, voting together as a single class, shall have the exclusive right to vote for the | | | The stockholders shall elect the directors to the class whose term expires at said meeting for a term of three (3) years or until his or her successor is duly elected and | | | So long as at least 2,800,000 shares of Series A Preferred Equivalent Securities remain outstanding, the holders of Series A Preferred Equivalent | |
STPK
|
| |
New Stem
|
| |
Stem
|
|
election of directors. At each annual meeting the holders of the Class A Common Stock and Class B Common Stock shall elect the directors to the class whose term expires at said meeting for a term of three (3) years or until his or her successor is duly elected and qualified, subject to such director’s earlier death, resignation, disqualification or removal. | | | qualified, subject to such director’s earlier death, resignation, disqualification or removal. | | | Securities, voting as a separate class, shall be entitled to elect one director. So long as at least 2,700,000 shares of Series B Preferred Stock remain outstanding, the holders of Series B Preferred Stock, voting as a separate class, shall be entitled to elect one director. So long as any shares of Series C Preferred Stock remain outstanding, the holders of Series C Preferred Stock, voting as a separate class, shall be entitled to elect three directors. So long as any shares of Series D Preferred Stock remain outstanding, the holders of Series D Preferred Stock, voting together as a separate class, on an as-converted basis, shall be entitled to elect two directors. So long as at least 5,500,000 shares of Stem Senior Preferred Stock remain outstanding, the holders of the Stem Senior Preferred Stock, voting as a single class on an as-converted basis, shall be entitled to elect one director. The holders of Common Stock and Series 1 Preferred Stock, voting together as a single class on an as-converted basis, shall be entitled to elect one director. | |
Removal of Directors
|
| ||||||
Any or all of the directors may be removed from office at any time, but only for cause and only by the affirmative vote of holders of a majority of the voting power of all then outstanding shares of capital stock entitled to vote generally in the election of directors, voting together as a single class.
Whenever the holders of one or more series of the Preferred Stock shall have the right, voting separately by class or series, to elect one or more directors, the term of office, the filling of vacancies, the removal from office
|
| |
Any director, or the entire board of directors, may be removed from office at any time, but only for cause and only by the affirmative vote of at least 662∕3% of the voting power of the stock outstanding and entitled to vote thereon.
Whenever the holders of one or more series of the New Stem Preferred Stock shall have the right, voting separately by class or series, to elect one or more directors, the term of office, the filling of vacancies, the removal from office and other features of such directorships shall be
|
| | No supermajority requirements removal requirements to the above election rights. | |
STPK
|
| |
New Stem
|
| |
Stem
|
|
and other features of such directorships shall be governed by the terms of such series of the Preferred Stock. | | | governed by the terms of such series of the New Stem Preferred Stock. | | | | |
Voting
|
| ||||||
Holders of Class A Common Stock and holders of the Class B Common Stock, voting together as a single class, shall have the exclusive right to vote on all matters properly submitted to a vote of the stockholders. Notwithstanding the foregoing, except as otherwise required by law, holders of shares of any series of common stock shall not be entitled to vote on any amendment to STPK’s existing charter (including any amendment to any preferred stock designation) that relates solely to the terms of one or more outstanding series of Preferred Stock or other series of common stock if the holders of such affected series of Preferred Stock or common stock, as applicable, are entitled exclusively, either separately or together with the holders of one or more other such series, to vote thereon pursuant to STPK’s existing charter (including any preferred stock designation) or the DGCL. | | | Each holder of New Stem Common Stock, as such, shall be entitled to one vote for each share of New Stem Common Stock held of record by such holder on all matters on which stockholders generally are entitled to vote; provided, however, that, except as otherwise required by law, holders of New Stem Common Stock, as such, shall not be entitled to vote on any amendment to New Stem certificate, including any certificate of designations relating to any series of New Stem Preferred Stock that relates solely to the terms of one or more outstanding series of New Stem Preferred Stock if the holders of such affected series are entitled, either separately or together with the holders of one or more other such series, to vote thereon pursuant to the New Stem certificate (including any preferred stock certificate of designation). | | |
Except as otherwise specified under the Stem certificate (such as the election of directors, as specified above) or as required by law, the holders of Stem preferred Stock and common stock shall vote together and not as separate classes and there shall be no preferred stock series voting.
On any matter presented to Stem stockholders for their action or consideration at any meeting of stockholders or by written consent of stockholders in lieu of meeting, each holder of Stem preferred stock shall be entitled to the number of votes equal to the number of shares of common stock into which the shares of preferred stock held by such holder could be converted as of the record date. The holders of shares of the preferred stock shall be entitled to vote on all matters on which the common stock shall be entitled to vote. Holders of preferred stock shall be entitled to notice of any stockholders’ meeting in accordance with the Stem bylaws. Fractional votes shall not be permitted and any fractional voting rights resulting from the conversion formula (after aggregating all shares into which shares of preferred stock held by each holder could be converted), shall be disregarded.
|
|
Cumulative Voting
|
| ||||||
Delaware law allows for cumulative voting only if provided for in a corporation’s charter; however, the STPK certificate does not authorize cumulative voting. | | | Same as STPK. | | | To the extent that Section 2115 of the California General Corporation Law makes Section 708 subdivisions (a), (b) and (c) of the California General Corporation Law applicable to Stem, Stem’s stockholders shall have the right | |
STPK
|
| |
New Stem
|
| |
Stem
|
|
| | | | | | to cumulate their votes in connection with the election of directors as provided by Section 708 subdivisions (a), (b) and (c) of the California General Corporation Law. | |
Vacancies on the Board of Directors
|
| ||||||
Any vacancies on the STPK board of directors resulting from death, resignation, retirement, disqualification, removal or other cause may be filled solely and exclusively by a majority vote of the remaining directors then in office, even if less than a quorum, or by a sole remaining director (and not by stockholders), and any director so chosen shall hold office for the remainder of the full term of the class of directors to which the new directorship was added or in which the vacancy occurred and until his or her successor has been elected and qualified, subject, however, to such director’s earlier death, resignation, retirement, disqualification or removal. | | | Same as STPK. | | | If a vacancy on the Stem board of directors is to be filled by the board of directors, only directors elected by the same class, classes or series of stockholders as those who would be entitled to vote to fill such vacancy shall vote to fill such vacancy. | |
Stockholder Action by Written Consent
|
| ||||||
Any action required or permitted to be taken by the STPK stockholders must be effected by a meeting of stockholders other than with respect to the Class B Common Stock with respect to which action may be taken by written consent | | | No action that is required or permitted to be taken by the stockholders of New Stem may be effected by consent of stockholders in lieu of a meeting of stockholders. | | | Action required by the DGCL to be taken at any annual or special meeting of stockholders of a corporation, or any action which may be taken at any annual or special meeting of such stockholders, may be taken without a meeting, without prior notice, and without a vote, if a consent or consents in writing, setting forth the action so taken, shall be signed by the holders of outstanding stock having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted. | |
STPK
|
| |
New Stem
|
| |
Stem
|
|
Amendment to Certificate of Incorporation and Bylaws
|
| ||||||
The affirmative vote of the holders of at least a majority of the voting power of all then outstanding STPK capital stock entitled to vote generally in the election of directors, voting together as a single class is required for amendments to the charter or bylaws (other than the requirement that any amendment to Article IX of the existing charter Business Combination Requirements; Existence) prior to the consummation of the initial “business combination” be approved by the affirmative vote of the holders of at 65% of all then outstanding shares of the common stock. | | | The affirmative vote of 66 2∕3% of the voting power of the New Stem capital stock outstanding and entitled to vote thereon, voting together as a single class, shall be required to adopt, amend or repeal the New Stem bylaws or any provision of the New Stem certificate inconsistent with, Section 5.2 of Article V (Classification of the Board of Directors), Article VI (Stockholder Action), Article VIII (Amendment), Article IX (Liability of Directors) or Article X (Corporate Opportunity) or Article XI (Form of Adjudication of Disputes). | | |
Other than the below protective provisions, the affirmative vote of the holders of at least a majority of the voting power of all then outstanding Stem capital stock entitled to vote generally in the election of directors, voting together as a single class is required for amendments to the charter or bylaws.
Article 8 of the Stem certificate establishes certain protective provisions applicable, respectively, to the Stem Senior Preferred Stock, Series D Preferred Stock, Series C Preferred Stock and Series B Preferred Stock. Subject to the conditions for the applicability of these protective provisions established under the Stem certificate, the provisions require, among other things, the approval of holders of the applicable series of Stem preferred stock to approve amend, alter or repeal any provision of the Stem certificate or bylaws if such action would adversely alter the rights, preferences, privileges or powers of, or restrictions provided for the benefit of the applicable series of preferred stock, certain changes to the authorized capital stock of Stem or the entry into certain specified transactions.
|
|
Quorum
|
| ||||||
Board of Directors. At all meetings of the STPK board of directors, a majority of the members of the board of directors shall constitute a quorum for the transaction of business. | | | Board of Directors. Same as STPK. | | | Board of Directors. Same as STPK. | |
Stockholders. At any meeting of STPK stockholders, a majority of the voting power of the stock outstanding and entitled to vote at the meeting, present in person or represented by proxy, shall | | |
Stockholders. Same as STPK.
|
| |
Stockholders. Same as STPK.
|
|
STPK
|
| |
New Stem
|
| |
Stem
|
|
constitute a quorum for the transaction of business; provided, however, that where a separate vote by a class or series or classes or series is required, a majority of the voting power of the stock of such class or series or classes or series outstanding and entitled to vote on that matter, present in person or represented by proxy, shall constitute a quorum entitled to take action with respect to such matter. | | | | | | | |
Special Stockholder Meetings
|
| ||||||
Except as otherwise required by law or a preferred stock designation, a special meeting of the STPK stockholders may be called at any time only by the STPK chairman of the board of directors, chief executive or the board of directors. | | | Except as otherwise required by law or a preferred stock designation, a special meeting of the New Stem stockholders may be called at any time only by the New Stem board of directors. | | | Special meetings of the Stem stockholders may be called at any time by the Stem board of directors, chairperson of the board of directors, chief executive officer or president (in the absence of a chief executive officer) or by one or more stockholders holding shares in the aggregate entitled to cast not less than 10% of the votes at such meeting. | |
Notice of Stockholder Meetings
|
| ||||||
Written notice of each STPK stockholders meeting stating the place, if any, date, and time of the meeting, and the means of remote communication, if any, by which stockholders and proxy holders may be deemed to be present in person and vote at such meeting and the record date for determining the stockholders entitled to vote at the meeting, if such date is different from the record date for determining stockholders entitled to notice of the meeting, shall be given in the manner permitted by Section 9.3 (Means of Giving Notice) of the STPK bylaws to each stockholder entitled to vote thereat as of the record date for determining the stockholders entitled to notice of the meeting, by STPK not less than ten (10) nor more than sixty (60) days before the date of the | | | Whenever New Stem stockholders are required or permitted to take any action at a meeting, notice of the place, if any, date, and time of the meeting of stockholders, the record date for determining the stockholders entitled to vote at the meeting (if such date is different from the record date for determining the stockholders entitled to notice of the meeting), the means of remote communications, if any, by which stockholders and proxyholders may be deemed to be present in person and vote at such meeting and, if the meeting is to be held solely by means of remote communications, the means for accessing the list of stockholders shall be given. The notice shall be given not less than ten (10) nor more than sixty (60) days before the date on which the | | | Whenever Stem stockholders are required or permitted to take any action at a meeting, a written notice of the meeting shall be given which shall state the place, if any, date and hour of the meeting, the means of remote communication, if any, by which stockholders and proxy holders may be deemed to be present in person and vote at such meeting, and, in the case of a special meeting, the purpose or purposes for which the meeting is called. Except as otherwise provided in the DGCL, the Stem certificate of incorporation or bylaws, the written notice of any meeting of stockholders shall be given not less than ten (10) nor more than sixty (60) days before the date of the meeting to each stockholder entitled to vote at such meeting. | |
STPK
|
| |
New Stem
|
| |
Stem
|
|
meeting unless otherwise required by the DGCL. If said notice is for a stockholders meeting other than an annual meeting, it shall in addition state the purpose or purposes for which the meeting is called, and the business transacted at such meeting shall be limited to the matters so stated in the STPK’s notice of meeting (or any supplement thereto). | | | meeting is to be held, to each stockholder entitled to vote at such meeting as of the record date for determining the stockholders entitled to notice of the meeting, except as otherwise provided by law, the New Stem certificate (including any preferred stock designation) or the New Stem bylaws. In the case of a special meeting, the purpose or purposes for which the meeting is called also shall be set forth in the notice. | | | | |
Annual and Special Meeting Proposals
|
| ||||||
No business may be transacted at an annual meeting of STPK stockholders, other than business that is either (A) specified in STPK’s notice of meeting (or any supplement thereto) given by or at the direction of the STPK board of directors, (B) otherwise properly brought before the annual meeting by or at the direction of the STPK board of directors or (C) otherwise properly brought before the annual meeting by any STPK stockholder (x) who is a stockholder of record entitled to vote at such annual meeting on the date of the giving of the notice provided for in the STPK bylaws and on the record date for the determination of stockholders entitled to vote at such annual meeting and (y) who complies with the notice procedures set forth in the STPK bylaws, including the requirement that notice be provided no later than the close of business on the 90th day nor earlier than the opening of business on the 120th day before the anniversary date of the immediately preceding annual meeting of STPK stockholders. Clause (C) is the exclusive means for a stockholder to make nominations or propose other business at an annual meeting of | | | Nominations of persons for election to the New Stem board of directors and the proposal of business other than nominations to be considered by the stockholders may be made at an annual meeting of stockholders only: (A) pursuant to New Stem’s notice of meeting (or any supplement thereto); (B) by or at the direction of the New Stem board of directors (or any authorized committee thereof); or (C) by any New Stem stockholder who is a stockholder of record at the time the notice is delivered to the Secretary of New Stem, who is entitled to vote at the meeting and who complies with the notice procedures set forth in the New Stem bylaws, including the requirement that notice be provided no later than the close of business on the 90th day nor earlier than the opening of business on the 120th day before the anniversary date of the immediately preceding annual meeting of New Stem stockholders; or (D) pursuant to and in accordance with that certain Investor Rights Agreement. Clause (C) is the exclusive means for a stockholder to make nominations or propose other business at an annual meeting of stockholders, other | | | If any person(s) other than the Stem board of directors calls a special meeting, the request shall: (i) be in writing; (ii) specify the time of such meeting and the general nature of the business proposed to be transacted; and (iii) be delivered personally or sent by registered mail or by facsimile transmission to the chairperson of the board of directors, the chief executive officer, the president (in the absence of a chief executive officer) or the secretary of Stem. The officer(s) receiving the request shall cause notice to be promptly given to the stockholders entitled to vote at such meeting. No business may be transacted at such special meeting other than the business specified in such notice to stockholders. | |
STPK
|
| |
New Stem
|
| |
Stem
|
|
stockholders, other than a proposal included in STPK’s proxy statement pursuant to and in compliance with Rule 14a-8 under the Exchange Act.
Only such business shall be conducted at a special meeting of STPK stockholders as shall have been brought before the meeting pursuant to STPK’s notice of meeting. Nominations of persons for election to the board of directors may be made at a special meeting of stockholders at which directors are to be elected pursuant to the STPK’s notice of meeting by any STPK stockholder of record entitled to vote at such meeting, pursuant to the requirements set forth in the STPK bylaws, including the requirement to provide notice not earlier than the 120th day prior to such special meeting and not later than the close of business on the later of the 90th day prior to such special meeting or the 10th day following the date on which public announcement of the date of the special meeting is first made by the STPK.
|
| |
than a proposal included in New Stem’s proxy statement pursuant to and in compliance with Rule 14a-8 under the Exchange Act.
Only such business shall be conducted at a special meeting of New Stem stockholders as shall have been brought before the meeting by or at the direction of the New Stem board of directors. Provided that one or more directors are to be elected at such meeting, nominations of persons for election to the New Stem board of directors may be made at a special meeting by any New Stem stockholder of record entitled to vote at such meeting, pursuant to the requirements set forth in the New Stem bylaws, including the requirement to provide notice not earlier than the 120th day prior to such special meeting and not later than the close of business on the later of the 90th day prior to such special meeting or the 10th day following the date on which public announcement of the date of the special meeting and of the nominees proposed by the New Stem board of directors to be elected at such meeting is first made by the New Stem.
|
| | | |
Limitation of Liability of Directors and Officers
|
| ||||||
A director of STPK shall not be personally liable to STPK or its stockholders for monetary damages for breach of fiduciary duty as a director, except to the extent such exemption from liability or limitation thereof is not permitted under the DGCL as the same exists or may hereafter be amended unless they violated their duty of loyalty to STPK or its stockholders, acted in bad faith, knowingly or intentionally violated the law, authorized unlawful payments of dividends, unlawful stock | | | To the fullest extent permitted by the DGCL as the same exists or as may hereafter be amended, no director of New Stem shall be personally liable to New Stem or its stockholders for monetary damages for breach of fiduciary duty as a director. | | | Same as New Stem. | |
STPK
|
| |
New Stem
|
| |
Stem
|
|
purchases or unlawful redemptions, or derived improper personal benefit from their actions as directors. | | | | | | | |
Indemnification of Directors, Officers, Employees and Agents
|
| ||||||
To the fullest extent permitted by applicable law, as the same exists or may hereafter be amended, STPK shall indemnify and hold harmless each person who is or was made a party or is threatened to be made a party to or is otherwise involved in any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (a “proceeding”) by reason of the fact that he or she is or was a director or officer of STPK or, while a director or officer of STPK, is or was serving at the request of STPK as a director, officer, employee or agent of another corporation or of a partnership, joint venture, trust, other enterprise or nonprofit entity, including service with respect to an employee benefit plan, whether the basis of such proceeding is alleged action in an official capacity as a director, officer, employee or agent, or in any other capacity while serving as a director, officer, employee or agent, against all liability and loss suffered and expenses (including, without limitation, attorneys’ fees, judgments, fines, ERISA excise taxes and penalties and amounts paid in settlement) reasonably incurred by such indemnitee in connection with such proceeding. STPK shall to the fullest extent not prohibited by applicable law pay the expenses (including attorneys’ fees) incurred by an indemnitee in defending or otherwise participating in any proceeding in advance of its final disposition; provided, however, that, to the | | | Same as STPK. | | | Stem shall have the power to indemnify, to the extent permitted by the DGCL, as it presently exists or may hereafter be amended from time to time, any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative by reason of the fact that he or she is or was a director, officer, employee or agent of Stem or is or was serving at the request of Stem as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, including service with respect to employee benefit plans, against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with any such proceeding. | |
STPK
|
| |
New Stem
|
| |
Stem
|
|
extent required by applicable law, such payment of expenses in advance of the final disposition of the proceeding shall be made only upon receipt of an undertaking, by or on behalf of the indemnitee, to repay all amounts so advanced if it shall ultimately be determined that the indemnitee is not entitled to be indemnified. | | | | | | | |
Dividends, Distributions and Stock Repurchases
|
| ||||||
Subject to applicable law, the rights, if any, of the holders of any outstanding series of the Preferred Stock and the business combination redemption rights provided under Article IX of STPK’s existing charter, the holders of STPK common stock shall be entitled to receive any dividends to the extent permitted by law when, as and if declared by the STPK board of directors. | | | Subject to the rights of the holders of any outstanding series of Preferred Stock, the holders of shares of New Stem Common Stock shall be entitled to receive any dividends to the extent permitted by law when, as and if declared by the New Stem board of directors. | | | Holders of Series D’ Preferred Stock, Series D Preferred Stock and holders of other Stem Senior Preferred Stock shall be entitled to receive dividends, when, as and if declared by the Stem board of directors, out of any assets at the time legally available therefor, at the dividend rates specified under the Stem certificate and according to the payment preferences and priority established under the Stem certificate. After the payment or setting aside for payment of such dividends, any additional dividends (other than dividends on common stock payable solely in common stock) set aside or paid in any fiscal year shall be set aside or paid among the holders of the Stem preferred stock and common stock then outstanding in proportion to the greatest whole number of shares of common stock which would be held by each such holder if all shares of preferred stock were converted at the then-effective conversion rate as established under the Stem certificate. | |
Liquidation
|
| ||||||
Subject to applicable law, the rights, if any, of the holders of any outstanding series of the Preferred Stock and the business combination redemption rights provided under Article IX of STPK’s existing charter, in the | | | Upon the dissolution, liquidation or winding up of New Stem, subject to the rights of the holders of any outstanding series of Preferred Stock, the holders of shares of New Stem Common Stock shall be entitled to receive | | | In the event of any liquidation, dissolution or winding up of Stem, either voluntary or involuntary, the holders of Stem Senior Preferred Stock shall receive liquidation distributions according to the priorities | |
STPK
|
| |
New Stem
|
| |
Stem
|
|
event of any voluntary or involuntary liquidation, dissolution or winding up of STPK, after payment or provision for payment of the debts and other liabilities of Stem, the holders of shares of common stock shall be entitled to receive all the remaining assets of STPK available for distribution to its stockholders, ratably in proportion to the number of shares of Class A Common Stock (on an as converted basis with respect to the Class B Common Stock) held by them. | | | the assets of New Stem available for distribution to its stockholders ratably in proportion to the number of shares held by them. | | |
applicable to each series of Stem Senior Preferred Stock established under the Stem certificate equal to the sum of (i) the liquidation preference applicable to each series of Stem Senior Preferred Stock as established under the Stem certificate and (ii) all declared but unpaid dividends (if any) on such series of preferred stock. If upon the liquidation, dissolution or winding up of Stem, the assets of Stem legally available for distribution to the holders a series of Stem Senior Preferred Stock are insufficient to permit the payment to such holders of the full amounts specified in the Stem certificate then the entire assets of Stem legally available for distribution shall be distributed with equal priority and pro rata among the holders of the relevant series of preferred stock on a pari passu basis in proportion to the full amounts they would otherwise be entitled to receive pursuant to the Stem certificate.
After the payment or setting aside for payment to the holders of the Stem Senior Preferred Stock of the full amounts specified in the Stem certificate, the entire remaining assets of Stem legally available for distribution shall be distributed with equal priority and pro rata among the holders of the Stem Series 1 Preferred Stock and the common stock in proportion to the number of shares of common stock held by them, with the shares of Series 1 Preferred Stock being treated for this purpose as if they had been converted to shares of common stock at the then applicable Conversion Rate (as defined in the Stem certificate) established under the Stem certificate.
|
|
Conversion
|
| ||||||
Shares of Class B Common Stock
|
| |
There will be no conversion rights
|
| | Each share of Stem Senior | |
STPK
|
| |
New Stem
|
| |
Stem
|
|
shall be convertible into shares of Class A Common Stock on a one-for-one basis at any time and from time to time at the option of the holder thereof and automatically on the closing of the business combination subject to the terms and conversion ratios set forth in the STPK certificate. | | | relating to the New Stem Common Stock. | | | Preferred Stock shall be convertible, according to the conversion mechanisms and subject to adjustments to the conversion price for diluting issues established under the Stem certificate, at the option of the holder thereof, at any time after the date of issuance of such share, into that number of fully-paid, nonassessable shares of common stock determined by dividing the original issue price for such series of Stem Senior Preferred Stock by the Conversion Price (as defined in the Stem certificate) for such series. Each share of Stem Senior Preferred Stock shall automatically be converted into fully-paid, non-assessable shares of common stock at the then effective Conversion Rate (as defined in the Stem certificate) for such share (i) immediately prior to the closing of a Qualified IPO (as defined in the Stem certificate), or (ii) upon the receipt by Stem of a written request for such conversion from the holders of the Requisite Threshold (as defined in the Stem certificate), or, if later, the effective date for conversion specified in such request. | |
Anti-Takeover Provisions and other Stockholder Protections
|
| ||||||
STPK is not subject to Section 203 of the DGCL; however, the STPK certificate contains a similar provision to Section 203 of the DGCL that excludes Star Peak Sponsor LLC and its affiliates from the definition of “interested stockholder.” | | | New Stem is subject to Section 203 of the DGCL, which prohibits a Delaware corporation from engaging in a “business combination” with an “interested stockholder” (i.e., a stockholder owning 15% or more of New Stem’s voting stock) for three (3) years following the time that the “interested stockholder” becomes such, subject to certain exceptions. | | | Stem is subject to Section 203 of the DGCL. | |
Stockholder Rights Plan
|
| ||||||
While Delaware law does not include a statutory provision | | | Same as STPK. | | | Same as STPK. | |
Investor
|
| |
Shares of
Series D Preferred Stock upon Conversion |
| |
Aggregate
Principal Amount ($) |
| ||||||
Angeleno Investors III, L.P.(1)
|
| | | | 775,537 | | | | | | 1,069,698 | | |
Mithril LP(2)
|
| | | | 3,567,471 | | | | | | 4,920,614 | | |
Mitsui & Co., Ltd.(3)
|
| | | | 1,945,994 | | | | | | 2,684,110 | | |
Investor
|
| |
Shares of
Series D Preferred Stock Purchased |
| |
Shares of
Common Stock Issued |
| |
Aggregate
Purchase Price ($) |
| |||||||||
Activate Capital Partners, L.P.(1)
|
| | | | 9,787,290 | | | | | | 716,826 | | | | | | 15,000,001 | | |
Esta Investments Pte. Ltd.(2)
|
| | | | 9,787,290 | | | | | | 716,826 | | | | | | 15,000,001 | | |
2561549 Ontario Limited.(3)
|
| | | | 19,574,579 | | | | | | 1,433,652 | | | | | | 30,000,000 | | |
OPG Investments Inc.(2)
|
| | | | 9,787,290 | | | | | | 716,826 | | | | | | 15,000,001 | | |
Investor
|
| |
Shares of
Series D’ Preferred Stock Received |
| |
Aggregate
Principal Amount ($) |
| ||||||
2561549 Ontario Limited(1)
|
| | | | 19,574,579 | | | | | | 14,649,022 | | |
RWE Supply & Trading GMBH(2)
|
| | | | 17,418,622 | | | | | | 9,654,893 | | |
Angeleno Investors III, L.P.(3)
|
| | | | 14,709,373 | | | | | | 9,264,648 | | |
Activate Capital Partners, L.P.(4)
|
| | | | 9,787,290 | | | | | | 7,063,722 | | |
Mitsui & Co., Ltd.(5)
|
| | | | 3,250,966 | | | | | | 2,000,000 | | |
David Buzby(6)
|
| | | | 254,888 | | | | | | 2,000,000 | | |
Copec Overseas S.P.A.(7)
|
| | | | 19,711,869(8) | | | | | | 30,000,000(8) | | |
|
I.
Index to Audited Financial Statements of Star Peak Energy Transition Corp. as of December 31, 2019 and for the Period from October 29, 2018 (inception) through December 31, 2019
|
| | | | | | |
| | | | | F-2 | | | |
| | | | | F-3 | | | |
| | | | | F-4 | | | |
| | | | | F-5 | | | |
| | | | | F-6 | | | |
| | | | | F-7 | | |
|
II.
Index to Unaudited Condensed Financial Statements of Star Peak Energy Transition Corp. as of
September 30, 2020 and for the Nine Months ended September 30, 2020
|
| | | | | | |
| | | | | F-18 | | | |
| | | | | F-19 | | | |
| | | | | F-20 | | | |
| | | | | F-21 | | | |
| | | | | F-22 | | |
|
III.
Index to Audited Consolidated Financial Statements of Stem, Inc. as of and for the Years ended December 31, 2019 and December 31, 2018
|
| | | | | | |
| | | | | F-36 | | | |
| | | | | F-37 | | | |
| | | | | F-38 | | | |
| | | | | F-39 | | | |
| | | | | F-40 | | | |
| | | | | F-41 | | | |
| | | | | F-42 | | |
|
IV.
Index to Unaudited Condensed Consolidated Financial Statements of Stem, Inc. as of
September 30, 2020 and for the Nine Months ended September 30, 2020 and September 30, 2019
|
| | | | | | |
| | | | | F-76 | | | |
| | | | | F-77 | | | |
| | | | | F-78 | | | |
| | | | | F-79 | | | |
| | | | | F-80 | | | |
| | | | | F-81 | | |
| | |
December 31,
|
| |||||||||
| | |
2019
|
| |
2018
|
| ||||||
Assets: | | | | | | | | | | | | | |
Current assets: | | | | | | | | | | | | | |
Cash
|
| | | $ | — | | | | | $ | 159,672 | | |
Prepaid expenses
|
| | | | 1,594 | | | | | | — | | |
Total current assets
|
| | | | 1,594 | | | | | | 159,672 | | |
Deferred offering costs associated with the proposed public offering
|
| | | | 251,424 | | | | | | 322,078 | | |
Total assets
|
| | | $ | 253,018 | | | | | $ | 481,750 | | |
Liabilities and Stockholder’s Equity: | | | | | | | | | | | | | |
Current liabilities: | | | | | | | | | | | | | |
Accounts payable
|
| | | $ | 35,093 | | | | | $ | 871 | | |
Accrued expenses
|
| | | | 154,174 | | | | | | 284,328 | | |
Franchise tax payable
|
| | | | — | | | | | | 4,695 | | |
Note payable
|
| | | | 57,301 | | | | | | 175,000 | | |
Total current liabilities
|
| | | | 246,568 | | | | | | 464,894 | | |
Commitments | | | | | | | | | | | | | |
Stockholder’s Equity: | | | | | | | | | | | | | |
Preferred stock, 0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
|
| | | | — | | | | | | — | | |
Class A common stock, 0.0001 par value; 400,000,000 shares authorized; none issued and outstanding
|
| | | | — | | | | | | — | | |
Class B common stock, 0.0001 par value; 40,000,000 shares authorized; 10,062,500 shares issued and outstanding(1)
|
| | | | 1,006 | | | | | | 1,006 | | |
Additional paid-in capital
|
| | | | 23,994 | | | | | | 23,994 | | |
Accumulated deficit
|
| | | | (18,550) | | | | | | (8,144) | | |
Total stockholder’s equity
|
| | | | 6,450 | | | | | | 16,856 | | |
Total Liabilities and Stockholder’s Equity
|
| | | $ | 253,018 | | | | | $ | 481,750 | | |
| | |
For the year ended
December 31, 2019 |
| |
For the period from
October 29, 2018 (inception) through December 31, 2018 |
| ||||||
General and administrative expenses
|
| | | $ | 9,566 | | | | | $ | 3,449 | | |
Franchise tax expense
|
| | | | 840 | | | | | | 4,695 | | |
Net loss
|
| | | $ | (10,406) | | | | | $ | (8,144) | | |
Weighted average shares outstanding, basic and diluted(1)
|
| | | | 8,750,000 | | | | | | 8,750,000 | | |
Basic and diluted net loss per share
|
| | | $ | (0.00) | | | | | $ | (0.00) | | |
| | |
For the year ended December 31, 2019 and for the period October 29, 2018 (inception)
through December 31, 2018 |
| |||||||||||||||||||||||||||||||||||||||
| | |
Common Stock
|
| |
Additional
Paid-In Capital |
| |
Equity
Accumulated Deficit |
| |
Total
Stockholder’s |
| ||||||||||||||||||||||||||||||
| | |
Class A
|
| |
Class B
|
| ||||||||||||||||||||||||||||||||||||
| | |
Shares
|
| |
Amount
|
| |
Shares
|
| |
Amount
|
| ||||||||||||||||||||||||||||||
Balance – October 29, 2018 (inception)
|
| | | | — | | | | | $ | — | | | | | | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | |
Issuance of Class B common stock to Sponsor(1)
|
| | | | — | | | | | | — | | | | | | 10,062,500 | | | | | | 1,006 | | | | | | 23,994 | | | | | | — | | | | | | 25,000 | | |
Net loss
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (8,144) | | | | | | (8,144) | | |
Balance – December 31, 2018
|
| | | | — | | | | | | — | | | | | | 10,062,500 | | | | | | 1,006 | | | | | | 23,994 | | | | | | (8,144) | | | | | | 16,856 | | |
Net loss
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (10,406) | | | | | | (10,406) | | |
Balance – December 31, 2019
|
| | | | — | | | | | $ | — | | | | | | 10,062,500 | | | | | $ | 1,006 | | | | | $ | 23,994 | | | | | $ | (18,550) | | | | | $ | 6,450 | | |
| | |
For the year ended
December 31, 2019 |
| |
For the period from
October 29, 2018 (inception) through December 31, 2018 |
| ||||||
Cash Flows from Operating Activities: | | | | | | | | | | | | | |
Net loss
|
| | | $ | (10,406) | | | | | $ | (8,144) | | |
Adjustments to reconcile net loss to net cash used in operating activities:
|
| | | | | | | | | | | | |
General and administrative expenses paid by related party under note payable
|
| | | | 7,129 | | | | | | — | | |
Changes in operating assets and liabilities: | | | | | | | | | | | | | |
Prepaid expenses
|
| | | | (1,594) | | | | | | — | | |
Accounts payable
|
| | | | (778) | | | | | | 871 | | |
Franchise tax payable
|
| | | | (4,695) | | | | | | 4,695 | | |
Net cash used in operating activities
|
| | | | (10,344) | | | | | | (2,578) | | |
Cash Flows from Financing Activities: | | | | | | | | | | | | | |
Proceeds from issuance of Class B common stock to Sponsor
|
| | | | — | | | | | | 25,000 | | |
Proceeds from note payable to related party
|
| | | | — | | | | | | 175,000 | | |
Repayment of note payable to related party
|
| | | | (124,828) | | | | | | — | | |
Payment of deferred offering costs
|
| | | | (24,500) | | | | | | (37,750) | | |
Net cash provided by (used in) financing activities
|
| | | | (149,328) | | | | | | 162,250 | | |
Net change in cash
|
| | | | (159,672) | | | | | | 159,672 | | |
Cash – beginning of the period
|
| | | | 159,672 | | | | | | — | | |
Cash – end of the period
|
| | | $ | — | | | | | $ | 159,672 | | |
Supplemental disclosure of noncash activities: | | | | | | | | | | | | | |
Deferred offering costs included in accrued expenses
|
| | | $ | 19,046 | | | | | $ | 284,328 | | |
Deferred offering costs included in accounts payable
|
| | | $ | 35,000 | | | | | $ | — | | |
Reduction of deferred offering costs and accrued expenses
|
| | | $ | (139,200) | | | | | $ | — | | |
Reclassification of accrued offering costs to accounts payable
|
| | | $ | — | | | | | $ | — | | |
Accounts payable paid by Sponsor
|
| | | $ | — | | | | | $ | — | | |
| | |
December 31,
|
| |||||||||
| | |
2019
|
| |
2018
|
| ||||||
Current | | | | | | | | | | | | | |
Federal
|
| | | $ | — | | | | | $ | — | | |
State
|
| | | | — | | | | | | — | | |
Deferred | | | | | | | | | | | | | |
Federal
|
| | | | 2,185 | | | | | | 1,710 | | |
State
|
| | | | — | | | | | | — | | |
Change in valuation allowance
|
| | | | (2,185) | | | | | | (1,710) | | |
Income tax provision
|
| | | $ | — | | | | | $ | — | | |
| | |
December 31,
|
| |||||||||
| | |
2019
|
| |
2018
|
| ||||||
Deferred tax asset | | | | | | | | | | | | | |
Net operating loss carryforward
|
| | | $ | 1,162 | | | | | $ | 986 | | |
Startup/Organizational Costs
|
| | | | 2,733 | | | | | | 724 | | |
Total deferred tax assets
|
| | | | 3,895 | | | | | | 1,710 | | |
Valuation Allowance
|
| | | | (3,895) | | | | | | (1,710) | | |
Deferred tax asset, net of allowance
|
| | | $ | — | | | | | $ | — | | |
| | |
December 31,
|
| |||||||||
| | |
2019
|
| |
2018
|
| ||||||
Statutory federal income tax rate
|
| | | | 21.0% | | | | | | 21.0% | | |
State taxes, net of federal tax benefit
|
| | | | 0.0% | | | | | | 0.0% | | |
Valuation allowance
|
| | | | (21.0)% | | | | | | (21.0)% | | |
Income tax provision
|
| | | | 0.0% | | | | | | 0.0% | | |
| | |
September 30,
2020 |
| |
December 31,
2019 |
| ||||||
| | |
(Unaudited)
|
| | | | | | | |||
Assets: | | | | | | | | | | | | | |
Current assets: | | | | | | | | | | | | | |
Cash
|
| | | $ | 1,840,514 | | | | | $ | — | | |
Prepaid expenses
|
| | | | 735,475 | | | | | | 1,594 | | |
Total current assets
|
| | | | 2,575,989 | | | | | | 1,594 | | |
Deferred offering costs associated with initial public offering
|
| | | | — | | | | | | 251,424 | | |
Investments held in Trust Account
|
| | | | 383,603,554 | | | | | | — | | |
Total Assets
|
| | | $ | 386,179,543 | | | | | $ | 253,018 | | |
Liabilities and Stockholders’ Equity: | | | | | | | | | | | | | |
Current liabilities: | | | | | | | | | | | | | |
Accounts payable
|
| | | $ | 445,093 | | | | | $ | 35,093 | | |
Accrued expenses
|
| | | | 121,296 | | | | | | 154,174 | | |
Note payable
|
| | | | — | | | | | | 57,301 | | |
Franchise tax payable
|
| | | | 149,639 | | | | | | — | | |
Total current liabilities
|
| | | | 716,028 | | | | | | 246,568 | | |
Deferred legal fees
|
| | | | 203,910 | | | | | | — | | |
Deferred underwriting commissions in connection with the initial public offering
|
| | | | 13,425,476 | | | | | | — | | |
Total liabilities
|
| | | | 14,345,414 | | | | | | 246,568 | | |
Commitments | | | | | | | | | | | | | |
Class A common stock, 0.0001 par value; 36,683,412 and -0- shares subject to
possible redemption at 10.00 per share as of September 30, 2020 and December 31, 2019, respectively |
| | | | 366,834,120 | | | | | | — | | |
Stockholders’ Equity: | | | | | | | | | | | | | |
Preferred stock, 0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
|
| | | | — | | | | | | — | | |
Class A common stock, 0.0001 par value; 400,000,000 shares authorized; 1,675,092 and -0- shares issued and outstanding (excluding 36,683,412 and -0- shares subject to possible redemption) as of September 30, 2020 and December 31, 2019, respectively
|
| | | | 168 | | | | | | — | | |
Class B common stock, 0.0001 par value; 40,000,000 shares authorized; 9,589,626 and 10,062,500 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively(1)
|
| | | | 959 | | | | | | 1,006 | | |
Additional paid-in capital
|
| | | | 5,394,034 | | | | | | 23,994 | | |
Accumulated deficit
|
| | | | (395,152) | | | | | | (18,550) | | |
Total stockholders’ equity
|
| | | | 5,000,009 | | | | | | 6,450 | | |
Total Liabilities and Stockholders’ Equity
|
| | | $ | 386,179,543 | | | | | $ | 253,018 | | |
| | |
For The Three Months Ended
September 30, |
| |
For The Nine Months Ended
September 30, |
| ||||||||||||||||||
| | |
2020
|
| |
2019
|
| |
2020
|
| |
2019
|
| ||||||||||||
General and administrative expenses
|
| | | $ | 110,673 | | | | | $ | 1,080 | | | | | $ | 110,673 | | | | | $ | 9,566 | | |
General and administrative expenses – related party
|
| | | | 133,210 | | | | | | — | | | | | | 133,210 | | | | | | — | | |
Franchise tax expense
|
| | | | 149,033 | | | | | | — | | | | | | 151,233 | | | | | | 390 | | |
Loss from operations
|
| | | | 392,916 | | | | | | 1,080 | | | | | | 395,116 | | | | | | 9,956 | | |
Other income: | | | | | | | | | | | | | | | | | | | | | | | | | |
Gain on investment (net), dividends and interest
held in Trust Account |
| | | | 18,514 | | | | | | — | | | | | | 18,514 | | | | | | — | | |
Loss before income tax benefit
|
| | | | 18,514 | | | | | | — | | | | | | 18,514 | | | | | | — | | |
Income tax benefit
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Net loss
|
| | | $ | (374,402) | | | | | $ | (1,080) | | | | | $ | (376,602) | | | | | $ | (9,956) | | |
Weighted average Class A ordinary shares outstanding, basic and diluted
|
| | | | 37,878,718 | | | | | | — | | | | | | 37,878,718 | | | | | | — | | |
Basic and diluted net loss per ordinary share, Class A
|
| | | $ | (0.00) | | | | | $ | — | | | | | $ | (0.00) | | | | | $ | — | | |
Weighted average Class B ordinary shares outstanding, basic and diluted(1)
|
| | | | 9,589,626 | | | | | | 9,589,626 | | | | | | 9,589,626 | | | | | | 9,589,626 | | |
Basic and diluted net loss per ordinary share, Class B
|
| | | $ | (0.04) | | | | | $ | (0.00) | | | | | $ | (0.04) | | | | | $ | (0.00) | | |
| | |
For The Three and Nine Months Ended September 30, 2020
|
| |||||||||||||||||||||||||||||||||||||||
| | |
Common Stock
|
| |
Additional
Paid-In Capital |
| |
Accumulated
Deficit |
| |
Total
Stockholders’ Equity |
| ||||||||||||||||||||||||||||||
| | |
Class A
|
| |
Class B
|
| ||||||||||||||||||||||||||||||||||||
| | |
Shares
|
| |
Amount
|
| |
Shares
|
| |
Amount
|
| ||||||||||||||||||||||||||||||
Balance – December 31, 2019
|
| | | | — | | | | | $ | — | | | | | | 10,062,500 | | | | | $ | 1,006 | | | | | $ | 23,994 | | | | | $ | (18,550) | | | | | $ | 6,450 | | |
Net loss
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Balance – March 31, 2020 (unaudited)
|
| | | | — | | | | | | — | | | | | | 10,062,500 | | | | | | 1,006 | | | | | | 23,994 | | | | | | (18,550) | | | | | | 6,450 | | |
Net loss
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (2,200) | | | | | | (2,200) | | |
Balance – June 30, 2020 (unaudited)
|
| | | | — | | | | | $ | — | | | | | | 10,062,500 | | | | | | 1,006 | | | | | | 23,994 | | | | | | (20,750) | | | | | | 4,250 | | |
Sale of units in initial public offering, gross
|
| | | | 38,358,504 | | | | | | 3,836 | | | | | | — | | | | | | — | | | | | | 383,581,204 | | | | | | — | | | | | | 383,585,040 | | |
Offering costs
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (22,152,459) | | | | | | — | | | | | | (22,152,459) | | |
Sale of private placement warrants to Sponsor in private placement
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 10,771,700 | | | | | | — | | | | | | 10,771,700 | | |
Class B common stock
forfeited |
| | | | — | | | | | | — | | | | | | (472,874) | | | | | | (47) | | | | | | 47 | | | | | | — | | | | | | — | | |
Class A common stock subject to
possible redemption |
| | | | (36,683,412) | | | | | | (3,668) | | | | | | — | | | | | | — | | | | | | (366,830,452) | | | | | | — | | | | | | (366,834,120) | | |
Net loss
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (374,402) | | | | | | (374,402) | | |
Balance – September 30, 2020
|
| | | | 1,675,092 | | | | | $ | 168 | | | | | | 9,589,626 | | | | | $ | 959 | | | | | $ | 5,394,034 | | | | | $ | (395,152) | | | | | $ | 5,000,009 | | |
Balance – December 31, 2018
|
| | | | — | | | | | $ | — | | | | | | 10,062,500 | | | | | $ | 1,006 | | | | | $ | 23,994 | | | | | $ | (8,144) | | | | | $ | 16,856 | | |
Net loss
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (8,798) | | | | | | (8,798) | | |
Balance – March 31, 2019 (unaudited)
|
| | | | — | | | | | | — | | | | | | 10,062,500 | | | | | | 1,006 | | | | | | 23,994 | | | | | | (16,942) | | | | | | 8,058 | | |
Net loss
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (78) | | | | | | (78) | | |
Balance – June 30, 2019 (unaudited)
|
| | | | — | | | | | | — | | | | | | 10,062,500 | | | | | | 1,006 | | | | | | 23,994 | | | | | | (17,020) | | | | | | 7,980 | | |
Net loss
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (1,080) | | | | | | (1,080) | | |
Balance -September 30, 2019 (unaudited)
|
| | | | — | | | | | $ | — | | | | | | 10,062,500 | | | | | $ | 1,006 | | | | | $ | 23,994 | | | | | $ | (18,100) | | | | | $ | 6,900 | | |
|
| | |
For The Nine Months Ended
September 30, |
| |||||||||
| | |
2020
|
| |
2019
|
| ||||||
Cash Flows from Operating Activities: | | | | | | | | | | | | | |
Net loss
|
| | | $ | (376,602) | | | | | $ | (9,956) | | |
Adjustments to reconcile net loss to net cash used in operating activities:
|
| | | | | | | | | | | | |
Gain on investment (net), dividends and interest held in Trust Account
|
| | | | (18,514) | | | | | | — | | |
Changes in operating assets and liabilities: | | | | | | | | | | | | | |
Prepaid expenses
|
| | | | (733,881) | | | | | | — | | |
Franchise tax payable
|
| | | | 149,639 | | | | | | 390 | | |
Accounts payable
|
| | | | 20,000 | | | | | | (778) | | |
Accrued expenses
|
| | | | 24,622 | | | | | | — | | |
Net cash used in operating activities
|
| | | | (934,736) | | | | | | (10,344) | | |
Cash Flows from Investing Activities | | | | | | | | | | | | | |
Cash deposited in Trust Account
|
| | | | (383,585,040) | | | | | | — | | |
Net cash used in investing activities
|
| | | | (383,585,040) | | | | | | — | | |
Cash Flows from Financing Activities: | | | | | | | | | | | | | |
Proceeds from note payable to related party
|
| | | | 200,000 | | | | | | — | | |
Repayment of note payable to related party
|
| | | | (292,301) | | | | | | (124,828) | | |
Proceeds received from initial public offering, gross
|
| | | | 383,585,040 | | | | | | — | | |
Proceeds received from private placement
|
| | | | 10,771,700 | | | | | | — | | |
Offering costs paid
|
| | | | (7,904,149) | | | | | | (24,500) | | |
Net cash provided by (used in) financing activities
|
| | | | 386,360,290 | | | | | | (149,328) | | |
Net change in cash
|
| | | | 1,840,514 | | | | | | (159,672) | | |
Cash – beginning of the period
|
| | | | — | | | | | | 159,672 | | |
Cash – end of the period
|
| | | $ | 1,840,514 | | | | | $ | — | | |
Supplemental disclosure of noncash activities: | | | | | | | | | | | | | |
Offering costs included in accounts payable
|
| | | $ | 292,500 | | | | | $ | 35,000 | | |
Offering costs included in accrued expenses
|
| | | $ | 75,000 | | | | | $ | 19,046 | | |
Adjust offering costs against accrued expenses
|
| | | $ | — | | | | | $ | (149,200) | | |
Deferred legal fees
|
| | | $ | 203,910 | | | | | $ | — | | |
Deferred underwriting commissions in connection with the initial public offering
|
| | | $ | 13,425,476 | | | | | $ | — | | |
Reclassification of accrued offering costs to accounts payable
|
| | | $ | (132,500) | | | | | $ | — | | |
Accounts payable paid by Sponsor
|
| | | $ | (35,000) | | | | | $ | — | | |
Initial value of Class A common stock subject to possible redemption
|
| | | $ | 334,952,900 | | | | | $ | — | | |
Change in value of Class A common stock subject to possible redemption
|
| | | $ | 31,881,220 | | | | | $ | — | | |
Forfeiture of Class B common stock
|
| | | $ | 47 | | | | | $ | — | | |
Description
|
| |
Quoted Prices in
Active Markets (Level 1) |
| |
Significant Other
Observable Inputs (Level 2) |
| |
Significant Other
Unobservable Input (Level 3) |
| |||||||||
Investments held in Trust Account
|
| | | | | | | | | | | | | | | | | | |
U.S. Treasury Securities
|
| | | $ | 383,603,554 | | | | | $ | — | | | | | $ | — | | |
| | | | $ | 383,603,554 | | | | | $ | | | | | $ | | | |
| | |
Page
|
| |||
Index to Audited Consolidated Financial Statements | | | | | | | |
| | | | F-36 | | | |
Financial Statements: | | | | | | | |
| | | | F-37 | | | |
| | | | F-38 | | | |
| | | | F-39 | | | |
| | | | F-40 | | | |
| | | | F-41 | | | |
| | | | F-42 | | |
| | |
December 31,
|
| |||||||||
| | |
2019
|
| |
2018
|
| ||||||
ASSETS | | | | | | | | | | | | | |
Current assets: | | | | | | | | | | | | | |
Cash and cash equivalents
|
| | | $ | 12,889 | | | | | $ | 21,894 | | |
Accounts receivable, net
|
| | | | 6,619 | | | | | | 1,500 | | |
Inventory, net
|
| | | | 3,580 | | | | | | 2,007 | | |
Other current assets (includes $483 and $2,826 due from related parties as of December 31,
2019 and 2018, respectively) |
| | | | 2,121 | | | | | | 5,316 | | |
Deferred costs with suppliers
|
| | | | 3,589 | | | | | | 700 | | |
Total current assets
|
| | | | 28,798 | | | | | | 31,417 | | |
Energy storage systems, net
|
| | | | 131,569 | | | | | | 101,215 | | |
Contract origination costs, net
|
| | | | 8,608 | | | | | | 7,811 | | |
Goodwill
|
| | | | 1,695 | | | | | | 1,625 | | |
Intangible assets, net
|
| | | | 10,695 | | | | | | 8,658 | | |
Other noncurrent assets
|
| | | | 6,682 | | | | | | 4,868 | | |
Total assets
|
| | | $ | 188,047 | | | | | $ | 155,594 | | |
LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT
|
| | | | | | | | | | | | |
Current liabilities: | | | | | | | | | | | | | |
Accounts payable
|
| | | $ | 12,691 | | | | | $ | 4,887 | | |
Accrued liabilities
|
| | | | 7,307 | | | | | | 3,006 | | |
Accrued payroll
|
| | | | 5,573 | | | | | | 5,504 | | |
Notes payable, current portion
|
| | | | 28,895 | | | | | | 48,502 | | |
Convertible promissory notes (includes $24,102 due to related parties as of December 31, 2019)
|
| | | | 34,925 | | | | | | — | | |
Financing obligation, current portion
|
| | | | 6,373 | | | | | | 7,763 | | |
Deferred revenue, current
|
| | | | 10,948 | | | | | | 2,919 | | |
Other current liabilities (includes $190 and $153 due to related parties as of December 31, 2019 and 2018, respectively)
|
| | | | 2,636 | | | | | | 2,288 | | |
Total current liabilities
|
| | | | 109,348 | | | | | | 74,869 | | |
Deferred revenue, noncurrent
|
| | | | 9,780 | | | | | | 8,940 | | |
Asset retirement obligation
|
| | | | 5,759 | | | | | | 6,092 | | |
Notes payable, noncurrent
|
| | | | 6,568 | | | | | | 7,066 | | |
Financing obligation, noncurrent
|
| | | | 74,640 | | | | | | 46,772 | | |
Warrant liabilities
|
| | | | 6,094 | | | | | | 1,700 | | |
Lease liability, noncurrent
|
| | | | 390 | | | | | | 1,265 | | |
Total liabilities
|
| | | | 212,579 | | | | | | 146,704 | | |
Commitments and contingencies (Note 19) | | | | | | | | | | | | | |
Convertible preferred stock, $0.00001 par value; 321,346,716 and 219,344,673 shares
authorized as of December 31, 2019 and 2018, respectively; 191,139,933 and 186,466,181 shares issued and outstanding as of December 31, 2019 and 2018, respectively; (liquidation preference of $258,041 and $226,929 as of December 31, 2019 and 2018, respectively) |
| | | | 231,129 | | | | | | 218,931 | | |
Stockholders’ Deficit: | | | | | | | | | | | | | |
Series 1 convertible preferred stock, $0.00001 par value; 4,305 shares authorized as of December 31, 2019 and 2018; 2,961 and 3,405 shares issued and outstanding as of December 31, 2019 and 2018, respectively
|
| | | | — | | | | | | — | | |
Common stock, $0.000001 par value; 386,728,323 and 278,728,323 authorized as of December 31, 2019 and 2018, respectively; 9,392,682 and 9,583,163 issued and outstanding as of December 31, 2019 and 2018, respectively
|
| | | | — | | | | | | — | | |
Additional paid-in capital
|
| | | | 3,339 | | | | | | 555 | | |
Accumulated other comprehensive income
|
| | | | 54 | | | | | | — | | |
Accumulated deficit
|
| | | | (259,054) | | | | | | (210,596) | | |
Total stockholders’ deficit
|
| | | | (255,661) | | | | | | (210,041) | | |
Total liabilities, convertible preferred stock and stockholders’ deficit
|
| | | $ | 188,047 | | | | | $ | 155,594 | | |
|
| | |
Years Ended December 31,
|
| |||||||||
| | |
2019
|
| |
2018
|
| ||||||
Service revenue
|
| | | $ | 13,482 | | | | | $ | 6,526 | | |
Hardware revenue
|
| | | | 4,070 | | | | | | 506 | | |
Total revenue
|
| | | | 17,552 | | | | | | 7,032 | | |
Cost of service revenue
|
| | | | 16,958 | | | | | | 9,234 | | |
Cost of hardware revenue
|
| | | | 3,854 | | | | | | 456 | | |
Total cost of revenue
|
| | | | 20,812 | | | | | | 9,690 | | |
Gross margin
|
| | | | (3,260) | | | | | | (2,658) | | |
Operating expenses: | | | | | | | | | | | | | |
Sales and marketing
|
| | | | 17,462 | | | | | | 16,226 | | |
Research and development
|
| | | | 14,703 | | | | | | 12,677 | | |
General and administrative
|
| | | | 12,425 | | | | | | 10,855 | | |
Total operating expenses
|
| | | | 44,590 | | | | | | 39,758 | | |
Loss from operations
|
| | | | (47,850) | | | | | | (42,416) | | |
Other income (expense), net: | | | | | | | | | | | | | |
Interest expense
|
| | | | (12,548) | | | | | | (5,533) | | |
Change in fair value of warrants and embedded derivative
|
| | | | 1,493 | | | | | | (253) | | |
Other expenses, net
|
| | | | (503) | | | | | | (832) | | |
Total other income (expense)
|
| | | | (11,558) | | | | | | (6,618) | | |
Loss before income taxes
|
| | | | (59,408) | | | | | | (49,034) | | |
Income tax expense
|
| | | | (6) | | | | | | (13) | | |
Net loss
|
| | | $ | (59,414) | | | | | $ | (49,047) | | |
Net loss per share attributable to common shareholders, basic and diluted
|
| | | $ | (6.05) | | | | | $ | (5.74) | | |
Weighted-average shares used in computing net loss per share, basic and diluted
|
| | | | 10,703,380 | | | | | | 8,541,606 | | |
| | |
Years Ended December 31,
|
| |||||||||
| | |
2019
|
| |
2018
|
| ||||||
Net loss
|
| | | $ | (59,414) | | | | | $ | (49,047) | | |
Other comprehensive income: | | | | | | | | | | | | | |
Foreign currency translation adjustment
|
| | | | 54 | | | | | | — | | |
Total comprehensive loss
|
| | | $ | (59,360) | | | | | $ | (49,047) | | |
| | |
Convertible
Preferred Stock |
| | |
Series 1
Convertible Preferred Stock |
| |
Common Stock
|
| |
Additional
Paid-In Capital |
| |
Accumulated
Other Comprehensive Income |
| |
Accumulated
Deficit |
| |
Total Stem, Inc.
Stockholders’ Deficit |
| |
Non-
controlling Interest |
| |
Total
Stockholders’ Deficit |
| |||||||||||||||||||||||||||||||||||||||||||||
| | |
Shares
|
| |
Amount
|
| | |
Shares
|
| |
Amount
|
| |
Shares
|
| |
Amount
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance at January 1, 2018
|
| | | | 111,882,709 | | | | | $ | 112,429 | | | | | | | 3,405 | | | | | $ | — | | | | | | 4,693,275 | | | | | $ | — | | | | | $ | 4,467 | | | | | $ | — | | | | | $ | (168,390) | | | | | $ | (163,923) | | | | | $ | 444 | | | | | $ | (163,479) | | |
Cumulative effect of adoption of ASC 606
|
| | | | — | | | | | | — | | | | | | | | | | | | | — | | | | | | | | | | | | — | | | | | | | | | | | | — | | | | | | 6,841 | | | | | | 6,841 | | | | | | — | | | | | | 6,841 | | |
Issuance of Series B preferred stock upon exercise of warrant
|
| | | | 45,698 | | | | | | 37 | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Issuance of Series D preferred stock and common stock for cash, net of issuance costs of $4,988
|
| | | | 58,814,245 | | | | | | 83,123 | | | | | | | — | | | | | | — | | | | | | 4,133,681 | | | | | | — | | | | | | 2,026 | | | | | | — | | | | | | — | | | | | | 2,026 | | | | | | — | | | | | | 2,026 | | |
Issuance of Series D preferred stock upon conversion of convertible promissory
notes |
| | | | 15,723,529 | | | | | | 21,687 | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Reclassification of fair value of embedded derivative upon redemption of notes
|
| | | | — | | | | | | 1,655 | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Issuance of common stock upon exercise of options and common stock warrant
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | 756,207 | | | | | | — | | | | | | 50 | | | | | | — | | | | | | — | | | | | | 50 | | | | | | — | | | | | | 50 | | |
Issuance of warrants in conjunction with business combination
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 613 | | | | | | — | | | | | | — | | | | | | 613 | | | | | | — | | | | | | 613 | | |
Stock-based compensation
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 1,257 | | | | | | — | | | | | | — | | | | | | 1,257 | | | | | | — | | | | | | 1,257 | | |
Acquisition of noncontrolling interest
|
| | | | — | | | | | | | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (7,858) | | | | | | — | | | | | | — | | | | | | (7,858) | | | | | | (444) | | | | | | (8,302) | | |
Net loss
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (49,047) | | | | | | (49,047) | | | | | | — | | | | | | (49,047) | | |
Balance as of December 31, 2018
|
| | | | 186,466,181 | | | | | | 218,931 | | | | | | | 3,405 | | | | | | — | | | | | | 9,583,163 | | | | | | — | | | | | | 555 | | | | | | — | | | | | | (210,596) | | | | | | (210,041) | | | | | | — | | | | | | (210,041) | | |
Effect of exchange transaction (Note 12)
|
| | | | (15,035,612) | | | | | | (15,946) | | | | | | | — | | | | | | — | | | | | | (603,874) | | | | | | — | | | | | | — | | | | | | — | | | | | | 10,956 | | | | | | 10,956 | | | | | | — | | | | | | 10,956 | | |
Issuance of warrants to purchase common stock
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 1,217 | | | | | | — | | | | | | — | | | | | | 1,217 | | | | | | — | | | | | | 1,217 | | |
Issuance of Series D preferred stock upon conversion of promissory note
|
| | | | 19,711,869 | | | | | | 28,144 | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Settlement of litigation (Note 19)
|
| | | | (2,505) | | | | | | | | | | | | | (444) | | | | | | — | | | | | | (10,540) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Issuance of common stock upon exercise of stock options and warrants
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | 423,933 | | | | | | — | | | | | | 36 | | | | | | — | | | | | | — | | | | | | 36 | | | | | | — | | | | | | 36 | | |
Stock-based compensation
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 1,531 | | | | | | — | | | | | | — | | | | | | 1,531 | | | | | | — | | | | | | 1,531 | | |
Foreign currency translation adjustments
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 54 | | | | | | — | | | | | | 54 | | | | | | — | | | | | | 54 | | |
Net loss
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (59,414) | | | | | | (59,414) | | | | | | — | | | | | | (59,414) | | |
Balance as of December 31, 2019
|
| | | | 191,139,933 | | | | | $ | 231,129 | | | | | | | 2,961 | | | | | $ | — | | | | | | 9,392,682 | | | | | $ | — | | | | | $ | 3,339 | | | | | $ | 54 | | | | | $ | (259,054) | | | | | $ | (255,661) | | | | | $ | — | | | | | $ | (255,661) | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | |
Years Ended December 31,
|
| |||||||||
| | |
2019
|
| |
2018
|
| ||||||
OPERATING ACTIVITIES
|
| | | | | | | | | | | | |
Net loss
|
| | | $ | (59,414) | | | | | $ | (49,047) | | |
Adjustments to reconcile net loss to net cash used in operating activities:
|
| | | | | | | | | | | | |
Depreciation and amortization expense
|
| | | | 13,889 | | | | | | 6,994 | | |
Non-cash interest expense, including interest expense associated with debt issuance costs
|
| | | | 4,759 | | | | | | 2,055 | | |
Stock-based compensation
|
| | | | 1,531 | | | | | | 1,257 | | |
Change in fair value of warrant liability and embedded derivative
|
| | | | (1,493) | | | | | | 253 | | |
Noncash lease expense
|
| | | | 906 | | | | | | 440 | | |
Accretion expense
|
| | | | 303 | | | | | | 208 | | |
Impairment of energy storage systems
|
| | | | 295 | | | | | | — | | |
Provision for doubtful accounts
|
| | | | 94 | | | | | | 14 | | |
Earnings from equity method investments
|
| | | | (76) | | | | | | (185) | | |
Other
|
| | | | — | | | | | | 166 | | |
Changes in operating assets and liabilities:
|
| | | | | | | | | | | | |
Accounts receivable
|
| | | | (5,206) | | | | | | (203) | | |
Inventory
|
| | | | (1,553) | | | | | | 1,232 | | |
Other assets
|
| | | | (1,860) | | | | | | (4,060) | | |
Contract origination costs
|
| | | | (1,302) | | | | | | (1,901) | | |
Accounts payable and accrued expenses
|
| | | | 10,562 | | | | | | (1,805) | | |
Deferred revenue
|
| | | | 9,007 | | | | | | 645 | | |
Lease liabilities
|
| | | | (230) | | | | | | (529) | | |
Other liabilities
|
| | | | 110 | | | | | | (379) | | |
Net cash used in operating activities
|
| | | | (29,678) | | | | | | (44,845) | | |
INVESTING ACTIVITIES
|
| | | | | | | | | | | | |
Purchase of energy storage systems
|
| | | | (40,995) | | | | | | (55,499) | | |
Capital expenditures on internally-developed software
|
| | | | (5,356) | | | | | | (6,059) | | |
Net assets acquired in business combination
|
| | | | — | | | | | | (3,588) | | |
Distributions from equity method investments
|
| | | | — | | | | | | 802 | | |
Purchase of property and equipment
|
| | | | (7) | | | | | | (31) | | |
Net cash used in investing activities
|
| | | | (46,358) | | | | | | (64,375) | | |
FINANCING ACTIVITIES
|
| | | | | | | | | | | | |
Proceeds from issuance of Series D preferred and common stock, net of issuance costs of $4,989
|
| | | | — | | | | | | 85,184 | | |
Proceeds from exercise of stock options and warrants
|
| | | | 36 | | | | | | 50 | | |
Proceeds from financing obligations
|
| | | | 32,310 | | | | | | 38,554 | | |
Repayment of financing obligations
|
| | | | (7,309) | | | | | | (2,790) | | |
Proceeds from issuance of convertible notes, net of issuance costs of $2,308
|
| | | | 63,250 | | | | | | — | | |
Proceeds from issuance of notes payable
|
| | | | 4,710 | | | | | | 48,100 | | |
Repayment of notes payable
|
| | | | (25,796) | | | | | | (42,273) | | |
Distributions to noncontrolling interest
|
| | | | — | | | | | | (470) | | |
Net cash provided by financing activities
|
| | | | 67,201 | | | | | | 126,355 | | |
Effect of exchange rate changes on cash and cash equivalents
|
| | | | (170) | | | | | | — | | |
Net (decrease) increase in cash and cash equivalents
|
| | | | (9,005) | | | | | | 17,135 | | |
Cash and cash equivalents, beginning of year
|
| | | | 21,894 | | | | | | 4,759 | | |
Cash and cash equivalents, end of year
|
| | | $ | 12,889 | | | | | $ | 21,894 | | |
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
|
| | | | | | | | | | | | |
Cash paid for income taxes
|
| | | $ | 3 | | | | | $ | 11 | | |
Cash paid for interest
|
| | | $ | 8,937 | | | | | $ | 5,552 | | |
NON-CASH INVESTING AND FINANCING ACTIVITIES
|
| | | | | | | | | | | | |
Change in asset retirement costs and asset retirement obligation
|
| | | $ | (636) | | | | | $ | 1,452 | | |
Right-of-use assets obtained in exchange for lease liabilities
|
| | | $ | — | | | | | $ | 397 | | |
Net asset acquired in business combination in exchange for issuance of warrants
|
| | | $ | — | | | | | $ | 613 | | |
Settlement of convertible debt and accrued interest upon issuance of Series D preferred stock
|
| | | $ | — | | | | | $ | 21,687 | | |
Settlement of embedded derivative in exchange for issuance of Series D preferred stock
|
| | | $ | — | | | | | $ | 1,655 | | |
Notes payable obligation in exchange for acquisition of noncontrolling interest
|
| | | $ | — | | | | | $ | (8,000) | | |
Issuance of common stock warrants
|
| | | $ | 1,216 | | | | | $ | — | | |
Conversion of convertible promissory notes and accrued interest into Series D preferred stock
|
| | | $ | 28,144 | | | | | $ | — | | |
| | |
2019
|
| |
2018
|
| ||||||
Partnership hardware revenue
|
| | | $ | 4,070 | | | | | $ | 506 | | |
Partnership service revenue
|
| | | | 6 | | | | | | — | | |
Host customer service revenue
|
| | | | 13,476 | | | | | | 6,526 | | |
Total revenue
|
| | | $ | 17,552 | | | | | $ | 7,032 | | |
| | |
Total remaining
performance obligations |
| |
Percent expected to be recognized as revenue
|
| ||||||||||||||||||
| | |
Less than
one year |
| |
Two to
five years |
| |
Greater than
five years |
| |||||||||||||||
(in thousands, except percentages) | | | | | | | | | | | | | | | | | | | | | | | | | |
Service Revenue
|
| | | $ | 59,426 | | | | | | 14% | | | | | | 48% | | | | | | 38% | | |
Hardware Revenue
|
| | | | 13,573 | | | | | | 92% | | | | | | 8% | | | | | | —% | | |
Total Revenue
|
| | | $ | 72,999 | | | | | | | | | | | | | | | | | | | | |
| | |
2019
|
| |
2018
|
| ||||||
Beginning balance at January 1,
|
| | | $ | 11,859 | | | | | $ | 9,638 | | |
Upfront payments received from customers
|
| | | | 6,698 | | | | | | 1,019 | | |
Upfront or annual incentive payments received
|
| | | | 8,240 | | | | | | 4,534 | | |
Revenue recognized related to amounts that were included in beginning balance of deferred revenue
|
| | | | (4,830) | | | | | | (3,117) | | |
Revenue recognized
|
| | | | (1,239) | | | | | | (215) | | |
Ending balance at December 31,
|
| | | $ | 20,728 | | | | | $ | 11,859 | | |
| | |
December 31, 2019
|
| |||||||||||||||||||||
| | |
Level 1
|
| |
Level 2
|
| |
Level 3
|
| |
Total
|
| ||||||||||||
Assets | | | | | | | | | | | | | | | | | | | | | | | | | |
Cash equivalents:
|
| | | | | | | | | | | | | | | | | | | | | | | | |
Money market fund
|
| | | $ | 67 | | | | | $ | — | | | | | $ | — | | | | | $ | 67 | | |
Liabilities | | | | | | | | | | | | | | | | | | | | | | | | | |
Convertible preferred stock warrant liability
|
| | | $ | — | | | | | $ | — | | | | | $ | 6,094 | | | | | $ | 6,094 | | |
Embedded derivative liabilities
|
| | | $ | — | | | | | $ | — | | | | | $ | 786 | | | | | $ | 786 | | |
Total liabilities
|
| | | $ | — | | | | | $ | — | | | | | $ | 6,880 | | | | | $ | 6,880 | | |
|
| | |
December 31, 2018
|
| |||||||||||||||||||||
| | |
Level 1
|
| |
Level 2
|
| |
Level 3
|
| |
Total
|
| ||||||||||||
Assets | | | | | | | | | | | | | | | | | | | | | | | | | |
Cash equivalents:
|
| | | | | | | | | | | | | | | | | | | | | | | | |
Money market fund
|
| | | $ | 11,136 | | | | | $ | — | | | | | $ | — | | | | | $ | 11,136 | | |
Liabilities | | | | | | | | | | | | | | | | | | | | | | | | | |
Convertible preferred stock warrant liability
|
| | | $ | — | | | | | $ | — | | | | | $ | 1,700 | | | | | $ | 1,700 | | |
Total liabilities
|
| | | $ | — | | | | | $ | — | | | | | $ | 1,700 | | | | | $ | 1,700 | | |
| | |
Year Ended December 31,
|
| |||||||||
| | |
2019
|
| |
2018
|
| ||||||
Volatility
|
| | | | 65.0% | | | | | | 70.0% | | |
Risk-free interest rate
|
| | | | 1.6% | | | | | | 2.3% | | |
Expected term (in years)
|
| | | | 2.5 | | | | | | 3.0 | | |
Dividend yield
|
| | | | —% | | | | | | —% | | |
Discount for lack of marketability
|
| | | | 40% | | | | | | 40% | | |
| | |
December 31,
|
| |||||||||
| | |
2019
|
| |
2018
|
| ||||||
Beginning balance at January 1,
|
| | | $ | 1,700 | | | | | $ | 1,750 | | |
Issuance of warrants
|
| | | | 3,999 | | | | | | — | | |
Change in fair value of warrants
|
| | | | 395 | | | | | | 77 | | |
Exercised or expired warrants
|
| | | | — | | | | | | (127) | | |
Ending balance at December 31,
|
| | | $ | 6,094 | | | | | $ | 1,700 | | |
| | |
December 31,
|
| |||||||||
| | |
2019
|
| |
2018
|
| ||||||
Beginning balance at January 1,
|
| | | $ | — | | | | | $ | 1,354 | | |
Issuance of derivative
|
| | | | 2,673 | | | | | | — | | |
Change in fair value
|
| | | | (1,887) | | | | | | 301 | | |
Exercise of embedded derivative
|
| | | | — | | | | | | (1,655) | | |
Ending balance at December 31,
|
| | | $ | 786 | | | | | $ | — | | |
| Assets acquired: | | | | | | | |
|
Developed technology
|
| | | $ | 500 | | |
|
Energy storage systems
|
| | | | 2,076 | | |
|
Right-of-use asset
|
| | | | 213 | | |
|
Total assets acquired
|
| | | $ | 2,789 | | |
|
Liabilities assumed — lease liability
|
| | | | (213) | | |
|
Net assets acquired
|
| | | | 2,576 | | |
|
Goodwill
|
| | | | 1,625 | | |
|
Total purchase price
|
| | | $ | 4,201 | | |
| | |
December 31,
|
| |||||||||
| | |
2019
|
| |
2018
|
| ||||||
Goodwill
|
| | | $ | 1,625 | | | | | $ | 1,625 | | |
Effect of foreign currency translation
|
| | | | 70 | | | | | | — | | |
Total goodwill
|
| | | $ | 1,695 | | | | | $ | 1,625 | | |
|
| | |
December 31,
|
| |||||||||
| | |
2019
|
| |
2018
|
| ||||||
Developed technology
|
| | | $ | 500 | | | | | $ | 500 | | |
Internally developed software
|
| | | | 16,722 | | | | | | 11,577 | | |
Intangible assets
|
| | | | 17,222 | | | | | | 12,077 | | |
Less: accumulated amortization
|
| | | | (6,549) | | | | | | (3,419) | | |
Add: Currency translation adjustment
|
| | | | 22 | | | | | | — | | |
Total intangible assets, net
|
| | | $ | 10,695 | | | | | $ | 8,658 | | |
| | |
Operating
Leases |
| |||
2020
|
| | | $ | 722 | | |
2021
|
| | | | 348 | | |
2022
|
| | | | 60 | | |
Total lease payments
|
| | | | 1,130 | | |
Less: imputed interest
|
| | | | (95) | | |
Total operating lease liability future lease payments
|
| | | $ | 1,035 | | |
|
| | |
December 31,
|
| |||||||||
| | |
2019
|
| |
2018
|
| ||||||
Current portion of operating lease liabilities included within other current liabilities
|
| | | $ | 645 | | | | | $ | 642 | | |
Non-current portion of operating lease liabilities
|
| | | | 390 | | | | | | 1,265 | | |
Total
|
| | | $ | 1,035 | | | | | $ | 1,907 | | |
| | |
December 31,
|
| |||||||||
| | |
2019
|
| |
2018
|
| ||||||
Weighted average remaining operating lease term (in years)
|
| | | | 2.1 | | | | | | 2.5 | | |
Weighted average discount rate
|
| | | | 11.03% | | | | | | 11.30% | | |
|
Balance at January 1, 2018
|
| | | $ | 4,433 | | |
|
Asset retirement obligation
|
| | | | 1,452 | | |
|
Accretion expense
|
| | | | 207 | | |
|
Balance at December 31, 2018
|
| | | | 6,092 | | |
|
Asset retirement obligation
|
| | | | 850 | | |
|
Retirement cost revaluation
|
| | | | (1,486) | | |
|
Accretion expense
|
| | | | 303 | | |
|
Balance at December 31, 2019
|
| | | $ | 5,759 | | |
| | |
December 31,
|
| |||||||||
| | |
2019
|
| |
2018
|
| ||||||
Energy storage systems placed into service
|
| | | $ | 124,789 | | | | | $ | 70,574 | | |
Less accumulated depreciation
|
| | | | (20,489) | | | | | | (10,188) | | |
Energy storage systems not yet placed into service
|
| | | | 27,269 | | | | | | 40,829 | | |
Total energy storage systems, net
|
| | | $ | 131,569 | | | | | $ | 101,215 | | |
| | |
December 31,
|
| |||||||||
| | |
2019
|
| |
2018
|
| ||||||
Work in process inventory
|
| | | $ | 2,535 | | | | | $ | — | | |
Batteries
|
| | | | 1,045 | | | | | | 2,007 | | |
Total inventory
|
| | | $ | 3,580 | | | | | $ | 2,007 | | |
| | |
December 31,
|
| |||||||||
| | |
2019
|
| |
2018
|
| ||||||
Prepaid Expenses
|
| | | $ | 868 | | | | | $ | 487 | | |
Utility program deposits
|
| | | | 770 | | | | | | 1,164 | | |
Due from related parties
|
| | | | 483 | | | | | | 2,826 | | |
Other
|
| | | | — | | | | | | 839 | | |
Total other current assets
|
| | | $ | 2,121 | | | | | $ | 5,316 | | |
| | |
December 31,
|
| |||||||||
| | |
2019
|
| |
2018
|
| ||||||
Receivable from SPEs (Note 16)
|
| | | $ | 3,161 | | | | | $ | — | | |
Self-generation incentive program deposits
|
| | | | 864 | | | | | | 1,377 | | |
Investment in VIEs
|
| | | | 843 | | | | | | 767 | | |
Revolver debt issuance costs
|
| | | | 416 | | | | | | 475 | | |
Right-of-use assets (Note 7)
|
| | | | 947 | | | | | | 1,853 | | |
Property and equipment, net
|
| | | | 71 | | | | | | 102 | | |
Other
|
| | | | 380 | | | | | | 294 | | |
Total other noncurrent assets
|
| | | $ | 6,682 | | | | | $ | 4,868 | | |
| | |
December 31,
|
| |||||||||
| | |
2019
|
| |
2018
|
| ||||||
Accrued payables
|
| | | $ | 5,493 | | | | | $ | 1,716 | | |
Accrued interest — notes payable
|
| | | | 1,757 | | | | | | 589 | | |
Other accrued liabilities
|
| | | | 57 | | | | | | 701 | | |
Total accrued liabilities
|
| | | $ | 7,307 | | | | | $ | 3,006 | | |
| | |
December 31,
|
| |||||||||
| | |
2019
|
| |
2018
|
| ||||||
System advances
|
| | | $ | 1,493 | | | | | $ | 1,493 | | |
Lease liabilities — current portion
|
| | | | 645 | | | | | | 642 | | |
Due to related parties
|
| | | | 190 | | | | | | 153 | | |
Other
|
| | | | 308 | | | | | | — | | |
Total other current liabilities
|
| | | $ | 2,636 | | | | | $ | 2,288 | | |
| | |
Payment
Schedule |
| |||
2020
|
| | | $ | 28,894 | | |
2021
|
| | | | 774 | | |
2022
|
| | | | 923 | | |
2023
|
| | | | 1,101 | | |
2024
|
| | | | 1,313 | | |
Thereafter
|
| | | | 2,458 | | |
Total
|
| | | $ | 35,463 | | |
| | |
December 31, 2019
|
| |||||||||||||||||||||
| | |
Issuance Date
|
| |
Exercise Price
|
| |
Number of
Shares |
| |
Term (years)
|
| ||||||||||||
Series A’
|
| | | | 2012 | | | | | $ | 0.4485 | | | | | | 178,372 | | | | | | 10 | | |
Series D
|
| | | | 2017 | | | | | | 1.5326 | | | | | | 6,269,223 | | | | | | 7 | | |
Series D’
|
| | | | 2019 | | | | | | 1.5326** | | | | | | 23,177,068 | | | | | | 7 | | |
Total
|
| | | | | | | | | | | | | | | | 29,624,663 | | | | | | | | |
| | |
December 31, 2018
|
| ||||||||||||||||||
| | |
Issuance Date
|
| |
Exercise Price
|
| |
Number of
Shares |
| |
Term (years)
|
| |||||||||
Series A’
|
| |
2012
|
| | | $ | 0.4485 | | | | | | 178,372 | | | | | | 10 | | |
Series B
|
| |
2014
|
| | | | 0.7755 | | | | | | 515,796 | | | | | | 5 | | |
Series D
|
| |
2018 and 2019
|
| | | | 1.5326 | | | | | | 6,269,223 | | | | | | 7 | | |
Total
|
| | | | | | | | | | | | | 6,963,391 | | | | | | | | |
| | |
December 31, 2019
|
| |||||||||||||||||||||
| | |
Authorized
Shares |
| |
Outstanding
Shares |
| |
Net Carrying
Value |
| |
Liquidation
Preference |
| ||||||||||||
| | | | | | | | | | | | | | |
(in thousands)
|
| |||||||||
Series D’
|
| | | | 102,000,000 | | | | | | 78,932,752 | | | | | $ | 99,588 | | | | | $ | 120,972 | | |
Series D
|
| | | | 87,235,535 | | | | | | 35,586,652 | | | | | | 49,772 | | | | | | 54,540 | | |
Series C
|
| | | | 64,129,209 | | | | | | 41,305,384 | | | | | | 62,570 | | | | | | 62,962 | | |
Series B
|
| | | | 36,969,407 | | | | | | 9,126,596 | | | | | | 7,071 | | | | | | 7,078 | | |
Series A’
|
| | | | 30,991,277 | | | | | | 26,171,809 | | | | | | 11,535 | | | | | | 11,738 | | |
Series A
|
| | | | 21,288 | | | | | | 16,740 | | | | | | 593 | | | | | | 751 | | |
Series 1
|
| | | | 4,305 | | | | | | 2,961 | | | | | | — | | | | | | — | | |
Total
|
| | | | 321,351,021 | | | | | | 191,142,894 | | | | | $ | 231,129 | | | | | $ | 258,041 | | |
|
| | |
December 31, 2018
|
| |||||||||||||||||||||
| | |
Authorized
Shares |
| |
Outstanding
Shares |
| |
Net Carrying
Value |
| |
Liquidation
Preference |
| ||||||||||||
| | | | | | | | | | | | | | |
(in thousands)
|
| |||||||||
Series D
|
| | | | 87,235,535 | | | | | | 74,537,774 | | | | | $ | 106,466 | | | | | $ | 114,237 | | |
Series C
|
| | | | 64,129,209 | | | | | | 47,640,215 | | | | | | 72,166 | | | | | | 72,618 | | |
Series B
|
| | | | 36,969,407 | | | | | | 34,374,161 | | | | | | 26,577 | | | | | | 26,657 | | |
Series A’
|
| | | | 30,991,277 | | | | | | 29,894,786 | | | | | | 13,129 | | | | | | 13,408 | | |
Series A
|
| | | | 19,245 | | | | | | 19,245 | | | | | | 593 | | | | | | 9 | | |
Series 1
|
| | | | 4,305 | | | | | | 4,305 | | | | | | — | | | | | | — | | |
Total
|
| | | | 219,348,978 | | | | | | 186,470,486 | | | | | $ | 218,931 | | | | | $ | 226,929 | | |
| | |
December 31,
|
| |||||||||
| | |
2019
|
| |
2018
|
| ||||||
Shares reserved for convertible preferred stock outstanding
|
| | | | 191,142,894 | | | | | | 186,470,486 | | |
Shares reserved for warrant to purchase shares of common stock
|
| | | | 6,001,639 | | | | | | 5,299,724 | | |
Shares reserved for warrant to purchase shares of preferred stock
|
| | | | 29,624,663 | | | | | | 6,963,391 | | |
Options issued and outstanding
|
| | | | 42,846,649 | | | | | | 32,109,995 | | |
Shares available for future option grants
|
| | | | 4,299,140 | | | | | | 13,881,022 | | |
Total
|
| | | | 273,914,985 | | | | | | 244,724,618 | | |
| | |
Options
Available for Grant |
| |
Number of
Options Outstanding |
| |
Weighted-
Average Exercise Price Per Share |
| |
Weighted-
Average Remaining Contractual Life (years) |
| |
Aggregate
Intrinsic Value (in thousands) |
| |||||||||||||||
Balances as of December 31, 2018
|
| | | | 13,881,022 | | | | | | 32,109,995 | | | | | $ | 0.31 | | | | | | 7.21 | | | | | $ | 5,889 | | |
Options granted
|
| | | | (18,425,599) | | | | | | 18,425,599 | | | | | | 0.49 | | | | | | | | | | | | | | |
Options exercised
|
| | | | — | | | | | | (101,977) | | | | | | 0.33 | | | | | | | | | | | | | | |
Options cancelled
|
| | | | 1,256,749 | | | | | | — | | | | | | | | | | | | | | | | | | | | |
Options expired/ forfeited
|
| | | | 7,586,968 | | | | | | (7,586,968) | | | | | | 0.36 | | | | | | | | | | | | | | |
Balances as of December 31, 2019
|
| | | | 4,299,140 | | | | | | 42,846,649 | | | | | $ | 0.34 | | | | | | 6.82 | | | | | $ | 5,821 | | |
Options vested and exercisable – December 31, 2019
|
| | | | | | | | | | 28,974,713 | | | | | $ | 0.33 | | | | | | 5.99 | | | | | $ | 5,175 | | |
| | |
Year Ended December 31,
|
| |||||||||
| | |
2019
|
| |
2018
|
| ||||||
Volatility
|
| | | | 69.10% | | | | | | 69.06% | | |
Risk-free interest rate
|
| | | | 2.47% | | | | | | 2.92% | | |
Expected term (in years)
|
| | | | 5.83 | | | | | | 5.89 | | |
Dividend yield
|
| | | | —% | | | | | | —% | | |
| | |
Year Ended December 31,
|
| |||||||||
| | |
2019
|
| |
2018
|
| ||||||
Sales and marketing
|
| | | $ | 364 | | | | | $ | 284 | | |
Research and development
|
| | | | 901 | | | | | | 422 | | |
General and administrative
|
| | | | 266 | | | | | | 551 | | |
Total stock-based compensation expense
|
| | | $ | 1,531 | | | | | $ | 1,257 | | |
|
| | | |
SPV II
|
| |
SPV III
|
| |
SPV IV
|
|
|
Date formed
|
| | January 23, 2015 | | | June 7, 2016 | | | June 30, 2017 | |
|
Initial ownership %
|
| | 49% | | | 50% | | | 50% | |
|
Stem’s interest
|
| |
100% of Class A shares
|
| | 100% of Class B shares | | | 100% of Class B shares | |
| Initial distributions: | | | | | | | | | | |
| Class A | | | 10% (Stem) | | | 80% (Stem – 50%) | | | 97.5% | |
| Class B | | | 90% | | | 20% (Stem – 100%) | | | 2.5% (Stem) | |
| | |
December 31,
|
| |||||||||
| | |
2019
|
| |
2018
|
| ||||||
Investment in SPV II
|
| | | $ | — | | | | | $ | 79 | | |
Investment in SPV III
|
| | | | 695 | | | | | | 688 | | |
Investment in SPV IV(1)
|
| | | | 148 | | | | | | — | | |
Total equity method investments
|
| | | $ | 843 | | | | | $ | 767 | | |
| | |
Year Ended December 31,
|
| |||||||||
| | |
2019
|
| |
2018
|
| ||||||
Numerator: | | | | | | | | | | | | | |
Net loss
|
| | | $ | (59,414) | | | | | $ | (49,047) | | |
Less: Deemed dividend to preferred stockholders (see Note 12)
|
| | | | (5,353) | | | | | | — | | |
Net loss attributable to common stockholders
|
| | | $ | (64,767) | | | | | $ | (49,047) | | |
Denominator: | | | | | | | | | | | | | |
Weighted-average number of shares outstanding used to compute net
loss per share attributable to common stockholders, basic and diluted |
| | | | 10,703,380 | | | | | | 8,541,606 | | |
Net loss per share attributable to common stockholders, basic and diluted
|
| | | $ | (6.05) | | | | | $ | (5.74) | | |
|
| | |
December 31,
|
| |||||||||
| | |
2019
|
| |
2018
|
| ||||||
Convertible preferred stock
|
| | | | 191,142,894 | | | | | | 186,470,486 | | |
Convertible promissory notes
|
| | | | 24,157,103 | | | | | | — | | |
Outstanding stock options
|
| | | | 42,846,649 | | | | | | 32,109,995 | | |
Outstanding common stock warrants
|
| | | | 6,001,639 | | | | | | 6,963,391 | | |
Outstanding convertible preferred stock warrants
|
| | | | 29,624,664 | | | | | | 5,299,724 | | |
Total
|
| | | | 293,772,949 | | | | | | 230,843,596 | | |
| | |
December 31,
|
| |||||||||
| | |
2019
|
| |
2018
|
| ||||||
Domestic
|
| | | $ | (59,408) | | | | | $ | (49,034) | | |
Foreign
|
| | | | — | | | | | | — | | |
Loss before income taxes
|
| | | $ | (59,408) | | | | | $ | (49,034) | | |
| | |
December 31,
|
| |||||||||
| | |
2019
|
| |
2018
|
| ||||||
Current: | | | | | | | | | | | | | |
Federal
|
| | | $ | — | | | | | $ | — | | |
State
|
| | | | 6 | | | | | | 13 | | |
Total current
|
| | | | 6 | | | | | | 13 | | |
Deferred: | | | | | | | | | | | | | |
Federal
|
| | | | — | | | | | | — | | |
State
|
| | | | — | | | | | | — | | |
Total deferred
|
| | | | — | | | | | | — | | |
Total provision for income taxes
|
| | | $ | 6 | | | | | $ | 13 | | |
|
| | |
December 31,
|
| |||||||||
| | |
2019
|
| |
2018
|
| ||||||
Statutory rate
|
| | | | 21.00% | | | | | | 21.00% | | |
State tax
|
| | | | 7.13% | | | | | | 10.87% | | |
Foreign income and withholding taxes
|
| | | | 0.08% | | | | | | —% | | |
Stock-based compensation
|
| | | | (0.51)% | | | | | | (0.50)% | | |
Change in fair value of warrants
|
| | | | 0.53% | | | | | | 0.02% | | |
Other
|
| | | | (0.04)% | | | | | | (5.45)% | | |
Non-deductible interest expense
|
| | | | (2.63)% | | | | | | (1.18)% | | |
Valuation allowance
|
| | | | (25.56)% | | | | | | (24.76)% | | |
Total
|
| | | | 0.00% | | | | | | 0.00% | | |
| | |
December 31,
|
| |||||||||
| | |
2019
|
| |
2018
|
| ||||||
Deferred tax assets: | | | | | | | | | | | | | |
Net operating losses
|
| | | $ | 50,821 | | | | | $ | 38,017 | | |
Tax credits
|
| | | | 761 | | | | | | 761 | | |
Depreciable assets
|
| | | | 189 | | | | | | 162 | | |
Intangible assets
|
| | | | 431 | | | | | | 1,712 | | |
Accruals and allowances
|
| | | | 1,317 | | | | | | 1,069 | | |
Stock-based compensation
|
| | | | 62 | | | | | | 40 | | |
Deferred revenue
|
| | | | 19,370 | | | | | | 15,517 | | |
Other
|
| | | | 2,004 | | | | | | 2,586 | | |
Total gross deferred tax assets
|
| | | | 74,955 | | | | | | 59,864 | | |
Less: Valuation allowance
|
| | | | (73,930) | | | | | | (58,743) | | |
Net deferred tax assets
|
| | | | 1,025 | | | | | | 1,121 | | |
Deferred tax liabilities: | | | | | | | | | | | | | |
Amortization of asset retirement obligation
|
| | | | (1,025) | | | | | | (1,121) | | |
Total gross deferred tax liabilities
|
| | | | (1,025) | | | | | | (1,121) | | |
Net deferred taxes
|
| | | $ | — | | | | | $ | — | | |
| | |
Page
|
| |||
Financial Statements (unaudited): | | | | | | | |
| | | | F-76 | | | |
| | | | F-77 | | | |
| | | | F-78 | | | |
| | | | F-79 | | | |
| | | | F-80 | | | |
| | | | F-81 | | |
| | |
September 30,
2020 |
| |
December 31,
2019 |
| ||||||
ASSETS | | | | | | | | | | | | | |
Current assets: | | | | | | | | | | | | | |
Cash and cash equivalents
|
| | | $ | 7,943 | | | | | $ | 12,889 | | |
Accounts receivable, net
|
| | | | 12,645 | | | | | | 6,619 | | |
Inventory, net
|
| | | | 21,174 | | | | | | 3,580 | | |
Other current assets (includes $57 and $483 due from related parties as of September 30, 2020 and
December 31, 2019, respectively) |
| | | | 1,589 | | | | | | 2,121 | | |
Deferred costs with suppliers
|
| | | | 838 | | | | | | 3,589 | | |
Total current assets
|
| | | | 44,189 | | | | | | 28,798 | | |
Energy storage systems, net
|
| | | | 126,114 | | | | | | 131,569 | | |
Contract origination costs, net
|
| | | | 10,241 | | | | | | 8,608 | | |
Goodwill
|
| | | | 1,673 | | | | | | 1,695 | | |
Intangible assets, net
|
| | | | 11,583 | | | | | | 10,695 | | |
Other noncurrent assets
|
| | | | 6,389 | | | | | | 6,682 | | |
Total assets
|
| | | $ | 200,189 | | | | | $ | 188,047 | | |
LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT | | | | | | | | | | | | | |
Current liabilities: | | | | | | | | | | | | | |
Accounts payable
|
| | | $ | 18,738 | | | | | $ | 12,691 | | |
Accrued liabilities
|
| | | | 6,290 | | | | | | 7,307 | | |
Accrued payroll
|
| | | | 5,844 | | | | | | 5,573 | | |
Notes payable, current portion
|
| | | | 33,849 | | | | | | 28,895 | | |
Convertible promissory notes (includes $38,238 and $24,102 due to related parties as of September 30, 2020 and December 31, 2019, respectively)
|
| | | | 49,895 | | | | | | 34,925 | | |
Financing obligation, current portion
|
| | | | 13,471 | | | | | | 6,373 | | |
Deferred revenue, current
|
| | | | 38,878 | | | | | | 10,948 | | |
Other current liabilities (includes $102 and $190 due to related parties as of September 30, 2020 and December 31, 2019, respectively)
|
| | | | 2,290 | | | | | | 2,636 | | |
Total current liabilities
|
| | | | 169,255 | | | | | | 109,348 | | |
Deferred revenue, noncurrent
|
| | | | 14,100 | | | | | | 9,780 | | |
Asset retirement obligation
|
| | | | 6,474 | | | | | | 5,759 | | |
Notes payable, noncurrent
|
| | | | 4,290 | | | | | | 6,568 | | |
Financing obligation, noncurrent
|
| | | | 75,268 | | | | | | 74,640 | | |
Warrant liabilities
|
| | | | 12,182 | | | | | | 6,094 | | |
Lease liability, noncurrent
|
| | | | 73 | | | | | | 390 | | |
Total liabilities
|
| | | | 281,642 | | | | | | 212,579 | | |
Commitments and contingencies (Note 13)
|
| | | | | | | | | | | | |
Convertible preferred stock, $0.00001 par value; 409,351,021 and 321,346,716 shares authorized as of
September 30, 2020 and December 31, 2019, respectively; 175,593,919 and 191,139,933 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively; (liquidation preference of $258,180 and $258,041 as of September 30, 2020 and December 31, 2019, respectively) |
| | | | 220,524 | | | | | | 231,129 | | |
Stockholders’ deficit:
|
| | | | | | | | | | | | |
Series 1 convertible preferred stock, $0.00001 par value; 4,305 shares authorized as of September 30,
2020 and December 31, 2019; 2,961 shares issued and outstanding as of September 30, 2020 and December 31, 2019 |
| | | | — | | | | | | — | | |
Common stock, $0.000001 par value; 474,728,323 and 386,728,323 shares authorized as of September 30, 2020 and December 31, 2019, respectively; 9,427,528 and 9,392,682 issued and outstanding as of September 30, 2020 and December 31, 2019, respectively
|
| | | | — | | | | | | — | | |
Additional paid-in capital
|
| | | | 4,964 | | | | | | 3,339 | | |
Accumulated other comprehensive income
|
| | | | 13 | | | | | | 54 | | |
Accumulated deficit
|
| | | | (306,954) | | | | | | (259,054) | | |
Total stockholders’ deficit
|
| | | | (301,977) | | | | | | (255,661) | | |
Total liabilities, convertible preferred stock and stockholders’ deficit
|
| | | $ | 200,189 | | | | | $ | 188,047 | | |
|
| | |
Nine Months Ended September 30,
|
| |||||||||
| | |
2020
|
| |
2019
|
| ||||||
Services revenue
|
| | | $ | 10,711 | | | | | $ | 9,235 | | |
Hardware revenue
|
| | | | 6,950 | | | | | | 1,194 | | |
Total revenue
|
| | | | 17,661 | | | | | | 10,429 | | |
Cost of service revenue
|
| | | | 16,083 | | | | | | 10,932 | | |
Cost of hardware revenue
|
| | | | 6,439 | | | | | | 1,053 | | |
Total cost of revenue
|
| | | | 22,522 | | | | | | 11,985 | | |
Gross margin
|
| | | | (4,861) | | | | | | (1,556) | | |
Operating expenses: | | | | | | | | | | | | | |
Sales and marketing
|
| | | | 11,699 | | | | | | 12,684 | | |
Research and development
|
| | | | 12,084 | | | | | | 11,576 | | |
General and administrative
|
| | | | 8,018 | | | | | | 11,220 | | |
Total operating expenses
|
| | | | 31,801 | | | | | | 35,480 | | |
Loss from operations
|
| | | | (36,662) | | | | | | (37,036) | | |
Other income (expense), net: | | | | | | | | | | | | | |
Interest expense
|
| | | | (13,826) | | | | | | (8,658) | | |
Change in fair value of warrants and embedded derivative
|
| | | | (3,005) | | | | | | 852 | | |
Other expenses, net
|
| | | | (1,602) | | | | | | (204) | | |
Total other income (expense)
|
| | | | (18,433) | | | | | | (8,010) | | |
Loss before income taxes
|
| | | | (55,095) | | | | | | (45,046) | | |
Income tax expense
|
| | | | (142) | | | | | | (2) | | |
Net loss
|
| | | $ | (55,237) | | | | | $ | (45,048) | | |
Net loss per share attributable to common shareholders, basic and diluted
|
| | | $ | (7.07) | | | | | $ | (4.65) | | |
Weighted-average shares used in computing net loss per share, basic and diluted
|
| | | | 9,155,906 | | | | | | 10,841,407 | | |
| | |
Nine Months Ended September 30,
|
| |||||||||
| | |
2020
|
| |
2019
|
| ||||||
Net loss
|
| | | $ | (55,237) | | | | | $ | (45,048) | | |
Other comprehensive loss: | | | | | | | | | | | | | |
Foreign currency translation adjustment
|
| | | | (41) | | | | | | — | | |
Total comprehensive loss
|
| | | $ | (55,278) | | | | | $ | (45,048) | | |
| | |
Convertible
Preferred Stock |
| |
Series 1 Convertible
Preferred Stock |
| |
Common
Stock |
| |
Additional
Paid-In Capital |
| |
Accumulated
Other Comprehensive Income |
| |
Accumulated
Deficit |
| |
Total
Stockholders’ Deficit |
| |||||||||||||||||||||||||||||||||||||||
| | |
Shares
|
| |
Amount
|
| |
Shares
|
| |
Amount
|
| |
Shares
|
| |
Amount
|
| ||||||||||||||||||||||||||||||||||||||||||
Balance at December 31, 2019
|
| | | | 191,139,933 | | | | | $ | 231,129 | | | | | | 2,961 | | | | | $ | — | | | | | | 9,392,682 | | | | | $ | — | | | | | $ | 3,339 | | | | | $ | 54 | | | | | $ | (259,054) | | | | | $ | (255,661) | | |
Effect of exchange transaction (Note 7)
|
| | | | (15,546,014) | | | | | | (10,605) | | | | | | — | | | | | | — | | | | | | (466,711) | | | | | | — | | | | | | — | | | | | | — | | | | | | 7,337 | | | | | | 7,337 | | |
Issuance of warrants to purchase common
stock |
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 168 | | | | | | — | | | | | | — | | | | | | 168 | | |
Issuance of common
stock upon exercise of stock options and warrants |
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 501,557 | | | | | | — | | | | | | 30 | | | | | | — | | | | | | — | | | | | | 30 | | |
Stock-based compensation
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 1,427 | | | | | | — | | | | | | — | | | | | | 1,427 | | |
Foreign currency
translation adjustments |
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (41) | | | | | | — | | | | | | (41) | | |
Net loss
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (55,237) | | | | | | (55,237) | | |
Balance as of September 30,
2020 |
| | | | 175,593,919 | | | | | $ | 220,524 | | | | | | 2,961 | | | | | $ | — | | | | | | 9,427,528 | | | | | $ | — | | | | | $ | 4,964 | | | | | $ | 13 | | | | | $ | (306,954) | | | | | $ | (301,977) | | |
|
| | |
Convertible
Preferred Stock |
| |
Series 1 Convertible
Preferred Stock |
| |
Common
Stock |
| |
Additional
Paid-In Capital |
| |
Accumulated
Other Comprehensive Income |
| |
Accumulated
Deficit |
| |
Total
Stockholders’ Deficit |
| |||||||||||||||||||||||||||||||||||||||
| | |
Shares
|
| |
Amount
|
| | | | | | | | | | | | | |
Shares
|
| |
Amount
|
| ||||||||||||||||||||||||||||||||||||
Balance at December 31, 2018
|
| | | | 186,466,181 | | | | | $ | 218,931 | | | | | | 3,405 | | | | | $ | — | | | | | | 9,583,163 | | | | | $ | — | | | | | $ | 555 | | | | | $ | — | | | | | $ | (210,596) | | | | | $ | (210,041) | | |
Effect of exchange transaction (Note 7)
|
| | | | (14,987,941) | | | | | | (15,946) | | | | | | — | | | | | | — | | | | | | (409,300) | | | | | | — | | | | | | — | | | | | | — | | | | | | 10,956 | | | | | | 10,956 | | |
Issuance of warrants to purchase common stock
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 1,217 | | | | | | — | | | | | | — | | | | | | 1,217 | | |
Issuance of Series D preferred stock upon conversion of promissory note
|
| | | | 19,711,869 | | | | | | 28,144 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Settlement of litigation (Note 13)
|
| | | | (2,505) | | | | | | — | | | | | | (444) | | | | | | — | | | | | | (10,540) | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Issuance of common stock upon exercise of stock options and warrants
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 186,874 | | | | | | — | | | | | | 24 | | | | | | — | | | | | | — | | | | | | 24 | | |
Stock-based compensation
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 1,237 | | | | | | — | | | | | | — | | | | | | 1,237 | | |
Net loss
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (45,048) | | | | | | (45,048) | | |
Balance as of September 30,
2019 |
| | | | 191,187,604 | | | | | $ | 231,129 | | | | | | 2,961 | | | | | $ | — | | | | | | 9,350,197 | | | | | $ | — | | | | | $ | 3,033 | | | | | $ | — | | | | | $ | (244,688) | | | | | $ | (241,655) | | |
|
| | |
Nine Months Ended September 30,
|
| |||||||||
| | |
2020
|
| |
2019
|
| ||||||
OPERATING ACTIVITIES | | | | | | | | | | | | | |
Net loss
|
| | | $ | (55,237) | | | | | $ | (45,048) | | |
Adjustments to reconcile net loss to net cash used in operating activities: | | | | | | | | | | | | | |
Depreciation and amortization expense
|
| | | | 13,769 | | | | | | 9,941 | | |
Non-cash interest expense, including interest expense associated with debt issuance costs
|
| | | | 7,080 | | | | | | 2,998 | | |
Stock-based compensation
|
| | | | 1,427 | | | | | | 1,237 | | |
Change in fair value of warrant liability and embedded derivative
|
| | | | 3,005 | | | | | | (852) | | |
Noncash lease expense
|
| | | | 435 | | | | | | 526 | | |
Accretion expense
|
| | | | 188 | | | | | | 220 | | |
Provision for doubtful accounts
|
| | | | 9 | | | | | | (11) | | |
Changes in operating assets and liabilities:
|
| | | | | | | | | | | | |
Accounts receivable
|
| | | | (6,039) | | | | | | (2,567) | | |
Inventory
|
| | | | (17,595) | | | | | | 163 | | |
Deferred costs with suppliers
|
| | | | 2,751 | | | | | | (6,900) | | |
Other assets
|
| | | | (105) | | | | | | 1,238 | | |
Contract origination costs
|
| | | | (2,135) | | | | | | (2,398) | | |
Accounts payable and accrued expenses
|
| | | | 2,836 | | | | | | 16,149 | | |
Deferred revenue
|
| | | | 32,251 | | | | | | 7,455 | | |
Lease liabilities
|
| | | | (475) | | | | | | 164 | | |
Other liabilities
|
| | | | (86) | | | | | | (319) | | |
Net cash used in operating activities
|
| | | | (17,921) | | | | | | (18,004) | | |
INVESTING ACTIVITIES | | | | | | | | | | | | | |
Purchase of energy storage systems
|
| | | | (4,121) | | | | | | (33,982) | | |
Capital expenditures on internally-developed software
|
| | | | (3,585) | | | | | | (4,205) | | |
Purchase of property and equipment
|
| | | | (13) | | | | | | (7) | | |
Net cash used in investing activities
|
| | | | (7,719) | | | | | | (38,194) | | |
FINANCING ACTIVITIES | | | | | | | | | | | | | |
Proceeds from exercise of stock options
|
| | | | 30 | | | | | | 24 | | |
Proceeds from financing obligations
|
| | | | 12,901 | | | | | | 11,467 | | |
Repayment of financing obligations
|
| | | | (7,776) | | | | | | (5,495) | | |
Proceeds from issuance of convertible notes, net of issuance costs of $1,740 and $2,308 for
the nine months ended September 30, 2020 and 2019, respectively |
| | | | 12,548 | | | | | | 63,249 | | |
Proceeds from issuance of notes payable
|
| | | | 25,000 | | | | | | 9,805 | | |
Repayment of notes payable
|
| | | | (21,660) | | | | | | (22,579) | | |
Net cash provided by financing activities
|
| | | | 21,043 | | | | | | 56,471 | | |
Effect of exchange rate changes on cash and cash equivalents
|
| | | | (349) | | | | | | (158) | | |
Net (decrease) increase in cash and cash equivalents
|
| | | | (4,946) | | | | | | 115 | | |
Cash and cash equivalents, beginning of year
|
| | | | 12,889 | | | | | | 21,894 | | |
Cash and cash equivalents, end of period
|
| | | $ | 7,943 | | | | | $ | 22,009 | | |
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION | | | | | | | | | | | | | |
Cash paid for interest
|
| | | $ | 6,446 | | | | | $ | 1,779 | | |
NON-CASH INVESTING AND FINANCING ACTIVITIES
|
| | | | | | | | | | | | |
Change in asset retirement costs and asset retirement obligation
|
| | | $ | 527 | | | | | $ | 546 | | |
Issuance of common stock warrants
|
| | | $ | 168 | | | | | $ | 1,217 | | |
Conversion of convertible promissory notes and accrued interest into Series D preferred stock
|
| | | $ | — | | | | | $ | 28,144 | | |
Conversion of accrued interest into outstanding Note Payable
|
| | | $ | 385 | | | | | $ | — | | |
| | |
Accounts Receivable
|
| |||||||||
| | |
September 30,
2020 |
| |
December 31,
2019 |
| ||||||
Customers: | | | | | | | | | | | | | |
Customer A
|
| | | | ―% | | | | | | 45% | | |
Customer B
|
| | | | 12% | | | | | | ―% | | |
Customer C
|
| | | | 13% | | | | | | ―% | | |
Customer D
|
| | | | 11% | | | | | | ―% | | |
Customer E
|
| | | | 33% | | | | | | ―% | | |
| | |
September 30,
|
| |||||||||
| | |
2020
|
| |
2019
|
| ||||||
Partnership hardware revenue
|
| | | $ | 6,950 | | | | | $ | 1,194 | | |
Partnership service revenue
|
| | | | 31 | | | | | | 3 | | |
Host customer service revenue
|
| | | | 10,680 | | | | | | 9,232 | | |
Total revenue
|
| | | $ | 17,661 | | | | | $ | 10,429 | | |
| | |
Total remaining
performance obligations |
| |
Percent Expected to be Recognized as Revenue
|
| ||||||||||||||||||
| | |
Less than
one year |
| |
Two to
five years |
| |
Greater than
five year |
| |||||||||||||||
(in thousands, except percentages) | | | | | | | | | | | | | | | | | | | | | | | | | |
Service Revenue
|
| | | $ | 91,429 | | | | | | 14% | | | | | | 49% | | | | | | 37% | | |
Hardware Revenue
|
| | | | 51,893 | | | | | | 100% | | | | | | —% | | | | | | —% | | |
Total Revenue
|
| | | $ | 143,322 | | | | | | | | | | | | | | | | | | | | |
|
Beginning balance as of January 1, 2020
|
| | | $ | 20,728 | | |
|
Upfront payments received from customers
|
| | | | 35,671 | | |
|
Upfront or annual incentive payments received
|
| | | | 5,454 | | |
|
Revenue recognized related to amounts that were included in beginning balance of deferred revenue
|
| | | | (5,697) | | |
|
Revenue recognized
|
| | | | (3,178) | | |
|
Ending balance as of September 30, 2020
|
| | | $ | 52,978 | | |
| | |
September 30, 2020
|
| |||||||||||||||||||||
| | |
Level 1
|
| |
Level 2
|
| |
Level 3
|
| |
Total
|
| ||||||||||||
Assets | | | | | | | | | | | | | | | | | | | | | | | | | |
Cash equivalents:
|
| | | | | | | | | | | | | | | | | | | | | | | | |
Money market fund
|
| | | $ | 67 | | | | | $ | — | | | | | $ | — | | | | | $ | 67 | | |
Liabilities | | | | | | | | | | | | | | | | | | | | | | | | | |
Convertible preferred stock warrant liability
|
| | | $ | — | | | | | $ | — | | | | | $ | 12,182 | | | | | $ | 12,182 | | |
Embedded derivative liabilities
|
| | | | — | | | | | | — | | | | | | 66 | | | | | | 66 | | |
Total liabilities
|
| | | $ | — | | | | | $ | — | | | | | $ | 12,248 | | | | | $ | 12,248 | | |
|
| | |
December 31, 2019
|
| |||||||||||||||||||||
| | |
Level 1
|
| |
Level 2
|
| |
Level 3
|
| |
Total
|
| ||||||||||||
Assets | | | | | | | | | | | | | | | | | | | | | | | | | |
Cash equivalents:
|
| | | | | | | | | | | | | | | | | | | | | | | | |
Money market fund
|
| | | $ | 67 | | | | | $ | — | | | | | $ | — | | | | | $ | 67 | | |
Liabilities | | | | | | | | | | | | | | | | | | | | | | | | | |
Convertible preferred stock warrant liability
|
| | | $ | — | | | | | $ | — | | | | | $ | 6,094 | | | | | $ | 6,094 | | |
Embedded derivative liabilities
|
| | | $ | — | | | | | $ | — | | | | | $ | 786 | | | | | $ | 786 | | |
Total liabilities
|
| | | $ | — | | | | | $ | — | | | | | $ | 6,880 | | | | | $ | 6,880 | | |
| | |
Nine Months Ended
September 30, |
| |||||||||
| | |
2020
|
| |
2019
|
| ||||||
Volatility
|
| | | | 65.0% | | | | | | 65.0% | | |
Risk-free interest rate
|
| | | | 0.13% | | | | | | 1.58% | | |
Expected term (in years)
|
| | | | 1.75 | | | | | | 2.75 | | |
Dividend yield
|
| | | | —% | | | | | | —% | | |
Discount for lack of marketability
|
| | | | 36.5% | | | | | | 40% | | |
| | |
Convertible
Preferred Warrant Warrant Stock |
| |||
Balance as of December 31, 2019
|
| | | $ | 6,094 | | |
Estimated fair value of warrants issued
|
| | | | 1,981 | | |
Changes in estimated fair value
|
| | | | 4,107 | | |
Balance as of September 30, 2020
|
| | | $ | 12,182 | | |
| | |
Derivative
Liabilities |
| |||
Balance as of December 31, 2019
|
| | | $ | 786 | | |
Initial estimated fair value of derivatives upon issuance of convertible notes
|
| | | | 382 | | |
Changes in estimated fair value
|
| | | | (1,102) | | |
Balance as of September 30, 2020
|
| | | $ | 66 | | |
|
| | |
September 30,
2020 |
| |||
Energy storage systems placed into service
|
| | | $ | 145,080 | | |
Less accumulated depreciation
|
| | | | (29,989) | | |
Energy storage systems not yet placed into service
|
| | | | 11,023 | | |
Total energy storage systems, net
|
| | | $ | 126,114 | | |
| | |
September 30,
2020 |
| |||
Outstanding principal
|
| | | $ | 39,187 | | |
Unamortized discount
|
| | | | (1,048) | | |
Carrying value of debt
|
| | | $ | 38,139 | | |
|
| | |
Payment
Schedule |
| |||
Remainder of 2020
|
| | | $ | 154 | | |
2021
|
| | | | 33,879 | | |
2022
|
| | | | 821 | | |
2023
|
| | | | 979 | | |
2024
|
| | | | 1,167 | | |
Thereafter
|
| | | | 2,187 | | |
Total
|
| | | $ | 39,187 | | |
| | |
September 30, 2020
|
| ||||||||||||||||||
| | |
Issuance Date
|
| |
Exercise Price
|
| |
Number of
Shares |
| |
Term (years)
|
| |||||||||
Series A’
|
| |
2012
|
| | | $ | 0.4485 | | | | | | 178,372 | | | | | | 10 | | |
Series D
|
| |
2017
|
| | | | 1.5326 | | | | | | 6,269,223 | | | | | | 7 | | |
Series D’
|
| |
2019 and 2020
|
| |
1.5326**
|
| | | | 33,249,868 | | | | | | 7 | | | |||
Total
|
| | | | | | | | | | | | | 39,697,463 | | | | | | | | |
| | |
September 30, 2020
|
| |||||||||||||||||||||
| | |
Authorized
Shares |
| |
Outstanding
Shares |
| |
Net Carrying
Value |
| |
Liquidation
Preference |
| ||||||||||||
| | | | | | | | | | | | | | |
(in thousands)
|
| |||||||||
Series D’
|
| | | | 190,000,000 | | | | | | 105,560,563 | | | | | $ | 129,341 | | | | | $ | 161,782 | | |
Series D
|
| | | | 87,235,535 | | | | | | 33,371,462 | | | | | | 46,548 | | | | | | 51,145 | | |
Series C
|
| | | | 64,129,209 | | | | | | 23,298,388 | | | | | | 35,293 | | | | | | 35,514 | | |
Series B
|
| | | | 36,969,407 | | | | | | 9,185,302 | | | | | | 7,046 | | | | | | 7,123 | | |
Series A’
|
| | | | 30,991,277 | | | | | | 4,158,503 | | | | | | 1,703 | | | | | | 1,865 | | |
Series A
|
| | | | 21,288 | | | | | | 16,740 | | | | | | 593 | | | | | | 751 | | |
Series 1
|
| | | | 4,305 | | | | | | 2,961 | | | | | | — | | | | | | — | | |
Total
|
| | | | 409,351,021 | | | | | | 175,593,919 | | | | | $ | 220,524 | | | | | $ | 258,180 | | |
| | |
September 30,
2020 |
| |||
Shares reserved for convertible preferred stock outstanding
|
| | | | 175,593,919 | | |
Shares reserved for warrants to purchase shares of common stock
|
| | | | 6,001,639 | | |
Shares reserved for warrants to purchase shares of preferred stock
|
| | | | 39,697,463 | | |
Options issued and outstanding
|
| | | | 43,971,965 | | |
Shares available for future option grants
|
| | | | 3,072,267 | | |
Total
|
| | | | 268,337,253 | | |
| | |
Options
Available for Grant |
| |
Number of
Options Outstanding |
| |
Weighted-
Average Exercise Price Per Share |
| |
Weighted-
Average Remaining Contractual Life (years) |
| |
Aggregate
Intrinsic Value (in thousands) |
| |||||||||||||||
Balances as of December 31, 2019
|
| | | | 4,299,140 | | | | | | 42,846,649 | | | | | $ | 0.34 | | | | | | 6.82 | | | | | $ | 5,821 | | |
Options granted
|
| | | | (2,440,000) | | | | | | 2,440,000 | | | | | | 0.43 | | | | | | | | | | | | | | |
Options exercised
|
| | | | | | | | | | (101,557) | | | | | | 0.32 | | | | | | | | | | | | | | |
Options forfeited
|
| | | | 800,317 | | | | | | (800,317) | | | | | | 0.43 | | | | | | | | | | | | | | |
Options expired
|
| | | | 412,810 | | | | | | (412,810) | | | | | | 0.32 | | | | | | | | | | | | | | |
Balances as of September 30, 2020
|
| | | | 3,072,267 | | | | | | 43,971,965 | | | | | $ | 0.39 | | | | | | 6.94 | | | | | $ | 23,951 | | |
Options vested and exercisable — September 30, 2020
|
| | | | | | | | | | 33,628,117 | | | | | $ | 0.35 | | | | | | 6.35 | | | | | $ | 19,347 | | |
| | |
Nine Months Ended
September 30, |
| |||||||||
| | |
2020
|
| |
2019
|
| ||||||
Research and development
|
| | | $ | 519 | | | | | $ | 652 | | |
Sales and marketing
|
| | | | 196 | | | | | | 361 | | |
General and administrative
|
| | | | 712 | | | | | | 224 | | |
Total stock-based compensation expense
|
| | | $ | 1,427 | | | | | $ | 1,237 | | |
| | |
Nine Months Ended
September 30, |
| |||||||||
| | |
2020
|
| |
2019
|
| ||||||
Numerator: | | | | | | | | | | | | | |
Net loss attributable to common stockholders
|
| | | $ | (55,237) | | | | | $ | (45,048) | | |
Less: Deemed dividend to preferred stockholders (see Note 7)
|
| | | | (9,484) | | | | | | (5,353) | | |
| | | | | (64,721) | | | | | | (50,401) | | |
Denominator: | | | | | | | | | | | | | |
Weighted-average number of shares outstanding used to compute net
loss per share attributable to common stockholders, basic and diluted |
| | | | 9,155,906 | | | | | | 10,841,407 | | |
Net loss per share attributable to common stockholders, basic and diluted
Net loss per share attributable to common stockholders, basic and diluted |
| | | $ | (7.07) | | | | | $ | (4.65) | | |
| | |
September 30,
2020 |
| |
September 30,
2019 |
| ||||||
Convertible preferred stock
|
| | | | 175,593,919 | | | | | | 191,187,604 | | |
Convertible promissory notes
|
| | | | 35,358,748 | | | | | | 23,663,283 | | |
Outstanding stock options
|
| | | | 43,971,965 | | | | | | 33,436,319 | | |
Outstanding common stock warrants
|
| | | | 6,001,639 | | | | | | 7,201,639 | | |
Outstanding convertible preferred stock warrants
|
| | | | 39,697,463 | | | | | | 30,215,460 | | |
Total
|
| | | | 300,623,734 | | | | | | 285,704,305 | | |
| | |
Page
|
| |||
| | | | A-3 | | | |
| | | | A-3 | | | |
| | | | A-17 | | | |
| | | | A-17 | | | |
| | | | A-17 | | | |
| | | | A-20 | | | |
| | | | A-20 | | | |
| | | | A-21 | | | |
| | | | A-21 | | | |
| | | | A-21 | | | |
| | | | A-21 | | | |
| | | | A-23 | | | |
| | | | A-23 | | | |
| | | | A-24 | | | |
| | | | A-24 | | | |
| | | | A-25 | | | |
| | | | A-26 | | | |
| | | | A-27 | | | |
| | | | A-27 | | | |
| | | | A-27 | | | |
| | | | A-29 | | | |
| | | | A-29 | | | |
| | | | A-30 | | | |
| | | | A-31 | | | |
| | | | A-32 | | | |
| | | | A-33 | | | |
| | | | A-34 | | | |
| | | | A-34 | | | |
| | | | A-34 | | | |
| | | | A-35 | | | |
| | | | A-35 | | | |
| | | | A-36 | | | |
| | | | A-36 | | | |
| | | | A-36 | | | |
| | | | A-37 | | | |
| | | | A-37 | | | |
| | | | A-37 | | | |
| | | | A-37 | | |
| | |
Page
|
| |||
| | | | A-38 | | | |
| | | | A-38 | | | |
| | | | A-38 | | | |
| | | | A-39 | | | |
| | | | A-39 | | | |
| | | | A-40 | | | |
| | | | A-40 | | | |
| | | | A-40 | | | |
| | | | A-40 | | | |
| | | | A-41 | | | |
| | | | A-41 | | | |
| | | | A-43 | | | |
| | | | A-43 | | | |
| | | | A-43 | | | |
| | | | A-43 | | | |
| | | | A-44 | | | |
| | | | A-44 | | | |
| | | | A-44 | | | |
| | | | A-47 | | | |
| | | | A-48 | | | |
| | | | A-49 | | | |
| | | | A-50 | | | |
| | | | A-51 | | | |
| | | | A-52 | | | |
| | | | A-52 | | | |
| | | | A-54 | | | |
| | | | A-56 | | | |
| | | | A-56 | | | |
| | | | A-56 | | | |
| | | | A-57 | | | |
| | | | A-58 | | | |
| | | | A-58 | | | |
| | | | A-58 | | | |
| | | | A-59 | | | |
| | | | A-60 | | | |
| | | | A-60 | | | |
| | | | A-61 | | | |
| | | | A-61 | | | |
| | | | A-61 | | |
| | |
Page
|
| |||
| | | | A-61 | | | |
| | | | A-61 | | | |
| | | | A-62 | | | |
| | | | A-63 | | | |
| | | | A-64 | | | |
| | | | A-64 | | | |
| | | | A-64 | | | |
| | | | A-65 | | | |
| | | | A-65 | | | |
| | | | A-65 | | | |
| | | | A-65 | | | |
| | | | A-65 | | | |
| | | | A-65 | | | |
| | | | A-66 | | | |
| | | | A-66 | | | |
| | | | A-66 | | | |
| | | | A-67 | | | |
| | | | A-67 | | | |
| | | | A-68 | | | |
| | | | A-68 | | | |
| | | | A-68 | | | |
| | | | A-68 | | | |
| | | | A-69 | | | |
| | | | A-69 | | | |
| | | | A-69 | | | |
| | | | A-69 | | | |
| | | | A-70 | | | |
| | | | A-70 | | | |
EXHIBITS | | | | | | | |
Exhibit A
Form of Support Agreement
|
| | | | | | |
Exhibit B
Form of Lock-Up Agreement
|
| | | | | | |
Exhibit C
Form of Investor Rights Agreement
|
| | | | | | |
Exhibit D
Form of Written Consent — Pre-Closing Holders
|
| | | | | | |
Exhibit E
Form of Warrant Exercise Agreements
|
| | | | | | |
Exhibit F
Form of Letter of Transmittal
|
| | | | | | |
Exhibit G
Form of Certificate of Merger
|
| | | | | | |
Exhibit H
Executed Subscription Agreements
|
| | | | | | |
Exhibit I
Form of New Incentive Plan
|
| | | | | | |
Exhibit J
Form of Governing Documents of STPK
|
| | | | | | |
|
NEW HOLDER:
|
| | ACCEPTED AND AGREED: | |
|
Print Name:
|
| |
STAR PEAK ENERGY TRANSITION CORP.
|
|
|
By:
|
| |
By:
|
|
Name of Supporting Holder
|
| |
Subject
Common Shares |
| |
Subject
Preferred Shares |
| |
Total Common
Shares |
| |
Total Preferred
Shares |
|
| | |
|
| |
|
| |
|
| |
|
|
| Name of Investor: | | | State/Country of Formation or Domicile: | | ||||||
| By: | | |
|
| | | | | | |
| Name: | | |
|
| | | | | | |
| Title: | | |
|
| | | ||||
| Name in which Shares are to be registered (if different): | | | Date: , 2020 | | ||||||
| Investor’s EIN: | | | | | | |||||
| Business Address-Street: | | | Mailing Address-Street (if different): | | ||||||
| City, State, Zip: | | | City, State, Zip: | | ||||||
| Attn: | | |
|
| | Attn: | | |
|
|
| Telephone No.: | | | Telephone No.: | | ||||||
| Facsimile No.: | | | Facsimile No.: | | ||||||
| Number of Shares subscribed for: | | | | | | |||||
| Aggregate Subscription Amount: $ | | | Price Per Share: $10.00 | |
| | | | STAR PEAK ENERGY TRANSITION CORP. | | |||
| | | | By: | | |
|
|
| | | | Name: | | | ||
| | | | Title: | | |
☐
|
Yes
|
☐
|
No |
☐
|
Other — Name:
|
☐
|
Other — Name:
|
X
|
Yes
|
☐
|
No |
| | | |
(Print name of the warrant holder)
|
|
| | | |
(Signature)
|
|
| | | |
(Name and title of signatory, if applicable)
|
|
| | | |
(Date)
|
|
| | | |
(Fax number)
|
|
| | | |
(Email address)
|
|
| If to STPK prior to the Closing, to: | | | With a copy (which will not constitute notice) to: | | ||||||
|
Star Peak Energy Transition Corp.
1603 Orrington Avenue, 13th Floor Evanston, Illinois 60201 |
| |
Kirkland & Ellis LLP
609 Main Street Houston, Texas 77002 |
| ||||||
| Attention: | | | Secretary | | | Attention: | | | Matthew R. Pacey, P.C. | |
| E-mail: | | |
info@starpeakcorp.com
|
| | | | | William J. Benitez, P.C. | |
| | | | | | | Email: | | |
matt.pacey@kirkland.com
|
|
| | | | | | | | | | william.benitez@kirkland.com | |
| If to the Company prior to the Closing, to: | | | With a copy (which shall not constitute notice) to: | | ||||||
|
Stem, Inc.
100 Rollins Road Millbrae, CA 94030 |
| |
Gibson, Dunn & Crutcher LLP
200 Park Avenue New York, New York 10166-0193 |
| ||||||
| Attention: | | | William Bush | | | Attention: | | | John Gaffney | |
| Email: | | |
bill.bush@stem.com
|
| | | | | Evan D’Amico | |
| | | | | | | Email: | | |
jgaffney@gibsondunn.com
|
|
| | | | | | | | | | edamico@gibsondunn.com | |
| If to STPK or the Company after the Closing, to: | | | With copies (which shall not constitute notice) to: | | ||||||
|
Stem, Inc.
100 Rollins Road Millbrae, CA 94030 |
| |
Gibson, Dunn & Crutcher LLP
200 Park Avenue New York, New York 10166-0193 |
| ||||||
| Attention: | | | William Bush | | | Attention: | | | John Gaffney | |
| Email: | | |
bill.bush@stem.com
|
| | | | | Evan D’Amico | |
| | | | | | | Email: | | |
jgaffney@gibsondunn.com
|
|
| | | | | | | | | | edamico@gibsondunn.com | |
| Star Peak Energy Transition Corp. | | |||
| By: | | | | |
| Name: | | | | |
| Title: | | | | |
| Stem, Inc. | | |||
| By: | | | | |
| Name: | | | | |
| Title: | | | | |
| Holder: | | |||
| Name of Holder: [ ] | | |||
| By: | | | | |
| Name | | | | |
| Title: | | | | |
|
| Number and Type of Company Securities: | | |||
|
[Company Common Stock]:
|
| | | |
|
[Company Preferred Stock]:
|
| | | |
| [Company Options]: | | | | |
| | | | | |
| Address for Notice: | | |||
| Address: | | | | |
| | | |||
| | | |||
|
Facsimile No.:
|
| | | |
|
Telephone No.:
|
| | | |
| Email: | | | | |
|
Exhibit
|
| |
Description
|
| |||
| | | 10.8*** | | | |
Form of Notice of Exercise (included as Annex I to the proxy statement/consent solicitation
statement/prospectus, which is a part of this Registration Statement). |
|
| | | 10.9* | | | | Form of Executive Employment Agreement | |
| | | 23.1* | | | | Consent of WithumSmith+Brown, PC. | |
| | | 23.2* | | | | Consent of Deloitte & Touche LLP. | |
| | | 23.3* | | | | Consent of Kirkland & Ellis LLP (included in Exhibit 5.1 hereto). | |
| | | 24.1*** | | | | Powers of Attorney (included as part of signature page hereto). | |
| | | 99.1* | | | | Form of Letter of Transmittal. | |
| | | 99.2* | | | | Form of Proxy Card for Registrant Special Meeting in Lieu of the 2021 Annual Meeting. | |
| | | 99.3* | | | | Form of Written Consent to be used by stockholders of Stem, Inc. | |
| | | | STAR PEAK ENERGY TRANSITION CORP. | |
| | | |
By:
/s/ Eric Scheyer
Name: Eric Scheyer
Title: Chief Executive Officer |
|
|
Signatures
|
| |
Title
|
| |
Date
|
|
|
/s/ Eric Scheyer
Eric Scheyer
|
| |
Chief Executive Officer and Director
(Principal Executive Officer) |
| |
January 22, 2021
|
|
|
*
Michael D. Wilds
|
| |
Chief Financial Officer and Chief Accounting Officer
(Principal Financial Officer) |
| |
January 22, 2021
|
|
|
*
Michael C. Morgan
|
| | Chairman of the Board | | |
January 22, 2021
|
|
|
*
Adam E. Daley
|
| | Director | | |
January 22, 2021
|
|
|
*
Alec Litowitz
|
| | Director | | |
January 22, 2021
|
|
|
*
C. Park Shaper
|
| | Director | | |
January 22, 2021
|
|
|
*
Desirée Rogers
|
| | Director | | |
January 22, 2021
|
|
| By: | | |
/s/ Eric Scheyer
Eric Scheyer
Attorney-in-fact |
|
Exhibit 5.1
609 Main Street
+1 (713) 836-3600
www.kirkland.com |
Facsimile:
|
January 22, 2021
Star Peak Energy Transition Corp.
1603 Orrington Avenue, 13th Floor
Evanston, Illinois 602
Ladies and Gentlemen:
We are acting as special counsel to Star Peak Energy Transition Corp., a Delaware corporation (the “Company”), in connection with the preparation and filing of a Registration Statement on Form S-4, which includes the Proxy Statement/Consent Solicitation Statement/Prospectus, originally filed with the Securities and Exchange Commission (the “Commission”) on December 17, 2020 (File No. 333-251397), under the Securities Act of 1933, as amended (the “Act”) (such Registration Statement, as amended or supplemented, is hereinafter referred to as the “Registration Statement”).
In connection with the transactions contemplated by that certain Agreement and Plan of Merger, dated as of December 3, 2020, by and among STPK Merger Sub Corp., the Company and Stem, Inc. (the “Merger Agreement”), the Company expects to issue 64,999,790 shares of its common stock, par value $0.0001 per share (the “Common Stock”). Such shares of Common Stock, when issued in accordance with the Merger Agreement, are referred to herein as the “Merger Shares” and the issuance of the Merger Shares is referred to herein as the “Issuance.”
In that connection, we have examined originals, or copies certified or otherwise identified to our satisfaction, of such documents, corporate records and other instruments as we have deemed necessary for the purposes of this opinion, including (i) the Merger Agreement attached to the Registration Statement as Annex A and filed as Exhibit 2.1 to the Registration Statement, (ii) the merger certificate prepared pursuant to the Merger Agreement and to be filed with the Secretary of State of the State of Delaware (the “Secretary”) prior to the Issuance (the “Merger Certificate”), (iii) the Amended and Restated Certificate of Incorporation of the Company in the form filed as Exhibit 3.1 to the Registration Statement, (iv) the Second Amended and Restated Certificate of Incorporation in the form attached to the Registration Statement as Annex B and filed as Exhibit 3.3 to the Registration Statement and to be filed with the Secretary prior to the Issuance (the “Charter”), (v) the Amended and Restated Bylaws (the “Bylaws”) of the Company attached to the Registration Statement as Annex C and filed as in the form filed as Exhibit 3.4 to the Registration Statement, (vi) resolutions of the board of directors and stockholders of the Company with respect to the Issuance (the “Resolutions”), and (vii) the Registration Statement.
Star Peak Energy Transition Corp. January 22, 2021 Page 2 |
For purposes of this opinion, we have assumed the authenticity of all documents submitted to us as originals, the conformity to the originals of all documents submitted to us as copies and the authenticity of the originals of all documents submitted to us as copies. We have also assumed the legal capacity of all natural persons, the genuineness of the signatures of persons signing all documents in connection with which this opinion is rendered, the authority of such persons signing on behalf of the parties thereto and the due authorization, execution and delivery of all documents by the parties thereto other than the Company. We have not independently established or verified any facts relevant to the opinion expressed herein, but have relied upon statements and representations of officers and other representatives of the Company and others as to factual matters.
Based upon and subject to the foregoing qualifications, assumptions and limitations and the further limitations set forth below, we are of the opinion that when (i) the Merger Certificate has been filed with and accepted by the Secretary, (ii) the Bylaws are adopted by the board of directors of the Company, (ii) the Charter is validly adopted and filed with the Secretary, (iii) the certificate evidencing the Merger Shares have been duly executed and authenticated in accordance with the provisions of the Merger Agreement and duly delivered to the stockholders of Stem, Inc. in exchange for their shares of common stock of Stem, Inc., (iv) the appropriate certificates representing the Merger Shares are duly countersigned and registered by the Company’s transfer agent/registrar and (v) the Registration Statement becomes effective under the Act, the Merger Shares will be duly authorized and validly issued, fully paid and nonassessable.
Our opinions expressed above are subject to the qualifications that we express no opinion as to the applicability of, compliance with, or effect of any laws except the General Corporation Law of the State of Delaware.
We hereby consent to the filing of this opinion with the Commission as Exhibit 5.1 to the Registration Statement. We also consent to the reference to our firm under the heading “Legal Matters” in the Registration Statement. In giving this consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Act or the rules and regulations of the Commission.
We do not find it necessary for the purposes of this opinion, and accordingly we do not purport to cover herein, the application of the securities or “Blue Sky” laws of the various states to the Offering.
This opinion is limited to the specific issues addressed herein, and no opinion may be inferred or implied beyond that expressly stated herein. We assume no obligation to revise or supplement this opinion should the General Corporation Law of the State of Delaware be changed by legislative action, judicial decision or otherwise.
This opinion is furnished to you in connection with the filing of the Registration Statement.
Sincerely,
/s/ Kirkland & Ellis LLP
KIRKLAND & ELLIS LLP
Exhibit 10.9
FINAL FORM
EXECUTIVE EMPLOYMENT AGREEMENT
This Executive Employment Agreement (the “Agreement”) is entered into as of [DATE], by and between [EXECUTIVE] (“Executive”) and Star Peak Energy Transition Corp., a Delaware corporation (the “Company”).
WHEREAS, Executive has been serving as the [POSITION] of Stem, Inc. (“Stem”) pursuant to that certain employment offer letter agreement, dated [●], by and between Stem and Executive (the “Prior Agreement”);
WHEREAS, Stem has entered into that certain Agreement and Plan of Merger, dated December 3, 2020, by and among the Company, STPK Merger Sub Corp., a Delaware corporation, a wholly-owned Subsidiary of the Company (“Merger Sub”), and the Company (such agreement, the “Merger Agreement”);
WHEREAS, pursuant to the terms of the Merger Agreement, Merger Sub will merge with and into Stem with Stem continuing as the surviving company and a wholly-owned subsidiary of the Company (the “Merger”), and following the consummation of the Merger, the Company will be named Stem, Inc.;
WHEREAS, the Company wishes to employ, and Executive wishes to accept employment with the Company, as the [POSITION] of the Company, pursuant to the terms and conditions set forth in this Agreement, effective as of the date of the consummation of the Merger (the “Effective Date”).
NOW, THEREFORE, in consideration of the mutual promises and covenants contained herein, it is hereby agreed by and between the parties hereto as follows:
ARTICLE I
DEFINITIONS
For purposes of the Agreement, the following terms are defined as follows:
1.1. “Board” means the Board of Directors of the Company.
1.2. “Cause” means a good faith determination by the Board that Executive’s employment be terminated for only one of the following: (i) willful failure to comply with, breach of or continued refusal to comply with, in each case, in any material respect, the material terms of this Agreement, of any written agreement or covenant with the Company or any affiliate (including, without limitation, any employment, consulting, confidentiality, non-competition, non-solicitation, non-disparagement or similar agreement or covenant); (ii) violation of any lawful policies, standards or regulations of the Company which have been furnished to Executive, including policies related to discrimination, harassment, performance of illegal or unethical activities, and ethical misconduct; (iii) indictment for, conviction of or plea of no contest to a felony under the laws of the United States or any state; (iv) fraud, embezzlement, dishonesty or breach of fiduciary duty against the Company or its affiliates or material misappropriation of property belonging to the Company or its affiliates; (v) Executive’s willful failure to perform Executive’s duties as specifically directed in any reasonable and lawful written directive of the Board; or (vi) willful misconduct or gross negligence in connection with the performance of Executive’s duties, in each case of (i), (v), (vi), after the receipt of written notice from the Board and Executive’s failure to cure (if curable) within thirty (30) days of Executive’s receipt of the written notice, providing that the Company must provide Executive with at least thirty (30) days to cure and if Executive cures, Cause shall not exist under (i), (v), (vi), as applicable.
1.3. “Change in Control” shall have the meaning ascribed to that term in the Stem, Inc. 2020 Equity Incentive Plan (the “Plan”) or any successor equity compensation plan of the Company.
1.4. “COBRA” means the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended.
1.5. “Code” means the Internal Revenue Code of 1986, as amended.
1.6. “Covered Termination” means (i) an Involuntary Termination Without Cause or (ii) a voluntary termination for Good Reason. For the avoidance of doubt, neither (x) the termination of Executive’s employment as a result of Executive’s death or Disability nor (y) the expiration of this Agreement due to non-renewal pursuant to the terms of Section 2.2 of this Agreement will be deemed to be a Covered Termination.
1.7. “Disability” shall mean a termination of Executive’s employment due to Executive’s absence from Executive’s duties with the Company on a full-time basis for at least 180 consecutive days as a result of Executive’s incapacity due to physical or mental illness which is determined to be total and permanent by a physician selected by the Company or its insurers.
1.8. “Good Reason” means any of the following taken without Executive’s written consent: (i) failure or refusal by the Company to comply in any material respect with the material terms of this Agreement, (ii) a material diminution in Executive’s duties, title, authority or responsibilities , (iii) a material reduction in Executive’s Base Salary (unless the annual base salary of all other executive officers is similarly reduced), or (iv) the Company requiring Executive to be located at any office or location more than 35 miles from the Company’s current headquarters in Millbrae, California, provided that any request or directive from the Company to not work in such office pursuant to any stay-at-home or work from home or similar law, order, directive, request or recommendation from a governmental entity shall not give rise to Good Reason under this Agreement. Notwithstanding the foregoing, Executive’s resignation shall not constitute a resignation for “Good Reason” as a result of any event described in the preceding sentence unless (x) Executive provides written notice thereof to the Company within thirty (30) days after the first occurrence of such event, (y) to the extent correctable, the Company fails to remedy such circumstance or event within thirty (30) days following the Company’s receipt of such written notice and (z) the effective date of Executive’s resignation for “Good Reason” is not later than ninety (90) days after the initial existence of the circumstances constituting Good Reason.
1.9. “Involuntary Termination Without Cause” means Executive’s dismissal or discharge by the Company other than for Cause or by reason of Executive’s death or Disability.
1.10. “Section 409A” means Section 409A of the Code and the Department of Treasury regulations and other interpretive guidance issued thereunder, including without limitation any such regulations or other guidance that may be issued after the Effective Date.
-2-
1.11. “Separation from Service” means Executive’s termination of employment constitutes a “separation from service” within the meaning of Treasury Regulation Section 1.409A-1(h).
ARTICLE II
EMPLOYMENT BY THE COMPANY
2.1. Position and Duties. Subject to terms set forth herein, Executive shall serve in an executive capacity and shall perform such duties as are customarily associated with the position of [POSITION] and such other duties as are assigned to Executive by the Board [and/or the Company’s Chief Executive Officer]. During the term of Executive’s employment with the Company, Executive will devote Executive’s best efforts and substantially all of Executive’s business time and attention (except for vacation periods and absences due to reasonable periods of illness or other incapacities permitted by the Company’s general employment policies or as otherwise set forth in this Agreement) to the business of the Company.
2.2. Term. The initial term of this Agreement shall commence on the Effective Date and shall terminate on the earlier of (i) the third (3rd) anniversary of the Effective Date and (ii) the termination of Executive’s employment under this Agreement; provided, that if the Merger is not consummated, this Agreement shall be null and void ab initio and neither the Company, Stem nor any other person shall have any liability to Executive under this Agreement. On the third (3rd) anniversary of the Effective Date and each annual anniversary of such date thereafter (in either case, provided Executive’s employment has not been terminated under this Agreement prior thereto), this Agreement shall automatically be extended for one additional year unless either Executive or the Company gives written notice of non-renewal to the other at least sixty (60) days prior to the automatic extension date. The period from the Effective Date until the earlier of (i) termination of Executive’s employment under this Agreement and (ii) the expiration of the term of this Agreement due to non-renewal pursuant to this Section 2.2 is referred to as the “Term.”
2.3. Employment at Will. The Company shall have the right to terminate Executive’s employment with the Company at any time, with or without cause, and, in the case of a termination by the Company, with or without prior notice. In addition to Executive’s right to resign for Good Reason, Executive shall have the right to resign at any time and for any reason or no reason at all, upon ninety (90) days’ advance written notice to the Company; provided, however, that if Executive has provided a resignation notice to the Company, the Company may determine, in its sole discretion, that such termination shall be effective on any date prior to the effective date of termination provided in such notice (and, if such earlier date is so required, then it shall not change the basis for Executive’s termination of employment nor be construed or interpreted as a termination of Executive’s employment by the Company) and any requirement to continue salary or benefits shall cease as of such earlier date. Upon certain terminations of Executive’s employment with the Company, Executive may become eligible to receive the severance benefits provided in Article IV of this Agreement.
2.4. Deemed Resignations. Except as otherwise determined by the Board or as otherwise agreed to in writing by Executive and the Company or any of its affiliates prior to the termination of Executive’s employment with the Company or any of its affiliates, any termination of Executive’s employment shall constitute, as applicable, an automatic resignation of Executive: (a) as an officer of the Company and each of its affiliates; (b) from the Board; and (c) from the board of directors or board of managers (or similar governing body) of any affiliate of the Company and from the board of directors or board of managers (or similar governing body) of any corporation, limited liability entity, unlimited liability entity or other entity in which the Company or any of its affiliates holds an equity interest and with respect to which board of directors or board of managers (or similar governing body) Executive serves as such designee or other representative of the Company or any of its affiliates. Executive agrees to take any further actions that the Company or any of its affiliates reasonably requests to effectuate or document the foregoing.
-3-
2.5. Employment Policies. The employment relationship between the parties shall also be governed by the general employment policies and practices of the Company, including those relating to protection of confidential information and assignment of inventions, except that when the terms of this Agreement differ from or are in conflict with the Company’s general employment policies or practices, this Agreement shall control.
ARTICLE III
COMPENSATION
3.1. Base Salary. As of the Effective Date, Executive shall receive for services to be rendered hereunder an annualized base salary of $________ (“Base Salary”), payable on the regular payroll dates of the Company (but no less often than monthly), subject to increase in the sole discretion of the Board or a committee of the Board.
3.2. Annual Bonus. For each calendar year ending during the Term, Executive shall be eligible to receive an annual performance bonus (the “Annual Bonus”) targeted at _________ percent (____%) of Base Salary or such other amount as determined in the sole discretion of the Board or a committee of the Board (the “Target Bonus”), on such terms and conditions determined by the Board or a committee of the Board. The actual amount of any Annual Bonus (if any) will be determined in the discretion of the Board or a committee of the Board and will be (i) subject to achievement of any applicable bonus objectives and/or conditions determined by the Board or a committee of the Board and (ii) subject to Executive’s continued employment with the Company through the date the Annual Bonus is paid (except as otherwise provided in Section 4.1). The Annual Bonus for any calendar year will be paid at the same time as bonuses for other Company executives are paid related annual bonuses generally.
3.3. Standard Company Benefits. During the Term, Executive shall be entitled to all rights and benefits for which Executive is eligible under the terms and conditions of the standard Company benefits and compensation practices that may be in effect from time to time and are provided by the Company to its executive employees generally, as well as any additional benefits provided to Executive consistent with past practice. Notwithstanding the foregoing, this Section 3.3 shall not create or be deemed to create any obligation on the part of the Company to adopt or maintain any benefits or compensation practices at any time.
3.4. Paid Time Off. During the Term, Executive shall be entitled to such periods of paid time off (“PTO”) each year as provided from time to time under the Company’s PTO policies and as otherwise provided for executive officers, as it may be amended from time to time.
-4-
3.5. Equity Awards. Executive will be eligible to receive equity incentive grants as determined by the Board or a committee of the Board in its sole discretion. All equity awards granted to Executive will be subject to the terms and conditions of the Company’s 2020 Equity Incentive Plan (the “LTIP”) and the applicable award agreement approved by the Board or a committee thereof (the “Award Agreements”), which shall be consistent with this Section 3.5. Nothing herein shall be construed to give any Executive any rights to any amount or type of grant or award except as provided in an award agreement and authorized by the Board or a committee thereof.
(a) Closing Grant. Promptly following the filing of the Form S-8 registration statement for the LTIP, Executive will receive a one-time grant of restricted stock units (“RSUs”) covering [__________] shares of the Company’s common stock (the “Closing Grant”), which Closing Grant shall vest as follows: [_____________].
(b) Annual Grant. Executive will be eligible to receive an annual equity award under the LTIP for the Company’s [____] fiscal year(s) in the form of RSUs having a grant date fair value equal to approximately $[_________], vesting 25% on each of the first four anniversaries of the grant date, subject to Executive’s continued employment with the Company through the applicable vesting date.
ARTICLE IV
SEVERANCE AND CHANGE IN CONTROL BENEFITS
4.1. Severance Benefits. Upon Executive’s termination of employment, Executive shall receive any accrued but unpaid Base Salary and other accrued and unpaid compensation, including any accrued but unpaid vacation. If the termination is due to a Covered Termination, provided that Executive (A) delivers an effective general release of all claims against the Company and its affiliates in a form provided by the Company (a “Release of Claims”) that becomes effective and irrevocable within sixty (60) days following the Covered Termination and (B) continues to comply with Articles V through VII of this Agreement, Executive shall be entitled to receive the severance benefits described in Section 4.1(a) or (b), as applicable.
(a) Covered Termination Not Related to a Change in Control. If Executive’s employment terminates due to a Covered Termination which occurs at any time other than during the period beginning three (3) months prior to a Change in Control and ending twelve (12) months after a Change in Control (the “CIC Protection Period”), Executive shall receive the following:
(i) An amount equal to [___] months of Executive’s Base Salary at the rate in effect (or required to be in effect before any diminution that is the basis of Executive’s termination for Good Reason) at the time of Executive’s termination of employment, payable in a lump sum payment, less applicable withholdings, as soon as administratively practicable following the date on which the Release of Claims becomes effective and, in any event, no later than the sixtieth (60th) day following the date of the Covered Termination; provided, however, if such sixty (60) day period falls in two different calendar years, payment will be made in the later calendar year.
-5-
(ii) Notwithstanding anything set forth in an award agreement or incentive plan to the contrary, (A) a pro-rata portion of Executive’s Annual Bonus for the fiscal year in which Executive’s termination occurs based on actual achievement of the applicable bonus objectives and/or conditions determined by the Board or a committee of the Board for such year (determined by multiplying the amount of the Annual Bonus that would be payable for the full fiscal year by a fraction, the numerator of which shall be equal to the number of days during the fiscal year of termination that Executive is employed by, and performing services for, the Company and the denominator of which is 365 days) and (B) the amount of any Annual Bonus earned, but not yet paid, for the fiscal year prior to Executive’s termination, in each case, payable, less applicable withholdings, at the same time bonuses for such year are paid to other senior executives of the Company, but in no event later than March 15 of the year following the year of Executive’s termination of employment.
(iii) Subject to Executive’s timely election of continuation coverage under COBRA, the Company shall directly pay, or reimburse Executive for the premium for Executive and Executive’s covered dependents to maintain continued health coverage pursuant to the provisions of COBRA through the earlier of (A) the [______] month anniversary of the date of Executive’s termination of employment and (B) the date Executive and Executive’s covered dependents, if any, become eligible for healthcare coverage under another employer’s plan(s). Notwithstanding the foregoing, if the Company is otherwise unable to continue to cover Executive under its group health plans without penalty under applicable law (including without limitation, Section 2716 of the Public Health Service Act), then, in either case, an amount equal to each remaining Company subsidy shall thereafter be paid to Executive in substantially equal monthly installments.
(iv) Accelerated vesting of the unvested portion of the Closing Grant that would have vested assuming that (i) the vesting schedule for the Closing Grant provided for annual vesting at a rate of [___]% per year on each anniversary of the Effective Date, and (ii) Executive remained employed by the Company through the date that is [__] months following the date of Executive’s termination of employment.
(b) Covered Termination Related to a Change in Control. If Executive’s employment terminates due to a Covered Termination that occurs during the CIC Protection Period, Executive shall receive the following:
(i) An amount equal to [____] times the sum of (i) Executive’s Base Salary at the rate in effect (or required to be in effect before any diminution that is the basis of Executive’s termination for Good Reason) at the time of Executive’s termination of employment and (ii) Executive’s Target Bonus in effect for the year in which Executive’s termination of employment occurs, payable in a lump sum payment, less applicable withholdings, as soon as administratively practicable following the date on which the Release of Claims becomes effective and, in any event, no later than the sixtieth (60th) day following the date of the Covered Termination; provided, however, if such sixty (60) day period falls in two different calendar years, payment will be made in the later calendar year.
(ii) Notwithstanding anything set forth in an award agreement or incentive plan to the contrary, (A) a pro-rata portion of Executive’s Annual Bonus for the fiscal year in which Executive’s termination occurs based on actual achievement of the applicable bonus objectives and/or conditions determined by the Board or a committee of the Board for such year (determined by multiplying the amount of the Annual Bonus that would be payable for the full fiscal year by a fraction, the numerator of which shall be equal to the number of days during the fiscal year of termination that Executive is employed by, and performing services for, the Company and the denominator of which is 365 days) and (B) the amount of any Annual Bonus earned, but not yet paid, for the fiscal year prior to Executive’s termination, in each case, payable, less applicable withholdings, at the same time bonuses for such year are paid to other senior executives of the Company, but in no event later than March 15 of the year following the year of Executive’s termination of employment.
-6-
(iii) Subject to Executive’s timely election of continuation coverage under COBRA, the Company shall directly pay, or reimburse Executive for the premium for Executive and Executive’s covered dependents to maintain continued health coverage pursuant to the provisions of COBRA through the earlier of (A) the [___]-month anniversary of the date of Executive’s termination of employment and (B) the date Executive and Executive’s covered dependents, if any, become eligible for healthcare coverage under another employer’s plan(s). Notwithstanding the foregoing, if the Company is otherwise unable to continue to cover Executive under its group health plans without penalty under applicable law (including without limitation, Section 2716 of the Public Health Service Act), then, in either case, an amount equal to each remaining Company subsidy shall thereafter be paid to Executive in substantially equal monthly installments.
(iv) Full vesting of any unvested portion of the Closing Grant.
4.2. 280G Provisions. Notwithstanding anything in this Agreement to the contrary, if any payment or distribution Executive would receive pursuant to this Agreement or otherwise (“Payment”) would (a) constitute a “parachute payment” within the meaning of Section 280G of the Code, and (b) but for this sentence, be subject to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”), then such Payment shall either be (i) delivered in full, or (ii) delivered as to such lesser extent which would result in no portion of such Payment being subject to the Excise Tax, whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes and the Excise Tax, results in the receipt by Executive on an after-tax basis, of the largest payment, notwithstanding that all or some portion of the Payment may be taxable under Section 4999 of the Code. The accounting firm engaged by the Company for general audit purposes as of the day prior to the effective date of the Change in Control shall perform the foregoing calculations. The Company shall bear all expenses with respect to the determinations by such accounting firm required to be made hereunder. The accounting firm shall provide its calculations to the Company and Executive within fifteen (15) calendar days after the date on which Executive’s right to a Payment is triggered (if requested at that time by the Company or Executive) or such other time as requested by the Company or Executive. Any good faith determinations of the accounting firm made hereunder shall be final, binding and conclusive upon the Company and Executive. Any reduction in payments and/or benefits pursuant to this Section 4.2 will occur in the following order: (1) reduction of cash payments; (2) cancellation of accelerated vesting of equity awards other than stock options; (3) cancellation of accelerated vesting of stock options; and (4) reduction of other benefits payable to Executive. Nothing in this Section 4.2 shall require the Company or any of its affiliates to be responsible for, or have any liability or obligation with respect to, Executive’s excise tax liabilities under Section 4999 of the Code.
-7-
4.3. Section 409A. Notwithstanding any provision to the contrary in this Agreement:
(a) All provisions of this Agreement are intended to comply with Section 409A of the Code, and the applicable Treasury regulations and administrative guidance issued thereunder (collectively, “Section 409A”) or an exemption therefrom and shall be construed and administered in accordance with such intent. Any payments under this Agreement that may be excluded from Section 409A either as separation pay due to an involuntary separation from service or as a short-term deferral shall be excluded from Section 409A to the maximum extent possible. Notwithstanding the foregoing, the Company makes no representations that the payments and benefits provided under this Agreement are exempt from, or compliant with, Section 409A and in no event shall the Company or any of its affiliates be liable for all or any portion of any taxes, penalties, interest or other expenses that may be incurred by Executive on account of non-compliance with Section 409A.
(b) If Executive is deemed at the time of Executive’s Separation from Service to be a “specified employee” for purposes of Section 409A(a)(2)(B)(i) of the Code, to the extent delayed commencement of any portion of the benefits to which Executive is entitled under this Agreement is required in order to avoid a prohibited distribution under Section 409A(a)(2)(B)(i) of the Code which would subject Executive to a tax obligation under Section 409A, such portion of Executive’s benefits shall not be provided to Executive prior to the earlier of (i) the expiration of the six- month period measured from the date of Executive’s Separation from Service or (ii) the date of Executive’s death. Upon the expiration of the applicable Code Section 409A(a)(2)(B)(i) period, all payments deferred pursuant to this Section 4.3(b) shall be paid in a lump sum to Executive, and any remaining payments due under the Agreement shall be paid as otherwise provided herein.
(c) Any reimbursements payable to Executive pursuant to the Agreement shall be paid to Executive no later than 30 days after Executive provides the Company with a written request for reimbursement, and to the extent that any such reimbursements are deemed to constitute “nonqualified deferred compensation” within the meaning of Section 409A (i) such amounts shall be paid or reimbursed to Executive promptly, but in no event later than December 31 of the year following the year in which the expense is incurred, (ii) the amount of any such payments eligible for reimbursement in one year shall not affect the payments or expenses that are eligible for payment or reimbursement in any other taxable year, and (iii) Executive’s right to such payments or reimbursement shall not be subject to liquidation or exchange for any other benefit; provided, that the foregoing clause shall not be violated with regard to expenses reimbursed under any arrangement covered by Section 105(b) of the Code solely because such expenses are subject to a limit related to the period in which the arrangement is in effect..
(d) For purposes of Section 409A (including, without limitation, for purposes of Treasury Regulation Section 1.409A-2(b)(2)(iii)), Executive’s right to receive installment payments under the Agreement shall be treated as a right to receive a series of separate payments and, accordingly, each installment payment hereunder shall at all times be considered a separate and distinct payment.
4.4. Mitigation. Executive shall not be required to mitigate damages or the amount of any payment provided under this Agreement by seeking other employment or otherwise, nor shall the amount of any payment provided for under this Agreement be reduced by any compensation earned by Executive as a result of employment by another employer or by any retirement benefits received by Executive after the date of the Covered Termination, or otherwise.
-8-
4.5. Equity Coordination. For the avoidance of doubt, all equity awards, including stock options, restricted stock units and other equity-based compensation granted by the Company to Executive under the Company’s equity-based compensation plans shall be subject to the terms of such plans and Executive’s equity award agreements with respect thereto.
ARTICLE V
PROPRIETARY INFORMATION AND CONFIDENTIALITY OBLIGATIONS
5.1. Proprietary Information. All Company Innovations shall be the sole and exclusive property of the Company without further compensation and are “works made for hire” as that term is defined under the United States copyright laws. Executive shall promptly notify the Company of any Company Innovations that Executive solely or jointly Creates. “Company Innovations” means all Innovations, and any associated intellectual property rights, which Executive may solely or jointly Create, during Executive’s employment with the Company, which (i) relate, at the time Created, to the Company’s business or actual or demonstrably anticipated research or development, or (ii) were developed on any amount of the Company’s time or with the use of any of the Company’s equipment, supplies, facilities or trade secret information, or (iii) resulted from any work Executive performed for the Company. Executive is notified that Company Innovations does not include any Innovation which qualifies fully under the provisions of California Labor Code Section 2870. “Create” means to create, conceive, reduce to practice, derive, develop or make. “Innovations” means processes, machines, manufactures, compositions of matter, improvements, inventions (whether or not protectable under patent laws), works of authorship, information fixed in any tangible medium of expression (whether or not protectable under copyright laws), mask works, trademarks, trade names, trade dress, trade secrets, know-how, ideas (whether or not protectable under trade secret laws), and other subject matter protectable under patent, copyright, moral rights, mask work, trademark, trade secret or other laws regarding proprietary rights, including new or useful art, combinations, discoveries, formulae, manufacturing techniques, technical developments, discoveries, artwork, software and designs. Executive hereby assigns (and will assign) to the Company all Company Innovations. Executive shall perform (at the Company’s expense), during and after Executive’s employment, all acts reasonably deemed necessary or desirable by the Company to assist the Company in obtaining and enforcing the full benefits, enjoyment, rights and title throughout the world in the Company Innovations. Such acts may include execution of documents and assistance or cooperation (i) in the filing, prosecution, registration, and memorialization of assignment of patent, copyright, mask work or other applications, (ii) in the enforcement of any applicable Proprietary Rights, and (iii) in other legal proceedings related to the Company’s Innovations. “Proprietary Rights” means patents, copyrights, mask work, moral rights, trade secrets and other proprietary rights. No provision in this Agreement is intended to require Executive to assign or offer to assign any of Executive’s rights in any invention for which Executive can establish that no trade secret information of the Company were used, and which was developed on Executive’s own time, unless the invention relates to the Company’s actual or demonstrably anticipated research or development, or the invention results from any work performed by Executive for the Company.
-9-
5.2. Confidentiality. In the course of Executive’s employment with the Company and the performance of Executive’s duties on behalf of the Company and its affiliates hereunder, Executive will be provided with, and will have access to, Confidential Information (as defined below). In consideration of Executive’s receipt and access to such Confidential Information, and as a condition of Executive’s employment, Executive shall comply with this Section 5.2
(a) Both during the Term and thereafter, except as expressly permitted by this Agreement, Executive shall not disclose any Confidential Information to any person or entity and shall not use any Confidential Information except for the benefit of the Company or its affiliates. Executive shall follow all Company policies and protocols regarding the security of all documents and other materials containing Confidential Information (regardless of the medium on which Confidential Information is stored). Except to the extent required for the performance of Executive’s duties on behalf of the Company or any of its affiliates, Executive shall not remove from facilities of the Company or any of its affiliates any information, property, equipment, drawings, notes, reports, manuals, invention records, computer software, customer information, or other data or materials that relate in any way to the Confidential Information, whether paper or electronic and whether produced by Executive or obtained by the Company or any of its affiliates. The covenants of this Section 5.2(a) shall apply to all Confidential Information, whether now known or later to become known to Executive during the period that Executive is employed by or affiliated with the Company or any of its affiliates.
(b) Notwithstanding any provision of Section 5.2(a) to the contrary, Executive may make the following disclosures and uses of Confidential Information:
(i) disclosures to other employees, officers or directors of the Company or any of its affiliates who have a need to know the information in connection with the businesses of the Company or any of its affiliates;
(ii) disclosures to customers and suppliers when, in the reasonable and good faith belief of Executive, such disclosure is in connection with Executive’s performance of Executive’s duties ;
(iii) disclosures and uses that are approved in writing by the Board; or
(iv) disclosures to a person or entity that has (x) been retained by the Company or any of its affiliates to provide services to the Company and/or its affiliates and (y) agreed in writing to abide by the terms of a confidentiality agreement.
(c) Upon the expiration of the Term, and at any other time upon request of the Company, Executive shall promptly and permanently surrender and deliver to the Company all documents (including electronically stored information) and all copies thereof and all other materials of any nature containing or pertaining to all Confidential Information and any other Company property (including any Company-issued computer, mobile device or other equipment) in Executive’s possession, custody or control and Executive shall not retain any such documents or other materials or property of the Company or any of its affiliates. Within ten (10) days of any such request, Executive shall certify to the Company in writing that all such documents, materials and property have been returned to the Company or otherwise destroyed.
-10-
(d) “Confidential Information” means all confidential, competitively valuable, non-public or proprietary information that is conceived, made, developed or acquired by or disclosed to Executive (whether conveyed orally or in writing), individually or in conjunction with others, during the period that Executive is employed or engaged by the Company or any of its affiliates (whether during business hours or otherwise and whether on the Company’s premises or otherwise) including: (i) technical information of the Company, its affiliates, its investors, customers, vendors, suppliers or other third parties, including computer programs, software, databases, data, ideas, know-how, formulae, compositions, processes, discoveries, machines, inventions (whether patentable or not), designs, developmental or experimental work, techniques, improvements, work in process, research or test results, original works of authorship, training programs and procedures, diagrams, charts, business and product development plans, and similar items; (ii) information relating to the Company or any of its affiliates’ businesses or properties, products or services (including all such information relating to corporate opportunities, operations, future plans, methods of doing business, business plans, strategies for developing business and market share, research, financial and sales data, pricing terms, evaluations, opinions, interpretations, acquisition prospects, the identity of customers or acquisition targets or their requirements, the identity of key contacts within customers’ organizations or within the organization of acquisition prospects, or marketing and merchandising techniques, prospective names and marks) or pursuant to which the Company or any of its affiliates owes a confidentiality obligation; and (iii) other valuable, confidential information and trade secrets of the Company, its affiliates, its customers or other third parties. Moreover, all documents, videotapes, written presentations, brochures, drawings, memoranda, notes, records, files, correspondence, manuals, models, specifications, computer programs, e-mail, voice mail, electronic databases, maps, drawings, architectural renditions, models and all other writings or materials of any type including or embodying any of such information, ideas, concepts, improvements, discoveries, inventions and other similar forms of expression are and shall be the sole and exclusive property of the Company or its other applicable affiliates and be subject to the same restrictions on disclosure applicable to all Confidential Information pursuant to this Agreement. For purposes of this Agreement, Confidential Information shall not include any information that (A) is or becomes generally available to the public other than as a result of a disclosure or wrongful act of Executive or any of Executive’s agents; (B) was available to Executive on a non-confidential basis before its disclosure by the Company or any of its affiliates; (C) becomes available to Executive on a non-confidential basis from a source other than the Company or any of its affiliates; provided, however, that such source is not bound by a confidentiality agreement with, or other obligation with respect to confidentiality to, the Company or any of its affiliates; or (D) is required to be disclosed by applicable law.
(e) Notwithstanding the foregoing, nothing in this Agreement shall prohibit or restrict Executive from lawfully: (i) initiating communications directly with, cooperating with, providing information to, causing information to be provided to, or otherwise assisting in an investigation by, any governmental authority regarding a possible violation of any law; (ii) responding to any inquiry or legal process directed to Executive from any such governmental authority; (iii) testifying, participating or otherwise assisting in any action or proceeding by any such governmental authority relating to a possible violation of law; or (iv) making any other disclosures that are protected under the whistleblower provisions of any applicable law. Additionally, pursuant to the federal Defend Trade Secrets Act of 2016, an individual shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that: (A) is made (1) in confidence to a federal, state or local government official, either directly or indirectly, or to an attorney and (2) solely for the purpose of reporting or investigating a suspected violation of law; (B) is made to the individual’s attorney in relation to a lawsuit for retaliation against the individual for reporting a suspected violation of law; or (C) is made in a complaint or other document filed in a lawsuit or proceeding, if such filing is made under seal. Nothing in this Agreement requires Executive to obtain prior authorization before engaging in any conduct described in this paragraph, or to notify the Company that Executive has engaged in any such conduct.
-11-
5.3. Nondisparagement. Subject to Section 5.2(e) above, Executive agrees that from and after the Effective Date, Executive will not, directly or indirectly, make, publish, or communicate any disparaging or defamatory comments regarding the Company, Magnetar Capital LLC, or any of their respective current or former directors, officers, members, managers, partners, or executives. The Company agrees that it will counsel its senior officers and directors to not make, publish, or communicate any disparaging or defamatory comments regarding Executive. The foregoing shall not be violated by truthful statements in response to legal process, required governmental testimony or filings or administrative or arbitral proceedings (including, without limitation, depositions in connection with such proceedings), and the foregoing limitation on the Company’s senior executives and directors shall not be violated by statements that they in good faith believe are necessary or appropriate to make in connection with performing their duties and obligations to the Company or any of its affiliates.
5.4. Remedies. Executive’s and the Company’s duties under this Article V shall survive termination of Executive’s employment with the Company and the termination of this Agreement. Because of the difficulty of measuring economic losses to the Company and its affiliates as a result of a breach or threatened breach of the covenants set forth in this Article V, Section 6.2 and Article VII, and because of the immediate and irreparable damage that would be caused to the Company and its affiliates for which they would have no other adequate remedy, Executive acknowledges that a remedy at law for any breach or threatened breach by Executive of Article V, as well as Executive’s obligations pursuant to Section 6.2 and Article VII below, would be inadequate, and Executive therefore agrees that the Company shall be entitled to seek injunctive relief in case of any such breach or threatened breach from any court of competent jurisdiction, without the necessity of showing any actual damages or that money damages would not afford an adequate remedy, and without the necessity of posting any bond or other security. The aforementioned equitable relief shall not be the Company’s or any of its affiliates’ exclusive remedy for a breach but instead shall be in addition to all other rights and remedies available to the Company and each of its affiliates at law and equity.
5.5. Modification. The covenants in this Article V, Section 6.2 and Article VII, and each provision and portion hereof, are severable and separate, and the unenforceability of any specific covenant (or portion thereof) shall not affect the provisions of any other covenant (or portion thereof). If it is determined by an arbitrator or a court of competent jurisdiction in any state that any restriction in this Article V, Section 6.2 and Article VII is excessive in duration or scope or is unreasonable or unenforceable under the laws of that state, it is the intention of the parties that such restriction may be modified or amended by the arbitrator or the court to render it enforceable to the maximum extent permitted by the law of that state.
-12-
ARTICLE VI
OUTSIDE ACTIVITIES
6.1. Other Activities.
(a) Except as otherwise provided in Section 6.1(b), Executive shall not, during the term of this Agreement undertake or engage in any other employment, occupation or business enterprise, other than ones in which Executive is a passive investor, unless Executive obtains the prior written consent of the Board.
(b) Executive may engage in civic and not-for-profit activities so long as such activities do not materially interfere with the performance of Executive’s duties hereunder. In addition, subject to advance approval by the Board, Executive shall be allowed to serve as a member of the board of directors of one (1) for-profit entity at any time during the term of this Agreement, so long as such service does not materially interfere with the performance of Executive’s duties hereunder; provided, however, that the Board, in its discretion, may require that Executive resign from such director position if it determines that such resignation would be in the best interests of the Company.
6.2. Competition/Investments. During the term of Executive’s employment by the Company, Executive shall not (except on behalf of the Company) directly or indirectly, whether as an officer, director, stockholder, partner, proprietor, associate, representative, consultant, or in any capacity whatsoever engage in, become financially interested in, be employed by or have any business connection with any other person, corporation, firm, partnership or other entity whatsoever which are known by Executive to compete directly with the Company or any of its affiliates, throughout the world, in any line of business engaged in (or planned to be engaged in) by the Company; provided, however, that anything above to the contrary notwithstanding, Executive may own, as a passive investor, securities of any competitor corporation, so long as Executive’s direct holdings in any one such corporation do not, in the aggregate, constitute more than 1% of the voting stock of such corporation.
6.3. Defense of Claims; Cooperation. During the Term and thereafter, upon reasonable request from the Company, Executive shall use commercially reasonable efforts to cooperate with the Company and its affiliates in the defense of any claims or actions that may be made by or against the Company or any of its affiliates that relate to Executive’s actual or prior areas of responsibility or knowledge. Executive shall further use commercially reasonable efforts to provide reasonable and timely cooperation in connection with any actual or threatened claim, action, inquiry, review, investigation, process, or other matter (whether conducted by or before any court, arbitrator, regulatory, or governmental entity, or by or on behalf of the Company or any of its affiliates), that relates to Executive’s actual or prior areas of responsibility or knowledge.
-13-
ARTICLE VII
NONINTERFERENCE
Executive shall not, during the term of Executive’s employment by the Company and, solely with respect to clause (ii) below, for twelve (12) months thereafter, either on Executive’s own account or jointly with or as a manager, agent, officer, employee, consultant, partner, joint venturer, owner or stockholder or otherwise on behalf of any other person, firm or corporation, directly or indirectly solicit, induce attempt to solicit any of (i) its customers or clients to terminate their relationship with the Company or to cease purchasing services or products from the Company or (ii) its officers or employees or offer employment to any person who is an officer or employee of the Company; provided, however, that a general advertisement to which an employee of the Company responds shall in no event be deemed to result in a breach of this Article VII. If it is determined by a court of competent jurisdiction in any state that any restriction in this Article VII is excessive in duration or scope or is unreasonable or unenforceable under the laws of that state, it is the intention of the parties that such restriction may be modified or amended by the court to render it enforceable to the maximum extent permitted by the law of that state.
ARTICLE VIII
GENERAL PROVISIONS
8.1. Notices. Any notices provided hereunder must be in writing and shall be deemed effective upon the earlier of personal delivery (including personal delivery by facsimile or electronic mail) or the third day after mailing by first class mail, to the Company at its primary office location and to Executive at Executive’s address as listed on the Company’s books and records.
8.2. Tax Withholding. Executive acknowledges that all amounts and benefits payable under this Agreement are subject to deduction and withholding to the extent required by applicable law.
8.3. Severability. Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability will not affect any other provision or any other jurisdiction, but this Agreement will be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provisions had never been contained herein.
8.4. Clawback. Amounts paid or payable under this Agreement shall be subject to the provisions of any applicable clawback policies or procedures adopted by the Company or any of its affiliates applicable to Executive, which clawback policies or procedures may provide for forfeiture and/or recoupment of amounts paid or payable under this Agreement. Notwithstanding any provision of this Agreement to the contrary, the Company and each of its affiliates reserves the right, without the consent of Executive, to adopt any such clawback policies and procedures, including such policies and procedures applicable to this Agreement with retroactive effect.
8.5. Waiver. Any waiver of this Agreement must be executed by the party to be bound by such waiver. If either party should waive any breach of any provisions of this Agreement, they shall not thereby be deemed to have waived any preceding or succeeding breach of the same or any other provision of this Agreement or any similar or dissimilar provision or condition at the same or any subsequent time. The failure of either party hereto to take any action by reason of any breach will not deprive such party of the right to take action at any time.
-14-
8.6. Complete Agreement. This Agreement constitutes the entire agreement between Executive and the Company and is the complete, final, and exclusive embodiment of their agreement with regard to this subject matter, and will supersede all prior agreements, understandings, discussions, negotiations and undertakings, whether written or oral, between the parties with respect to the subject matter hereof (including, for the avoidance of doubt, the Prior Agreement), including that certain Employment Agreement Term Sheet, dated [●], 2020, by and between Executive and the Company. This Agreement is entered into without reliance on any promise or representation other than those expressly contained herein or therein, and cannot be modified or amended except in a writing signed by a duly-authorized officer of the Company and Executive.
8.7. Counterparts. This Agreement may be executed in separate counterparts, any one of which need not contain signatures of more than one party, but all of which taken together will constitute one and the same Agreement.
8.8. Headings. The headings of the sections hereof are inserted for convenience only and shall not be deemed to constitute a part hereof nor to affect the meaning thereof.
8.9. Successors and Assigns. This Agreement is intended to bind and inure to the benefit of and be enforceable by Executive and the Company, and their respective successors, assigns, heirs, executors and administrators, except that Executive may not assign Executive’s rights or delegate Executive’s duties or obligations hereunder without the prior written consent of the Company.
8.10. Effect of Termination. The provisions of Section 2.4 and Articles IV, V, VII and VIII and those provisions necessary to interpret and enforce them, shall survive any termination of this Agreement and any termination of the employment relationship between Executive and the Company.
8.11. Third-Party Beneficiaries. Each affiliate of the Company that is not a signatory to this Agreement shall be a third-party beneficiary of Executive’s obligations under Sections 2.4 and 8.14 and Articles V, VI and VII and shall be entitled to enforce such obligations as if a party hereto.
8.12. Executive Acknowledgement. Executive acknowledges and agrees that (a) Executive was represented by counsel in connection with the negotiation of this Agreement, and (b) that Executive has read and understands the Agreement, is fully aware of its legal effect, and has entered into it freely based on Executive’s own judgment.
8.13. Choice of Law. All questions concerning the construction, validity and interpretation of this Agreement will be governed by the law of the State of California without regard to the conflicts of law provisions thereof. With respect to any claim or dispute related to or arising under this Agreement, the parties hereby consent to the arbitration provisions of Section 8.14 and recognize and agree that should any resort to a court be necessary and permitted under this Agreement, then they consent to the exclusive jurisdiction, forum and venue of the state and federal courts (as applicable) located in California.
-15-
8.14. Arbitration.
(a) Subject to Section 8.14(b), any dispute, controversy or claim between Executive and the Company or any of its affiliates arising out of or relating to this Agreement or Executive’s employment or engagement with the Company or any of its affiliates (“Disputes”) will be finally settled by confidential arbitration in the State of California in accordance with the then-existing American Arbitration Association (“AAA”) Employment Arbitration Rules. The arbitration award shall be final and binding on both parties. Any arbitration conducted under this Section 8.14 shall be private, shall be heard by a single arbitrator (the “Arbitrator”) selected in accordance with the then-applicable rules of the AAA and shall be conducted in accordance with the Federal Arbitration Act. The Arbitrator shall expeditiously hear and decide all matters concerning the Dispute. Except as expressly provided to the contrary in this Agreement, the Arbitrator shall have the power to (i) gather such materials, information, testimony and evidence as the Arbitrator deems relevant to the Dispute before him or her (and each party will provide such materials, information, testimony and evidence requested by the Arbitrator), and (ii) grant injunctive relief and enforce specific performance. All Disputes shall be arbitrated on an individual basis, and each party hereto hereby foregoes and waives any right to arbitrate any Dispute as a class action or collective action or on a consolidated basis or in a representative capacity on behalf of other persons or entities who are claimed to be similarly situated, or to participate as a class member in such a proceeding. The decision of the Arbitrator shall be reasoned, rendered in writing, be final and binding upon the disputing parties and the parties agree that judgment upon the award may be entered by any court of competent jurisdiction. The parties acknowledge and agree that in connection with any such arbitration and regardless of outcome, except as provided under this Section 8.14, each party will pay all of its own costs and expenses, including its own legal fees and expenses, and the arbitration costs will be shared equally by the Company and Executive.
(b) Notwithstanding Section 8.14(a), either party may make a timely application for, and obtain, judicial emergency or temporary injunctive relief to enforce any of the provisions of Articles V through VII; provided, however, that the remainder of any such Dispute (beyond the application for emergency or temporary injunctive relief) shall be subject to arbitration under this Section 8.14.
(c) By entering into this Agreement and entering into the arbitration provisions of this Section 8.14, THE PARTIES EXPRESSLY ACKNOWLEDGE AND AGREE THAT THEY ARE KNOWINGLY, VOLUNTARILY AND INTENTIONALLY WAIVING THEIR RIGHTS TO A JURY TRIAL.
(d) Nothing in this Section 8.14 shall prohibit a party to this Agreement from (i) instituting litigation to enforce any arbitration award, or (ii) joining the other party to this Agreement in a litigation initiated by a person or entity that is not a party to this Agreement. Further, nothing in this Section 8.14 precludes Executive from filing a charge or complaint with a federal, state or other governmental administrative agency.
[Signature page follows]
-16-
In Witness Whereof, the parties have executed this Agreement as of the date first written above.
STAR PEAK ENERGY TRANSITION CORP. | ||
By: | ||
[____________] | ||
Title: [____________] | ||
Accepted and Agreed: | ||
[_________________] |
Signature Page to Executive Employment Agreement
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Proxy Statement constituting a part of this Registration Statement Amendment No. 1 on Form S-4 of our report dated July 31, 2020, relating to the financial statements of Star Peak Energy Transition Corp. which is contained in that Proxy Statement, and to the reference to our Firm under the caption “Experts” in the proxy statement/prospectus.
/s/ WithumSmith+Brown, PC | |
New York, New York | |
January 19, 2021 |
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Registration Statement on Form S-4 of our report dated December 16, 2020 (January 22, 2021 as to the effects of the immaterial correction of errors discussed in Note 2), relating to the consolidated financial statements of Stem, Inc. We also consent to the reference to us under the heading "Experts" in such Registration Statement.
/s/DELOITTE & TOUCHE LLP
San Jose, California
January 22, 2021
| |
BOX A — Signature of Registered Stockholder(s)
|
| |
| |
(Must be signed by all registered stockholders.
Include legal capacity if signing on behalf of an entity.) |
| |
| | By signing below, I/we certify that I/we agree to the terms and conditions set forth in this Letter of Transmittal, have complied with all instructions to this Letter of Transmittal, was/were the registered holder of the Company Stock submitted herewith immediately prior to the Effective Time, have full authority to surrender the Company Stock and give the instructions in this Letter of Transmittal and warrant that the Company Stock submitted herewith are free and clear of all Liens (except, if applicable, pursuant to restrictions on transfer under applicable Securities Law). | | |
| |
Signature
|
| |
| |
Signature
|
| |
| |
Telephone Number and/or Email Address
|
| |
| | | | |
| |
BOX B
COMPANY STOCK SURRENDERED |
| | ||||||||
| |
Certificate #
|
| | |
Type and Series of
Company Stock |
| | |
# of Shares
|
| |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| |
TOTAL:
|
| | | | | | | | | |
| |
BOX C — One Time Delivery Instructions
|
| |
| |
To be completed ONLY if the check is to be
delivered to an address other than that listed in Box D. MAIL TO: |
| |
| |
Name
|
| |
| |
Street Address
|
| |
| |
City, State and Zip Code
|
| |
| | | | |
| |
BOX D — Name and Address of Registered
Stockholder(s) |
| |
| |
|
| |
| | Name: | | |
| | Address: | | |
|
Dated:
|
| |
Signature:
|
|
| | | |
Print Name:
|
|
Exhibit 99.2
Star Peak Energy Transition Corp.
Continental Stock Transfer & Trust
Company
One State Street, 30th Floor
New York, New York 10004
SPECIAL MEETING IN LIEU OF 2021 ANNUAL MEETING OF STOCKHOLDERS OF
STAR PEAK ENERGY TRANSITION CORP.
YOUR VOTE IS IMPORTANT
THIS PROXY IS SOLICITED BY THE BOARD
OF DIRECTORS
FOR THE SPECIAL MEETING IN LIEU OF 2021 ANNUAL MEETING OF STOCKHOLDERS
TO BE HELD VIRTUALLY VIA LIVE AUDIO WEBCAST ON , 2021.
Important Notice Regarding the Availability
of
Proxy Material for the Special Meeting of Shareholders to be held on , 2021
are available at: https://www.cstproxy.com/starpeakcorp/2021
Vote Virtually at the Meeting — If you plan to attend the virtual Special Meeting, you will need your 12 digit control number printed on this proxy card to vote electronically at the Special Meeting. To attend, please access the following URL address: https://www.cstproxy.com/starpeakcorp/2021.
CONTROL NUMBER | |
P
R
O
X
Y
C
A
R
D
|
The undersigned, revoking any previous proxies relating to these shares, hereby acknowledges receipt of the Notice and Proxy Statement/Consent Solicitation Statement/Prospectus, dated , 2021 in connection with the Special Meeting in lieu of the 2021 annual meeting of stockholders (the “Special Meeting”) to be held virtually, conducted via live audio webcast, at Eastern Time on , 2021, and hereby appoints [Eric Scheyer and Michael D. Wilds], and each of them (with full power to act alone), the attorneys and proxies of the undersigned, with power of substitution to each, to vote all ordinary shares of Star Peak Energy Transition Corp. (“STPK”) registered in the name provided, which the undersigned is entitled to vote at the Special Meeting, and at any adjournments thereof, with all the powers the undersigned would have if personally present. Without limiting the general authorization hereby given, said proxies are, and each of them is, instructed to vote or act as follows on the proposals set forth in the accompanying Proxy Statement/Consent Solicitation Statement/Prospectus.
THIS PROXY, WHEN EXECUTED, WILL BE VOTED IN THE MANNER DIRECTED HEREIN. IF NO DIRECTION IS MADE, THIS PROXY WILL BE VOTED “FOR” PROPOSAL NO. 1, PROPOSAL NO. 2, PROPOSAL NO. 3, PROPOSAL NO. 4, PROPOSAL NO. 5, PROPOSAL NO. 6, PROPOSAL NO. 7, PROPOSAL NO. 8, PROPOSAL NO. 9, PROPOSAL NO. 10 AND, IF NECESSARY, PROPOSAL NO. 11.
|
(Continued and to be marked, dated and signed on reverse side)
Please mark vote as indicated in this example | x | THE BOARD OF DIRECTORS RECOMMENDS A VOTE “FOR” PROPOSAL NOS. 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 AND 11. |
Proposal No. 1 — The Business Combination Proposal — To consider and vote upon a proposal to approve the Agreement and Plan of Merger, dated as of December 3, 2020 (as it may be amended and/or restated from time to time, the “Merger Agreement”), by and among Stem, Inc., a Delaware corporation (“Stem” or the “Company”), STPK and STPK Merger Sub Corp., a Delaware corporation (“Merger Sub”) and the transactions contemplated thereby, pursuant to which Merger Sub will merge with and into Stem with Stem surviving the merger as a wholly owned subsidiary of STPK (the “Merger”). |
FOR
¨
|
AGAINST
¨
|
ABSTAIN
¨
|
The Charter Proposals — To consider and vote upon the following seven separate proposals (collectively, the “Charter Proposals”) to approve the following material differences between the current amended and restated certificate of incorporation of STPK (the “Existing Charter”) and the proposed amended and restated certificate of incorporation of STPK (the “Proposed Charter”) that will be in effect upon the closing of the Merger. | |||
Proposal No. 2 — to increase the number of authorized shares of New Stem (as defined in the accompanying Proxy Statement/Consent Solicitation Statement/Prospectus) common stock from 400,000,000 to 500,000,000 and to authorize the issuance of up to 1,000,000 shares of New Stem preferred stock. |
FOR
¨
|
AGAINST
¨
|
ABSTAIN
¨
|
Proposal No. 3 — to eliminate the Class B Common Stock classification and provide for a single class of common stock. |
FOR
¨
|
AGAINST
¨
|
ABSTAIN
¨
|
Proposal No. 4 — to provide that the number of authorized shares of common stock or preferred stock may be increased or decreased by the affirmative vote of the holders of at least a majority of the voting power of the stock outstanding and entitled to vote thereon irrespective of the provisions of Section 242(b)(2) of the Delaware General Corporation Law. |
FOR
¨
|
AGAINST
¨
|
ABSTAIN
¨
|
Proposal No. 5 — to provide that any director, or the entire board, may be removed from office at any time, but only for cause and only by the affirmative vote of at least 66 2/3% of the voting power of the stock outstanding and entitled to vote thereon. |
FOR
¨
|
AGAINST
¨
|
ABSTAIN
¨
|
Proposal No. 6 — to provide that amendments to STPK’s waiver of corporate opportunities will be prospective only and provide certain other clarificatory amendments to the waiver of corporate opportunities provision. |
FOR
¨
|
AGAINST
¨
|
ABSTAIN
¨
|
Proposal No. 7 — to provide that the vote of 66 2∕3% of the voting power of the stock outstanding and entitled to vote thereon, voting together as a single class, shall be required to adopt, amend or repeal the bylaws or any provision of the Proposed Charter inconsistent with Section 5.2 of Article V (classification of the board of directors), Article VI (Stockholder Action), Article VIII (Amendment), Article IX (Liability of Directors), Article X (Corporate Opportunity) or Article XI (Forum for Adjudication of Disputes) (Proposal No. 7). |
FOR
¨
|
AGAINST
¨
|
ABSTAIN
¨
|
Proposal No. 8 — conditioned upon the approval of Proposals No. 2 through 7 above, a proposal to approve the Proposed Charter, which includes the approval of all other changes in the Proposed Charter in connection with replacing the Existing Charter with the Proposed Charter, including changing STPK’s name from “Star Peak Energy Transition Corp.” to “Stem, Inc.” as of the closing of the merger. |
FOR
¨
|
AGAINST
¨
|
ABSTAIN
¨
|
Proposal No. 9 — The NYSE Proposal — To consider and vote upon a proposal to approve, for purposes of complying with applicable listing rules of the New York Stock Exchange: (i) the issuance of shares of New Stem Common Stock immediately following the consummation of the merger) pursuant to the PIPE Agreements (as defined in the accompanying Proxy Statement/Consent Solicitation Statement/Prospectus); (ii) the issuance of shares of New Stem Common Stock pursuant to the Merger Agreement; and (iii) the related change of control of STPK that will occur in connection with consummation of the merger and the other transactions contemplated by the Merger Agreement and PIPE Agreements. |
FOR
¨
|
AGAINST
¨ |
ABSTAIN
¨
|
Proposal No. 10 — The Incentive Plan Proposal — To consider and vote upon a proposal to approve and adopt the Incentive Plan (as defined in the accompanying Proxy Statement/Consent Solicitation Statement/Prospectus). |
FOR
¨
|
AGAINST
¨
|
ABSTAIN
¨
|
Proposal No. 11 — The Adjournment Proposal — To consider and vote upon a proposal to adjourn the STPK Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the STPK Special Meeting, there are not sufficient votes to approve the Business Combination Proposal, the Charter Proposals, the NYSE Proposal or the Incentive Plan Proposal, or holders of STPK’s Class A Common Stock have elected to redeem an amount of Class A Common Stock such that STPK would have less than $5,000,001 of net tangible assets. |
FOR
¨
|
AGAINST
¨
|
ABSTAIN
¨
|
Dated: | , 2021 | |
(Signature) | ||
(Signature if held Jointly) | ||
Signature should agree with name printed hereon. If stock is held in the name of more than one person, EACH joint owner should sign. Executors, administrators, trustees, guardians and attorneys should indicate the capacity in which they sign. Attorneys should submit powers of attorney. | ||
PLEASE SIGN, DATE AND RETURN THE PROXY IN THE ENVELOPE ENCLOSED TO CONTINENTAL STOCK TRANSFER & TRUST COMPANY. THIS PROXY WILL BE VOTED IN THE MANNER DIRECTED HEREIN BY THE UNDERSIGNED SHAREHOLDER. IF NO DIRECTION IS MADE, THIS PROXY WILL BE VOTED “FOR” THE PROPOSAL SET FORTH IN PROPOSAL NOS. 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 AND 11 AND WILL GRANT DISCRETIONARY AUTHORITY TO VOTE UPON SUCH OTHER MATTERS AS MAY PROPERLY COME BEFORE THE MEETING OR ANY ADJOURNMENTS THEREOF. THIS PROXY WILL REVOKE ALL PRIOR PROXIES SIGNED BY YOU. |
Exhibit 99.3
Final Form
ACTION BY WRITTEN CONSENT OF THE STOCKHOLDERS
OF
STEM, INC.
(a Delaware corporation)
In accordance with Section 228 of the Delaware General Corporation Law (the “DGCL”), the Company’s Ninth Amended and Restated Certificate of Incorporation (as amended, the “Certificate of Incorporation”) and the amended and restated bylaws, of Stem, Inc., a Delaware corporation (the “Company”), the undersigned stockholders, representing at least the Requisite Threshold (as defined in the Certificate of Incorporation), voting together as a single class on an as converted to Common Stock basis, hereby adopt and approve the following resolutions by their written consent without a formal meeting and direct that this Action by Written Consent (this “Written Consent”) be filed with the minutes of the proceedings of the stockholders of the Company and that the resolutions set forth below shall have the same force and effect as if they were adopted at a meeting at which the undersigned were personally present, effective as of the date upon which the last required consent was obtained:
Approval of the Merger Agreement, the Merger and the Transactions Contemplated Thereby
WHEREAS, the Board of Directors of the Company (the “Board”) has unanimously approved and declared advisable, fair to, and in the best interests of the Company and the Company’s stockholders that the Company enter into a proposed transaction, whereby Star Peak Energy Transition Corp., a Delaware corporation (“STPK”), will acquire the Company by means of a merger of STPK Merger Sub Corp., a Delaware corporation and a wholly owned subsidiary of STPK (“Merger Sub”), with and into the Company, with the Company continuing as the surviving corporation of such merger and as a wholly-owned subsidiary of STPK (the “Merger”), and the Board has unanimously recommended that the stockholders of the Company adopt the Merger Agreement (as defined below) and approve the Merger and the other transactions contemplated by the Merger Agreement;
WHEREAS, capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Merger Agreement;
WHEREAS, the Merger is to be effected pursuant to the terms and conditions of an Agreement and Plan of Merger attached hereto as Exhibit A (collectively with all of the schedules, exhibits and attachments thereto, the “Merger Agreement”) by and among STPK, the Company and Merger Sub;
WHEREAS, upon the terms and subject to the conditions of the Merger Agreement, at the Effective Time of the Merger, each share of Common Stock of the Company that is issued and outstanding immediately prior to the Effective Time (for the avoidance of doubt, after giving effect to the Company Preferred Conversion, the Convertible Notes Conversion and the Company Warrant Exercise), shall be canceled and converted into and become the right to receive [ ] shares of common stock of STPK (or an aggregate amount equal to 65,000,000 shares less the amount of shares that would be issuable upon the exercise of all STPK Options, whether vested or unvested), with the aggregate value of all such shares of common stock of STPK issued in the merger to be approximately $650,000,000;
WHEREAS, the undersigned stockholders of the Company, after careful consideration of the terms and conditions of the Merger Agreement, the Merger and the other transactions contemplated thereby, have determined that the Merger Agreement, the Merger and the other transactions contemplated thereby are fair to and in the best interests of the Company and its stockholders, and desire to adopt and approve the Merger Agreement and the Merger;
1
WHEREAS, reference is made to that certain (a) Fifth Amended and Restated Investor Rights Agreement, dated as of June 18, 2019 (as amended, the “Investor Rights Agreement”), by and among the Company and certain stockholders thereof, (b) Fifth Amended and Restated Right of First Refusal and Co-Sale Agreement, dated as of June 18, 2019 (as amended, the “ROFR Agreement”), by and among the Company and certain stockholders thereof and (c) Fifth Amended and Restated Voting Agreement, dated as of June 18, 2019 (as amended, the “Voting Agreement”), by and among the Company and certain stockholders thereof; and
WHEREAS, the undersigned constituting a Requisite Threshold (as defined in each of the Investor Rights Agreement and ROFR Agreement, respectively) desire to (a) terminate the Investor Rights Agreement effective as of the Effective Time pursuant to Section 6.1 thereof and (b) terminate the ROFR Agreement as of the Effective Time pursuant to Section 7.1 thereof.
NOW, THEREFORE, BE IT RESOLVED, that the Merger Agreement and the transactions contemplated thereby, including the Merger, are hereby consented to, adopted and approved in accordance with the DGCL; and that the Company be, and hereby is, authorized, directed and empowered to (i) enter into and perform its obligations under the Merger Agreement and (ii) enter into and/or perform its obligations under each other agreement, instrument, document or certificate required or permitted to be entered into by the Company under the terms of the Merger Agreement;
RESOLVED, FURTHER, that conditioned upon consummation of the Merger, the Investor Rights Agreement and ROFR Agreement are hereby terminated effective as of the Effective Time;
RESOLVED, FURTHER, that the officers of the Company be, and each of them hereby is, authorized and directed, on behalf and in the name of the Company and its subsidiaries, to do or cause to be done any and all such further acts and things and to execute and deliver any and all such additional agreements, certificates, documents and instruments as any such officer may deem necessary or appropriate in connection with the transactions contemplated by the Merger Agreement;
RESOLVED, FURTHER, that the officers of the Company be, and each of them hereby is, authorized and directed, on behalf and in the name of the Company and its subsidiaries, to cause to be prepared, executed and filed with the appropriate foreign, federal, state or local governmental authorities or instrumentalities, such registrations, declarations or other filings as any such officer may deem necessary or desirable or as may be required by such governmental authorities or instrumentalities in connection with the transactions contemplated by the Merger Agreement; and
RESOLVED, FURTHER, that the Board of Directors be, and hereby is, authorized and empowered to amend the Merger Agreement and take any other action with respect to the Merger Agreement permitted under the DGCL, as the Board of Directors may, in the exercise of its discretion, deem advisable, appropriate and in the best interests of the Company and its stockholders.
2
Approval of the Conversion of Senior Preferred Stock
WHEREAS, the Merger Agreement contemplates that stockholders of the Company who, collectively, represent at least the Requisite Threshold will execute and deliver to the Company an irrevocable written consent in order to effect a conversion of all of the Senior Preferred Stock to Common Stock of the Company immediately prior to the effective time of the Merger in accordance with Article V, Section 4(b) of the Certificate of Incorporation, with the effective time for such conversion to be conditioned upon the satisfaction of the conditions to the parties’ obligations in the Merger Agreement;
WHEREAS, pursuant to Article V, Section 4(b) of the Certificate of Incorporation, all outstanding shares of Senior Preferred Stock shall automatically convert into shares of Common Stock of the Company upon the vote or written consent or agreement of the stockholders of the Company representing the Requisite Threshold (voting together as a single class on an as-converted to Common Stock basis);
WHEREAS, in connection with the Merger Agreement, the undersigned stockholders desire to convert all shares of Senior Preferred Stock outstanding and held of record by such stockholder of the Company into shares of Common Stock of the Company in accordance with Article V, Section 4(b) of the Certificate of Incorporation, immediately prior to, and conditioned upon, the occurrence of the effective time of the Merger; and
WHEREAS, after giving effect to the Company Preferred Conversion, the Voting Agreement shall automatically terminate pursuant to Section 5.1 thereof.
NOW, THEREFORE, BE IT RESOLVED, that all of the existing Senior Preferred Stock be converted into shares of Common Stock of the Company, in accordance with the Certificate of Incorporation, with such conversion to be subject to, and effective immediately prior to, the occurrence of the effective time of the Merger;
RESOLVED FURTHER, any and all other rights, notices, procedures or entitlements contained in the Certificate of Incorporation applicable to such conversion that may be inconsistent with the Merger Agreement and these resolutions are hereby waived; and
RESOLVED FURTHER, that the appropriate officers of the Company are hereby authorized and directed to execute any and all documents necessary to effect the conversion of the Senior Preferred Stock as contemplated by these resolutions.
General Resolutions
RESOLVED, that the officers of the Company be, and each of them hereby is, authorized and empowered to take any and all such further action, to execute and deliver any and all such further agreements, instruments, documents and certificates and to pay such expenses, in the name and on behalf of the Company or such officer, as any such officer may deem necessary or advisable to effectuate the purposes and intent of the resolutions hereby adopted, the taking of such actions, the execution and delivery of such agreements, instruments, documents and certificates and the payment of such expenses by any such officer to be conclusive evidence of the Company’s authorization hereunder and approval thereof;
RESOLVED FURTHER, that any and all actions taken by the directors or officers of the Company to carry out the purposes and intent of the foregoing resolutions prior to their adoption are approved, ratified and confirmed in all respects; and
RESOLVED FURTHER, that this Written Consent may be signed in counterparts, including counterparts delivered by facsimile, email or other electronic means, all of which taken together shall constitute one and the same instrument.
3
[Signature Pages to Follow]
4
IN WITNESS WHEREOF, this Action by Written Consent of the Stockholders has been executed by the undersigned stockholder. This Action by Written Consent of the Stockholders shall be effective immediately following the execution of the Merger Agreement by the parties thereto. This Action by Written Consent and Release of the Stockholders shall be irrevocable.
INVESTOR: | |
By: | |
Name: | |
Title: |
EXHIBIT A
AGREEMENT AND PLAN OF MERGER